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ABBREVIATIONS, SYMBOLS AND DEFINITIONS 
A absorbance 
ANS 8-anilino-1-naphthalene sulphonate 
BSP bromosulphophthalein 
CDNB 1-chloro-2,4-dinitrobenzene 
CM-cellulose - carboxymethylcellulose 
Cys cysteine 
DCNB 1,2-dichloro-4-nitrobenzene 
DEAE-cellulose - diethylaminoethylcellulose 
DME 1,2-dimethoxyethane 
DMSO dimethylsulphoxide 
DNA deoxyribonucleic acid 














K A app 
K 
enzyme 
molar extinction coefficient (M-1cm-1) 
ethylene dibromide 
ethylenediaminetetraacetate 





high pressure liquid chromatography 
inhibitor 
[I] causing 50% inhibition of enzyme activity under specified conditions. 
- (apparent Km) [A] required for Y2 V max at specified finite [B] (similarly for KB a ) 
(inhibitor constant) dissociation constant of EI complex PP 
lll 
I 
Km (Michaelis constant) [S] required for Vi V max - for reactions involving two substrates (A & B), KA 
is used to represent [A] required for Y2 V max when [B] is extrapolated to infinity (similarly for KB) 
k k 




velocity constants for the forward and backward reactions in the nth step of an enzymic reaction. 
rate constant for the breakdown of ES to E + P 





microperoxidase-X; X = number of amino acid residues of cytochrome-c retained in haempeptide 









revolutions per minute 
substrate 
standard deviation 
sodium dodecyl sulphate 
sodium dodecyl sulphate polyacrylamide-gel electrophoresis 














( enzyme activity units) one unit is the amount of E catalysing the formation of 1 µmol of P per min under 
the conditions of the specific assay (µmol/min/ml). 
ultraviolet 
initial velocity of appearance of P or disappearance of S at a given [S] 
maximum initial velocity when E is saturated with S, in the absence of I 
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SUMMARY 
The glutathione S-transferases are a group of enzymes which catalyse the 
conjugation of reduced glutathione with a variety of electrophilic molecules, and 
they are therefore thought to play a major role in drug biotransformation and the 
detoxification of xenobiotics [39,179]. The cytosolic GSH S-transferase 
isoenzymes of rat, man and mouse have been assigned to three groups, Alpha, Mu 
and Pi, based on N-terrninal amino acid sequences, substrate specificities, 
immunological cross-reactivity and sensitivities to inhibitors [182]. 
The kinetic mechanism of the GSH S-transferases is controversial, due to the 
observation of non-Michaelian (non-hyperbolic) substrate-rate saturation curves. 
The most detailed investigations of the steady-state kinetics of glutathione 
S-transferase have been performed with isoenzyme 3-3 ( class Mu) and the 
substrate 1,2-dichloro-4-nitrobenzene (DCNB) [12,215]. Explanations for the 
apparently anomalous non-hyperbolic kinetics have included subunit co-
operativity, steady-state mechanisms of differing degrees of complexity and the 
superimposition of either product inhibition or enzyme memory on these 
mechanisms [39,179]. 
This study has confirmed the biphasic kinetics for isoenzyme 3-3 with DCNB and 
shown non-hyperbolic kinetics for this isoenzyme with 1-chloro-2,4-dinitro-
benzene (CDNB) and for isoenzyme 3-4 with DCNB and CDNB. It is proposed 
that the basic steady-state random sequential Bi Bi mechanism is the simplest 
mechanism sufficient to explain the non-hyperbolic kinetics of GSH S-transfer-
ases 3-3 and 3-4 under initial rate conditions. Neither more complex steady-state 
mechanisms nor the superimposition of product inhibition or enzyme memory on 
the simplest steady-state mechanism are necessary. 
XIV 
The steady-state kinetic analysis involved initial velocity studies performed both in 
the presence and absence of the product of the enzymic reaction, as well as 
computer modelling of the experimental data. An initial optimisation of the GSH 
S-transferase (GST) assay system was performed to ensure a high degree of 
accuracy and reproducibility in the kinetic studies. Factors considered included the 
selection of spectrophotometric instrument, choice of solvent for the hydrophobic 
substrate, order of addition of reactants and linearity of product formation with 
time. 
Since detailed steady-state kinetic studies have only been done for isoenzymes of 
class Mu, representative isoenzyrnes from the other two classes of GST (Alpha and 
Pi) were isolated and their kinetic mechanisms were characterised. Isoenzyme 2-2 
(class Alpha) was isolated from rat liver and found to show non-hyperbolic 
kinetics, although the biphasic nature of the plots was less pronounced than for 
class Mu. In contrast to isoenzymes 3-3, 3-4 and 2-2, the kinetics of human 
placental GST 7f ( class Pi) were hyperbolic over wide ranges of both CDNB and 
GSH concentration. Computer modelling of the initial velocity data showed that 
this isoenzyme was more adequately described by a rapid equilibrium random 
kinetic mechanism than by the analogous steady-state system. This was confirmed 
by the observed pattern of product inhibition with the GSH·CDNB conjugate, 
which also indicated the presence of a dead-end enzyme• CDNB • conjugate 
, complex. These findings demonstrate that the kinetic mechanism of the GSH 
S-transferases is isoenzyme-dependent. 
The time-dependent inactivation of several GSTs, by a variety of different 
inactivating agents in unrelated experiments, appears to follow a pseudo-first-order 
rate law with a pseudo-first-order rate constant of approximately 2.5 x 10-3 s-1. 
The similarity between this value and that of the pseudo-first-order rate constant 
for the inhibition observed on dilution of concentrated solutions of GST suggests 
that these compounds may inactivate GST by facilitating an increase in the extent 
of salvation of the hydrophobic active-site. It is possible that this phenomenon 
could account for the various stable activity states which are observed when GSTs 
are incubated with foreign proteins prior to the addition of inactivating agents 
[304]. 
xv 
In addition to their enzymic function, the GSH S-transferases bind a variety of 
non-substrate ligands, such as bilirubin, haem.in, bile acids and certain carcinogens, 
which suggests that they also play a role in the intracellular transport and storage 
of xenobiotics and endogenous substances [39]. One of the most biologically 
significant non-substrate ligands is haem.in, and although a number of equilibrium 
binding studies of the interaction of haem.in and the GSTs have been performed, 
no investigations of the kinetics of binding have yet been reported. A major reason 
for the paucity of kinetic studies is the tendency of haemin to aggregate in aqueous 
solution, forming oligimers which prevent the acquisition of 'clean' kinetic data. 
We have used microperoxidase-8 (MP-8), a sterically hindered analogue of 
protoporphyrin IX which remains monomeric in solution at experimentally useful 
concentrations, to model the kinetics of binding of haem.in to human placental 
GST 7f. 
In order to obtain MP-8 of highest purity for kinetic studies, the kinetics of the 
formation of MP-8 were studied by HPLC monitoring of the peptic and tryptic 
hydrolysis of horse heart cytochrome-c, and conditions for the preparation of 
MP-8 were thus optimised. 
The kinetics of the reaction between MP-8 and human placental GST 7f, and the 
effects of other substrate/non-substrate ligands on these kinetics, were followed 
using the quenching of the MP-8 Soret absorbance (396 nm) which is observed on 
mixing the two species. The binding constants obtained in these 'extra-
thermodynamic' studies were assessed directly from microscopic rate constants and 
therefore are more directly interpretable than those obtained in the thermo-
dynamic procedures employed in previous investigations of GST /non-substrate 
ligand interactions. 
Under pseudo-first-order conditions ([MP-8] > > [GST]) and over a concentra-
tion range in which the MP-8 is monomeric in aqueous solution, the kinetics of 
binding are biphasic. The slower binding phase reflects the hydrophobic 
interaction of MP-8 with or spatially close to the bilirubin binding site on the 
enzyme, while the more rapid binding phase is associated with MP-8 binding at a 
hydrophobic site at or close to the binding site for the co-substrate CDNB. From 
the fact that GSH had only a minimal effect on the interaction of MP-8 with 
GST 7f, it can be inferred that the kinetically fast binding site is not identical to the 
XVl 
CDNB binding site but is adjacent to it, with possibly one or more residues of the 
octapeptide chain able to overlap the CDNB site. These studies have also provided 
direct confirmation of the independence of the catalytic and bilirubin-binding sites 
of GST 1r [308]. 
In order to further clarify the nature of the MP-8 binding site(s) of human 
placental GST, the inhibition by MP-8 of the GST-catalysed conjugation of GSH 
with CDNB was also investigated. Steady-state kinetic studies of the MP-8-
mediated inhibition of the GST n-catalysed conjugation of GSH with CDNB were 
performed after incubation of the enzyme with varying concentrations of MP-8 
for 15 minutes prior to initiation of the reaction. At a fixed GSH concentration 
with varying CDNB concentration, the data conformed closely to inhibition 
kinetics of the mixed-type (Ki = 3.2 x 10-7 M; pH 6.5; 30°C). For varying GSH 
concentration at a fixed CDNB concentration, the extent of inhibition was 
insufficient for analysis. These results are in excellent agreement with the results of 
the MP-8/GST binding kinetics, indicating that MP-8 and GSH affect each 
others interaction with the enzyme only minimally, and that the effect of MP-8 on 
catalysis occurs in the region of the CDNB locus at the active-site. 
The fact that the ·Ki value above is consistent with the independently calculated 
value of the binding constant for MP-8 binding proximal to the CDNB site 
demonstrates further agreement between the MP-8/GST binding kinetics and the 
studies of the MP-8-mediated inhibition of the conjugation reaction. This 
agreement provides strong evidence that the MP-8/GST fast binding site and the 
MP-8 catalytic inhibition site are one and the same. 
Analysis of the time-course of the MP-8-mediated inhibition of GST 1r indicated a 
pseudo-first-order partial inactivation of the enzyme (kobs = 2.3 ± 0.4 x 10-3 s-1; 
pH 6.5; 22.5 ° C). This value is identical to that found for dilutional inactivation of 
the enzyme in buffer alone, with MP-8 only increasing the extent of inactivation 
above that observed for dilutional inactivation. In view of the agreement between 
these values, as well as all the other observations of this study, the mechanism for 
the interaction of MP-8 and GST 1r is shown to be of the random sequential form 
with perturbation due to solvational elimination of the fast site. 
These studies recommend the non-substrate ligand MP-8 as a potentially valuable 
model for monomeric haemin, with which to investigate the nature and location of 
metalloporphyrin binding sites on the haem-binding GSTs. 
1. INTRODUCTION 
The greater part of this chapter comprises a review of the glutathione 
S-transferases; their distribution, properties, purification and biological function. 
Also described is the current understanding of their kinetic mechanism and of the 
binding of non-substrate ligands to this family of enzymes, since both topics are of 
particular relevance to this investigation. 
One of the most physiologically important of the non-substrate ligands of the 
glutathione S-transferases is haemin, yet experimental difficulties complicate 
studies of haemin binding in aqueous solution. In this study, novel use was made of 
microperoxidase-8 as a model compound for the binding of haemin to the 
glutathione S-transferases. A description of microperoxidase-8, and the rationale 
behind its use in this investigation, is therefore also presented here. Finally, the 
objectives of this study are briefly outlined. 
1.1 THE ISOENZYMES OF GLUTATHIONE S-TRANSFERASE 
1 
The glutathione S-transferases (EC 2.5.1.18) are a group of enzymes which 
catalyse the conjugation of reduced glutathione (GSH) with a variety of 
electrophilic molecules; these enzymes are therefore thought to play a major role 
in drug and xenobiotic biotransformation and detoxification. Their importance can 
be appraised by their abundance in nature. GSH S-transferases have been 
identified in fungi and bacteria, plants, insects, molluscs, nematodes, fish and birds 
(see Table 1.1) as well as in mammals. Man and the rat are the most intensively 
studied species. The physiological significance of the GSH S-transferases is 
further reinforced by the fact that they account for 10% of the cytosolic protein in 
rat liver [39]. 
In addition to their enzymic function, the GSH S-transferases bind a variety of 
non-substrate ligands, such as bilirubin, haem, bile acids and certain carcinogens, 
and there is evidence that they play a role in intracellular transport and storage of 
xenobiotics and endogenous substances [39]. 
Table 1.1 : Sources of Glutathione S-transferases 
Source Organ Reference 





















Mouse Liver 169,319 
Lung 263 
Sheep Liver 234 
Lung 170 
Ox Eye 14 
Rabbit Liver 194 
Pig Liver 92 
Dog Liver 320 
Rhesus Monkey Liver 119 
Camel Liver 123 
Chicken Liver 327 
Shark Liver 278 
Atlantic Salmon 26 
Bluegill & Channel Catfish 10 
Blue Crab 149 
Flour Beetle 60 
American Cockroach 168 
Housefly 205 
Yellowfever Mosquito 117 
Australian Sheep Blowfly 161 
Greater Wax Moth 168 
Earth worm 168 
Com 206 
Daplmia magna 168 
Schistosoma mansoni 210,287 
Purification methods are detailed in most references cited in table. This table is not intended 
to be complete, but rather to demonstrate the diversity of species in which GSTs are found. 
2 
The GSH S-transferases are primarily cytosolic proteins and occur as several 
homo- and heterodimeric isoenzymes in virtually all species studied. Although the 
tissue distribution and physical properties have only been determined in detail for 
a few species, the expression of GSH S-transferase (GST) isoenzymes is clearly 
species- and tissue-specific [19,115,301]. 
1.1.1 Rat Glutathione S-Transferases 
3 
The earliest and most intensive studies of the GSTs have been performed on the 
transferases of adult rat liver. The nomenclature describing the rat GST 
isoenzymes has undergone modification several times over the years; the major 
notations that have been used are shown in Table 1.2. 
Originally the GST isoenzymes of rat liver cytosol were classified on the basis of 
their assumed substrate specificities with various aryl, alkyl, alkene and epoxide 
substrates [44), but the inadequacy of this nomenclature became apparent once the 
broad and overlapping substrate specificity of the GSTs was demonstrated [107). It 
was, for example, discovered that 1-chloro-2,4-dinitrobenzene (CDNB) appears 
to be a substrate for all GST isoenzymes [55), making the classification 'GSH S-
aryl transferase' redundant. CDNB, which is a 'universal substrate' for the 
transferases, has become the basis of the general assay for transferase activity [107) 
(see Section 1.2.1). Other names that have been used in the past for the GSTs are 
ligandin [106), azo-dye carcinogen-binding protein, and Y-protein [171). These 
terms are based on the binding properties of various GST isoenzymes. 
In view of the overlapping substrate specificities of the GSTs, Jakoby [107,138] 
proposed a nomenclature based on the alphabetical naming of the enzymes in 
reverse order of their gradient elution from a CM-cellulose column. 
Subsequently, the GST nomenclature was further modified to reflect the subunit 
composition of the dimeric proteins. The three major cytosolic subunits were 
named Ya' Yb and Y c• in order of their increasing apparent molecular weight on 
SDS-PAGE [23,111). 
This more informative system became somewhat complicated when the Yb band 
was shown to contain two components, which were named Yb 1 and Yb 2 [25]. The 
possibility that GST variants might become too numerous for an alphabetical 
system, particularly after recombinant DNA technology demonstrated micro-


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































prompted the development of a numeric system of nomenclature, capable of 
expansion as required. In this system, subunits are numbered consecutively, based 
on the order in which they are characterised as separate entities. 
Although some workers in the field retain the Ya/Yb nomenclature [115,282,311], 
the simpler numeric system, which has been endorsed by several other 
investigators at a workshop on nomenclature [140], has been adopted throughout 
this thesis. 
1.1.1.1 Characteristics and Tissue Distribution of the Cytosolic Isoenzymes 
5 
The GST subunits in the cytosol of rat tissues are coded for by three multigenic 
families and all rat cytosolic GSTs arise from binary combinations of these 
subunits [19]. For example, subunits 1 and 2 form a family of related isoenzymes 
consisting of two homodimers (1-1 and 2-2) and one heterodimer (1-2). 
Likewise another family comprises transferases 3-3, 4-4 and 3-4. Only subunits 
within the same gene family have been found to hybridise [113,125]. 
The distribution of GST isoenzymes varies considerably in different tissues (see 
Figure 1.1). At least ten GST isoenzymes occur in rat hepatic cytosol, which has 
the highest capacity for conjugation of CDNB with GSH (followed by the testes 
and then the kidney). Extrahepatic tissues, with the exception of the kidney, 
express predominantly acidic isoenzymes [115]. A membrane-bound microsomal 
form which is completely different to the cytosolic forms also occurs in rat liver 
(see Section 1.1.1.2). There are indications that the cell nucleus also contains GSH 
S-transferase [27,48]. When GST subunits were isolated from rat hepatocyte 
nuclei and then reinjected into the cytoplasm of cultured cells, 44% of the 
reintroduced subunits rapidly migrated to the nuclear fraction [28] (see Section 
1.3). 
Rat liver cytosol contains the basic subunits 1, 2, 3 and 4 in high concentration. 
Subunit 1 is also abundant in the kidney but is either absent or present in low 
concentrations in other tissues [239]. While subunit 2 occurs in most tissues, it is 
especially predominant in the adrenal [286]. Subunit 3 is apparently absent from 
the cytosolic fraction of kidney [151] although subunits 1, 2, 4 and transferase 7-7, 
an isoenzyme not found in liver, have been identified in this tissue [98]. The cytosol 
of rat testis contains negligible amounts of transferases 1-1 and 1-2 and the 
major isoenzyme of this tissue (about 50% of the transferase activity) is the acidic 
6 
transferase 6-6 [38,95-97], which is not found in rat liver. Another acidic 
isoenzyme with distinct enzymatic properties (transferase 5-5) is present in 
proportionally large amounts in the seminiferous tubules [192]. A novel rat 
transferase isoenzyme (M, 25 000, pl 6.1) that is present in high concentrations in 
the colon has been reported [113]. Rat heart lacks the majority of basic 
isoenzymes, and most of the GST activity in this tissue is associated with near-
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Figure 1.1 : The Tissue Distribution of GSH S-Transferases in the Rat 
Adapted from reference 151. 
It is interesting to note that primary hepatoma, arising from hepatic parenchymal 
tissue, expresses a quite different profile of isoenzymes to its parent tissue. Subunit 
1 decreases in quantity, subunit 2 remains at a high level, and subunit 3 becomes a 
major component [286]. Particularly significant in hyperplastic nodules and 
hepatocellular carcinomas is the predominance of isoenzyme 7-7, which is almost 
absent in the mature rat liver (see Figure 1.1). This isoenzyme is therefore 
regarded as a hepatoma marker [195,209,219,243,245,286]. Although the 
mechanism by which this marked increase in transferase 7-7 content occurs is 
unknown, proportional increases in tissue mRNA content have indicated at least 
partial control at the transcriptional level [209]. 
The rat GST subunits can be differentiated by their apparent molecular weight and 
isoelectric point, shown in Table 1.2, as well as by their characteristic specific 
activities with a range of substrates (see Table 1.3) and sensitivities to selective 
inhibitors (Table 1.4 ). 
7 
Rat GST 1-1 is one of the major hepatic isoenzymes and, together with 1-2, was 
ascribed the functions of 'ligandin' with respect to binding of haem derivatives 
[153], and other compounds [171]. The isomerase activity of 1-1 with 85-andro-
stene-3, 17-dione is higher than other rat GST isoenzymes [ 188], and this 
isoenzyme is strongly inhibited by haematin [325]. When rat liver is treated with 
inducing agents, such as phenobarbital, 3-methylcholanthrene and trans-stilbene 
oxide, isoenzyme 1-1 is the most effectively induced isoenzyme, with the greatest 
induction observed for trans-stilbene oxide [179]. 
Isoenzyme 2-2 is characterised by a high specific GSH peroxidase activity [188]. 
Tributyltin acetate is the strongest inhibitor of those studied, but weak inhibition 
by bromosulphophthalein (BSP) differentiates isoenzyme 2-2 from other cytosolic 
GSTs, as these are also strongly inhibited by tributyltin acetate [325]. Inducing 
agents, such as phenobarbital, 3-methylcholanthrene and trans-stilbene oxide, 
decrease the cytosolic concentration of isoenzyme 2-2 [78]. 
The heterodimeric isoenzyme 1-2 has a pattern of specific activity toward 
different substrates [188] and sensitivity to inhibitors [325] intermediate between 
the homodimeric transferases 1-1 and 2-2. The two non-identical subunits are 
readily separated using SDS-polyacrylamide gels [23]. Inducing agents increase 
the levels of transferase 1-2 in the rat hepatic cytosol [78]. 
Isoenzyme 3-3 is best identified by a high specific activity with BSP, together with 
strong inhibition by triphenyltin chloride and triethyltin bromide [188,325]. This 
isoenzyme is induced almost as much as transf erase 1-1 by the inducing agents 
mentioned above [179]. 







Ethacrynic acid 0.4 
trans-4-Phenyl-3-buten-2-one ND 
1,2-Epoxy-3-(p-nitrophenoxy )propane 0.4 
Cumene hydroperoxide 8 
e:,5-Androstene-3,17-dione 13 
p-Nitrophenyl acetate 2 
Relative Specific Activity(% )* 
Isoenzyme 
1-2 2-2 3-3 3-4 
100 100 100 100 
(28) (19) (38) (28) 
<0.2 0.2 10 9 
ND ND 2 1 
3 7 0.3 1 
ND ND 0.2 2 
0.3 0.3 1.3 1.6 
14 40 1.4 2 
8 2 0.05 0.03 













*values given as percentages of the specific activities determined with CDNB as substrate (specific activity 
in parentheses). ND = no detectable activity. From reference 179. 
Table 1.4 Inhibition Characteristics of Major Rat GSH S-Transferases 
Inhibitor 
1-1 1-2 
Cibacron blue 0.6 4 
Tributyltin acetate 2 1 
Triethyltin bromide 350 100 
Triphenyltin chloride 0.5 1 
Bromosulphophthalein 2 10 
Haematin 0.05 0.2 





























*values are ID50s (µM), i.e. the concentration of inhibitor giving 50% inhibition of enzyme 









Distinctive properties of isoenzyme 4-4 are its catalytic efficiency and 
stereoselectivity toward arene oxide substrates [59,71]. The characteristic substrate 
for GST 4-4 is trans-4-phenyl-3-buten-2-one [188], and the isoenzyme is most 
strongly inhibited by BSP [325]. Transferase 4-4 has been shown [64] to be the 
only GST isoenzyme strongly inhibited by indomethacin, a finding which is useful 
for its identification. Treatment with inducing agents decreases the relative 
concentration of isoenzyme 4-4 in hepatic cytosol [78]. 
Like isoenzyme 1-2, GST 3-4 has properties intermediate between the homo-
dimeric isoenzymes related to it (3-3 and 4-4 ). A combination of substrates and 
inhibitors must therefore be used to characterise the isoenzyme (see Tables 1.3 
and 1.4). 
9 
Transferase 5-5 can be best identified with 1,2-epoxy-3-(p-nitrophenoxy)-
propane, although iodomethane is also a good substrate [107]. A low specific 
activity with CDNB is also characteristic. 
The specific activity of GST 6-6, the major isoenzyme m rat testis, 1s 
characteristically higher with CDNB than any other rat transferase characterised 
[95,97]. The strongest inhibitor known for this isoenzyme is Cibacron Blue [179]. 
The isoelectric point of transferase 6-6 (pH 5.8) is considerably lower than those 
of the isoenzymes containing subunits 1 to 5 (see Table 1.2). Inducing agents do 
not elevate the levels of this isoenzyme in rat testis [179]. 
The most characteristic property of isoenzyme 7-7 (pl 8.7) is its low apparent 
subunit M, (24 000) compared with the transferases isolated from rat liver cytosol, 
as well as its relatively high activity with ethacrynic acid [98]. 
GST 8-8 (pl 6.0; apparent subunit M, 24 500) has been shown to be the most 
active of several GST isoenzymes towards 4-hydroxynon-2-enals, major products 
of the peroxidative degradation of polyunsaturated fatty acids [144], although 
GST 4-4 is also highly efficient in the detoxification of these compounds [8]. 
10 
1.1.1.2 Microsomal Glutathione S-Transferases 
A membrane-bound GST isoenzyme that differs from the soluble forms of the 
enzyme is found in several rodent species and has also been identified in human 
liver [67]. Microsomal GST constitutes 3% and 5% of the total protein in the rat 
liver endoplasmic reticulum and outer mitochondrial membrane, respectively 
[199,203]. The subunit molecular weight of microsomal GST is 17 000, compared 
with 25 000 for the subunits of the cytosolic isoenzymes [42]. The amino acid 
sequence of rat liver microsomal GST lacks obvious homology with any of the 
characterised cytosolic enzymes [200], and antibodies directed against GSTs 1-1, 
1-2, 3-3 and 3-4 do not react with the purified microsomal GST [202]. 
Microsomal GST has been found to be activated 15-fold by treatment with 
N-ethylmaleimide, and to a lesser extent by other sulphydryl agents, whereas the 
cytosolic isoenzymes are not similarly activated [198,199,204]. In its purified form, 
microsomal GST is dependent on detergent for activity and in a protein/Triton X-
100 micelle is thought to exist as a trimeric protein [200]. Radiation inactivation 
studies have demonstrated that the isoenzyme also exists as a trimeric protein in 
the microsomal membrane, and is dependent on the integrity of all three subunits 
for catalytic activity (42]. 
The specific activity of purified rat liver microsomal GST comprises only 10% of 
that of the cytosolic GSTs [39], although in some species the microsomal activity is 
greater and may be important in the metabolism of electrophiles produced within 
the microsomal membrane by lipid peroxidation [198,199]. 
11 
1.1.2 Human Glutathione S-Transferases 
The human cytosolic GSTs are currently denoted by Greek letters (Table 1.5) and 
can be differentiated into three distinct classes of dimeric isoenzymes, on the basis 
of an analysis of their structural and kinetic properties. These are referred to as 
the basic, near-neutral and acidic classes [187]. There has been no evidence to date 
of major functional differences between the isoenzymes within each class [179]. 
Some of the physical properties of the human GST isoenzymes are shown in Table 
1.5, and their substrate specificities and inhibition characteristics are shown in 
Tables 1.6 and 1.7, respectively. 
The human GSTs are thought to be the products of at least three distinct 
autosomal gene loci, designated as GSTl, GST2 and GST3 [266]. On the basis of 
their electrophoretic mobility, these gene loci are thought to correspond to the 
near-neutral, basic and acidic GST isoenzyme types, respectively [20]. Genetic 
polymorphism has been suggested for some or all of the three loci [125,267]. A 
minimum of four genes has been proposed by Singh et al. [264 ], each gene 
resulting in an immunologically and functionally distinct subunit. The human GST 
isoenzymes are thought to arise from different homo- and heterodimeric 
combinations of three of these subunits. These subunits are designated A-type 
(M, 26 500), B-type (M, 24 500) and C-type (M, 22 500) [20,264] . 
Table 1.5 : Nomenclature and Physical Characteristics 
of Major Human GSH S-Transferases 
Isoenzyme pl SubunitM * 
(x 103)' 
a 7.8 25 
/3 8.25 25 
"f 8.55 25 
0 8.75 24.5,26 
E 8.8 24.5,26 
µ 6.0-6.5 26.3 
VJ 5.4 26.5 
w 4.6 22.5,24.5 
11" 4.8 22.5,23 
p 4.7 24 
*M, based on SDS-PAGE 
Table adapted from 179, 39, 137. 










































Table 1.7: Inhibition Characteristics of Major Human GSH S-Transferases 
ID50 (µM) 
GST isoenzymes 
Inhibitor Basic Near-Neutral Acidic 
(0-€) (J.L) (7r) 
Cibacron blue 5 0.05 0.5 
Gossypol acetic acid 50 2 >100 
Tributyltin acetate 0.01 0.5 4 
Triethyltin bromide 10 5 6 
Triphenyltin chloride 0.25 0.5 >10 
Bromosulphophthalein 75 2 100 
Haematin 0.5 1 5 
S-Hexylglutathione 3 10 20 
S-(p-Bromobenzyl)glutathione 4 1 4 
Values are ID50s (µM), i.e. the concentration of inhibitor giving 50% inhibition of enzyme 
activity at pH 6.5, 30°C, with 1 mM CDNB and 1 mM GSH as substrates. From reference 179. 
12 
13 
In human liver there are five isoenzymes with basic isoelectric points (pl 7.8-8.9), 
called a, /3, 'Y, o and c [145]. These GST isoenzyrnes are homo- and heterodimers 
of A- and B-type subunits, with M, values between 24 500 and 26 500 [65,119,264]. 
The basic isoenzymes are characterised by high GSH peroxidase activity toward 
organic peroxides [17], and are strongly inhibited by tributyltin acetate [179]. 
A near-neutral (pl 6.6) isoenzyme (transferase µ), which has high specific activity 
towards epoxides and a high affinity for the non-substrate ligand haematin [119], is 
not found in the liver of all humans but, when present, constitutes 15-20% of the 
total GST activity [316,317]. The near-neutral GST µ is a homodimer of 
M,-26 300 subunits and is immunochernically distinct from the cationic 
isoenzymes [275,315]. 
The characteristic substrate for the human acidic transferases is ethacrynic acid, 
and these isoenzymes are best inhibited by Cibacron Blue [179]. Human liver 
possesses two such anionic transferases, w and l/J (with pl values of 4.6 and 5.4, 
respectively) [17,179,266]. Transferase w is a heterodimer of B-type and C-type 
subunits [65], while GST l/J is composed of M,-26 500 subunits, designated 
A' -type as they are imrnunochemically distinct from the A-type subunits [264]. It 
has recently been shown that the anionic GST l/J of human liver is more closely 
related in structure to the near-neutral (GST µ) than to the acidic isoenzymes 
[266]. 
In human liver the five basic isoenzymes a-c comprise 90% of hepatic GST 
activity. The remainder of this activity is distributed between the near-neutral 
GST, which is only expressed in 60% of individuals, and two acidic transferases, w 
and l/J [266]. The extrahepatic human organs contain primarily acidic transferases. 
The predominant GST of human placenta, isoenzyme 71", is an acidic (pl 4.8) 
homodimer of C-type subunits (M, 22 500) [66,100,102,119,275]. With respect to 
physical, catalytic and immunochemical properties, it is distinct from the major, 
basic human liver isoenzymes, but closely related or identical to the human 
erythrocyte GST isoenzyme p [100,190,305]. 
Transferase 1r is found in high concentration in human placenta [186] and might be 
expected to play a major role in the protection of the developing foetus from the 
toxic effects of circulating electrophilic substances [232]. However, only one 
transferase isoenzyme has been found in the placenta [94,228,231] and this appears 
14 
to possess narrow substrate specificity, so it would seem that the placental GST 
provides less protection to the tissue than the liver isoenzymes [16]. Most drugs 
administered to pregnant women have been found in measurable quantities in the 
foetal circulation, so the putative role of the placenta as a 'surrogate liver' of the 
foetus or a 'barrier' against xenobiotic passage is uncertain [74,216]. Conceivably, 
for some drugs the low drug metabolising activity of the placenta may be sufficient 
for decisive effects on foetotoxicity [216]. Placental GST activity was reportedly not 
altered following exposure of pregnant women to cigarette smoke [174,216] nor 
was it affected by several inducing agents [163]. 
An acidic GST isoenzyme with properties similar to those of the placental/ 
erythrocytic form has also been found in human lung [160], breast [73], thyroid 
[69], lens and kidney [39] as well as in all foetal organs studied [72,102]. The acidic 
forms of rat liver have also been reported to be imrnunochemically similar to the 
erythrocyte/placental enzymes [66]. 
lsoenzymes representing all three major classes of transferases have been found in 
human lung [20] and kidney [267], although the patterns of isoenzyme expression 
differ. The kidney has also been found to possess at least two isoenzymes which 
have not previously been characterised [267]. Five GST isoenzymes have been 
isolated from human uterus, including one which may be specific to that organ 
[72]. Four GSTs, comprised of subunits representing each of the three major 
transferase classes, have been reported in human prostatic tissue [290]. A new 
basic transferase (pl 9.9; apparent subunit M, 26 500) has been found in human 
skin [68], which also contains two other isoenzymes that are related to the 
established acidic and basic transferases of human liver. As well as the anionic 
transferase p, human erythrocytes have a cationic (pl > 10) isoenzyme designated 
GST a [261]. 
The ontogeny of the human GST isoenzymes in lung [89], liver, adrenal, kidney 
and spleen [83] has been investigated. Studies on the development of GST 
isoenzymes show that, at least after the first trimester, no foetal-specific 
isoenzymes are present [83,102,217]. A major component of human foetal liver is 
isoenzyme 71", but a basic transferase of the Ct-£ class found in the adult liver is also 
present [39]. 
15 
A GST of the Pi class ( see Section 1.1.4) has been found to be overexpressed in 
certain human cancer cells, and this enzyme may therefore have potential as a 
marker for preneoplastic cells and neoplastic tissues [24,185,246,248,255,297]. 
Although the properties of this isoenzyme were indistinguishable from transferase 
7£, variant forms within the Pi class may exist [185]. The increased concentrations of 
GST Pi may also contribute to the characteristic resistance of malignant tissues to 
cytostatic drugs [24,185,240]. 
1.1.3 Glutathione S-Transferases of Other Species 
Table 1.1 shows the variety of species and tissues from which GSTs have been 
isolated. With the exception of the microsomal enzyme which is trimeric in situ 
(see Section 1.1.1.2) and a monomeric isoenzyme isolated from the protozoan, 
Tetrahymena thermophila [213], all GSTs discovered so far have been found to be 
composed of two subunits [137]. 
Hoesch and Boyer [119] have demonstrated that the hepatic cytosol of rhesus 
monkeys contains a number of GST isoenzymes that are very similar to those of 
human liver. 
Four isoenzymes have been isolated from the liver of the DBA/2J strain of mouse, 
and have been named Fl, F2, F3 and F4, on the basis of their increasing isoelectric 
points [169]. Three homodimeric isoenzymes were isolated from the NMRI strain 
of mouse [319] and named Ml, MIi and MIii, on the basis of their respective 
subunit compositions. Forms Fl and F2 seem similar to MIi and F3 is apparently 
analogous to transferase MIii [319]. A new nomenclature for the GST isoenzymes 
of mouse tissues which signifies the strain of mouse as well as the subunit 
composition has been proposed [319]. 
Although few isoenzymes seem to be expressed in insects [149], fish possess a 
number of acidic, basic and near-neutral GST isoenzymes. Transferases from fish 
and molluscs have been extensively studied because levels of enzyme induction, 
caused by environmental pollutants, provide a useful index of marine and 
freshwater pollution levels [35,39]. The GST forms of insects and crops are of 
interest from the perspective of resistance to herbicides and insecticides, and those 
in microorganisms are studied to gain insight into resistance to antimicrobial drugs 
[39,117,161]. 
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1.1.4 Species-Independent Classification of Isoenzymes 
Mannervik [182] has proposed a species-independent classification of the cytosolic 
GST isoenzymes into three groups, namely Alpha, Mu and Pi (shown in Figure 
1.2). This proposal was based on the pattern recognition analysis of data on the 
substrate specificities, sensitivities to inhibitors, immunochemical cross-reactivity 
and amino-terminal amino acid sequences of the cytosolic GST isoenzymes of rat, 
mouse and man. Rat liver microsomal GST is clearly distinct from the cytosolic 
isoenzymes [202] and is therefore thought to belong to an additional GST class 
[182]. 
Figure 1.2 : Inter-Species Classification of GSH S-Transferases 
Classified by pattern recognition analysis according to amino-terminal amino 
acid sequences, substrate specificities, sensitivities to inhibitors and 
immunological cross-reactivity. From reference 182. 
Glutathione S-Transferase 
Microsomal Cytosolic 
Class Alpha Class Mu 















Characteristic substrate specificities and inhibitor sensitivities of the three classes 
are shown in Table 1.8. Class Alpha isoenzymes exhibit high non-selenium GSH 
peroxidase activity, class Mu shows high activity with epoxides, and the members of 
class Pi are characterised by comparatively high activity with ethacrynic acid [182]. 
Class Pi has the notable characteristic of high stereoselectivity for the proximate 
carcinogen derived from benzo(a)pyrene, the 'bay-region' diol epoxide (+)-anti-
7,8-dihydrodiol-9,10-epoxide [181]. The characteristic inhibitor sensitivities of 
class Alpha isoenzymes are a low IC50 value for haematin and a high value for 
Cibacron blue, while both groups Mu and Pi show the converse. Class Mu can be 
distinguished from class Pi by its low IC50 values for triphenyltin chloride. 
Table 1.8 : Class-Discriminating Substrate Specificities and Inhibitor 
Sensitivities of GSH S-Transferases 
Transf erase Class 
Alpha Mu Pi 
Specific Activity with Substrate 
(µmol/min/mg) 
Ethacrynic acid 0.01-1.2 0.08-0.6 0.9-4 
Bromosulphophthalein <0.01 0.002-0.9 <0.01 
trans-4-Phenyl-3-buten-2-one <0.01 0.04-1.2 0.01-0.02 
Cumene hydroperoxide 3-12 0.1-0.7 0.03-0.14 
Ii 5 -Androstene-3,17-dione 0.04-8 0.002-0.1 0.01-0.17 
ID
50 values with Inhibitor (µM) 
Cibacron blue 0.6-20 0.05-0.7 0.1-0.5 
Triphenyltin chloride 0.3-30 0.04-0.5 >10 
Bromosulphophthalein 2-200 0.5-10 20-100 
Haematin 0.05-2 1-2 4-5 
Isoelectric Point (pl) Alkaline Neutral Acidic 
( >8.0) (7-8) ( <7.0) 
Characteristically high specific activities and low ID.SO values are given in bold type. 
Members of class Alpha or Mu have high activity with at least one of the two substrates 
indicated. Members of class Pi are distinguished from those of classes Alpha and Mu by 
low sensitivity to both triphenyltin chloride and haematin. No characteristic inhibitor 
for class Pi has yet been identified. Adapted from reference 179. 
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There may however be large differences in the substrate and inhibitor specificities 
of isoenzymes within the same class [64]. In addition, most isoenzymes have 
measurable specific activities or inhibitor sensitivities with the substrates/ 
inhibitors listed in Table 1.8, and considerable overlap in the given ranges is 
observable between some of the GST classes. 
For the three mammalian species studied, immunochemical cross-reactivity was 
shown among GSTs within each class, but none was observed between isoenzymes 
in different classes [182,299]. 
All of the enzymes of class Mu and Pi that have been characterised have an 
unblocked N-terminus; the isoenzymes within a class have 70-80% amino acid 
sequence homology, whereas enzymes from different classes have an homology of 
only 20-30% [68,181,224,236]. A 95 % conservation of amino acid sequence has 
been demonstrated in rat and human microsomal GSTs [67]. Del Boccio et al. [68] 
have also shown a striking relationship between the primary structures of a 
previously unknown basic transf erase isoenzyme from human skin and rat 
isoenzyme 2-2, both of the Alpha class. Even GST isoenzymes isolated from 
parasitic schistosomes possessed regions with high homology to isoenzymes of one 
or other of the vertebrate multigene families [271,287]. This level of conservation 
of structure between enzymes isolated from different species supports the 
proposed species-independent classification (182,299]. 
1.1.5 Primary Protein Structure and Evolution 
The primary protein structure and evolution of the many isoforms of GST have 
been described in several recent papers [19,39,83,125,151,179,180,222,286]. It was 
originally unclear whether or not the GST subunits were the products of a single 
gene [31]. Scully and Mantle (251] suggested that subunits 1, 2 and 3 arose from 
the proteolytic cleavage of such a single gene product. Later studies showing 
differential induction of the subunits and immunochemical dissimilarities among 
them suggested that these subunits may rather have had separate origins 
[18,40,269]. The concept that subunits 1, 2 and 3 are the products of separate genes 
has been further substantiated by numerous reports of heterogeneity within these 
subunit types [40,88,223,269,298]. 
The primary structures of several subunits have been determined from a 
combination of chemical sequencing and analysis of coding sequences from cDNA 
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clones [76,223,298]. Six of the subunits named to date have been assigned to three 
multigenic families (the 1/2, 3/4/6, and 7 gene families) and two (5 and 8) have 
yet to be characterised [25,179,225,286]. A minimum of four GST gene families in 
the rat has been recently proposed, on the basis of the nucleotide and amino acid 
sequence analysis of cDNA clones and purified proteins [288]. 
A high degree of conservation of amino acid sequences is apparent along the full 
length of subunits of the 3/4/6 family [241], while subunits of the 1/2 family 
exhibit varying degrees of conservation, but possess two regions of high homology 
[289]. All the subunits of rat GSTs show three regions of conserved structure, 
possibly reflecting a common purpose such as the binding of GSH [165,236]. 
Shared conserved regions of amino acid sequence have also been observed 
between transferases of different species [179,196] (see Section 1.1.4), further 
indicating that these regions are important to the structure-function relationship of 
the transferases [286]. 
Kinetic and binding data have indirectly inferred certain structural features of the 
GSTs, and X-ray diffraction investigations with crystallised enzymes are likely to 
yield more structural information (preliminary studies have been performed with 
isoenzyme 3-3) [254]. 
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1.2 PURIFICATION AND PHYSICAL CHARACTERISATION 
The relative abundance of GST activity in mammalian liver and the fact that some 
transferases are among the most alkaline of hepatic cytosolic proteins facilitates 
their purification [39]. The method used depends greatly upon the source from 
which the enzyme is obtained, and many purification procedures have been 
reported in the literature (see Table 1.1 for examples). The different techniques 
utilised for the purification of GST isoenzymes are described in outline only here, 
while specific details of the purification methods used in this investigation are 
found in Section 2.4. 
In one of the earlier purification methods [107], the rat liver cytosolic fraction was 
passed through a DEAE-cellulose column, which retained 80% of the cytosolic 
proteins, but allowed 90% of the GST activity to pass through unbound in the 
eluent. The GST isoenzymes were subsequently separated by CM-cellulose and 
hydroxylapatite chromatography [12,107]. The disadvantages of these methods 
were the many chromatographic steps, irreproducibilities arising from the 
variability in the properties of hydroxylapatite, and lack of isoenzyme resolution on 
CM-cellulose [39]. 
Boyer et al. [40] combined some of the features of previous methods with GSH 
affinity chromatography. The introduction of this step eliminated non-GSH-
specific proteins and improved the subsequent purification on CM-cellulose. 
Several types of affinity columns have been used for GST isolation. Earlier affinity 
columns employed organic ligands such as BSP [92,322] and cholic acid [218], 
known to bind to the transferases. However the very tight binding of some 
transferases to BSP has caused problems in their elution from matrices linked to 
BSP, and columns utilizing cholic acid as a ligand do not bind subunits 1 and 2 
[179]. The most commonly used affinity columns are those with matrices consisting 
of epoxy-activated agarose derivatives coupled to either GSH or to S-alkyl 
derivatives of GSH, the latter method being based on the high affinity of these 
compounds for GSTs [39,126]. 
With the GSH-affinity column [257], GSH is usually covalently linked through the 
thiol group to epoxy-activated sepharose, although coupling may also occur 
through the a-amino group of GSH under certain conditions. Transferases are 
eluted from these columns with high concentrations of GSH. A second method 
employs S-hexylglutathione coupled through the N-terminal a-amino group to 
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activated sepharose, and elution with low concentrations of S-hexylglutathione 
[100). Because this compound is a strong inhibitor of the GSTs, it must be removed 
before use of the enzyme [39). It has been found that transferase 5-5 does not 
bind to S-hexylglutathione affinity columns, and transferase 1-1 binds more 
weakly than most other isoenzymes [ 179). 
Isoelectric focusing has also been used to separate GST isoenzymes [12), but this 
technique is slow and has limited capacity [179). The introduction of HPLC 
[231,260] and FPLC (fast protein liquid chromatofocusing) [9] techniques has 
improved the resolution of GST isoenzymes and shortened separation times 
considerably. Rapid separation times are considered essential to minimise loss of 
GST activity and the formation of oxidation or degradation products of the GSTs 
which can be erroneously interpreted as new isoenzymes [179). A reverse-phase 
HPLC method has been proposed for quantifying the GST subunit content of a 
given tissue [211). 
Techniques used to characterise and confirm the homogeneity of the GST 
isoenzymes include SDS polyacrylamide gels, electrofocusing, chromatofocusing, 
and immunological procedures ( detailed by Boyer [39)). As has been described 
previously ( see Section 1.1.1.1 ), a variety of substrates and inhibitors may be used 
to facilitate the identification of different forms of GST [182). 
1.2.1 Assay Systems 
The most convenient and sensitive assay for the GSTs is the spectrophotometric 
monitoring of the conjugation of GSH with the universal substrate, CDNB (see 
Section 1.1.1). It has been noted that some isoenzymes exhibit low specific activity 
toward CDNB, and therefore its exclusive use as a screen for GST activity may 
impede detection of some isoforms [55). A number of other useful spectro-
photometric methods have been developed [104,107,137]; the most frequently used 
are summarised in Table 1.9. Details of assays used in this investigation are 
described in Section 2.2. 
Titrimetric methods have been developed for measuring the GST-catalysed 
metabolism of iodomethane, and radioactive substrates are used for assays of 





































































































































































































































































































































































































































1.3 SUBSTRATES AND BIOLOGICAL FUNCTION 
The GSTs are thought to play a central part in the biotransformation and detoxifi-
cation of a wide range of drugs and xenobiotics. In these reactions, the transferases 
catalyse the nucleophilic attack by the electrons of the sulphur atom of reduced 
glutathione on an electrophilic centre of an acceptor substrate such as CDNB: 
GSH + HCI 
This electrophilic centre may be a carbon, sulphur or nitrogen atom, but the basic 
chemical mechanism remains as shown below, where the GSH attacks the 
Cl-bonded carbon atom: 





The transferases are thought to catalyse this reaction by bringing the substrates 
into close juxtaposition, thereby increasing their effective local concentrations, and 
by enhancing the nucleophilicity of the sulphydryl group of GSH, thereby causing it 
to react more readily with an electrophile bound at the hydrophobic site [39,249]. 
The nucleophilic reactivity mentioned above may be enhanced by the ability of the 
protein to lower the effective pKa of the sulphydryl group of GSH [54]. 
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The GSH conjugate formed may be excreted from the cell as such or hydrolysed by 
peptidases to an S-(substituted)-cysteine derivative, which may subsequently be 
N-acetylated in a CoA-linked reaction to yield a mercapturic acid, a classical 
excretion product of many xenobiotics (see Figure 1.3) [179]. Alternatively, the 
unacetylated cysteine derivative may be cleaved at the C-S bond with the 
elimination of pyruvate and NH3, and the conversion of the S-substituent to a 
mercaptan. The resulting thiol group can be either glucuronidated with 
uridinediphosphoglucuronate to a thioglucuronide or methylated with S-adenosyl-
methionine to a methylthio conjugate. The latter product may be sequentially 
oxidised to a methylsulphinyl and a methylsulphonyl derivative. 
IGlu 
I 
Cys -SH+ ®-x 
I 
Gly 
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Figure 1.3: The Mercapturic Acid Pathway 
-
Flow scheme of possible biotransformation of an electrophilic species after conjugation 
with GSH (I) . The reactive electrophile (II) forms a stable conjugate (III) with GSH. The 
conjugate is degraded in two steps to a cysteine conjugate (IV), which on acetylation with 
acetylcoenzyme-A is converted to a mercapturate (V). Alternatively, the cysteine 
conjugate may be cleaved to a mercaptan (VI) by elimination of pyruvate and ammonia. 
The resulting thiol group can either be glucuronidated with uridinediphosphoglucuronate 
to a thioglucuronide (VII) or methylated with S-adenosylmethionine to a methylthio 
conjugate (VIII). The latter compound may be oxidised sequentially to a methylsulphinyl 
(IX) and a methylsulphonyl derivative (X). The reactions do not have to take place in the 
same cell or organ. Some reactions are probably catalysed by enzymes in the intestinal 
microbial flora. Compounds V, VIII-X are major excretion products resulting from the 
initial conjugation with GSH. From reference 179. 
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As well as their role in the detoxification of xenobiotics, the transferases appear to 
catalyse the conjugation of GSH with a number of endogenous substrates; these 
are thought to include steroids, prostaglandins, leukotrienes, and organic hydro-
peroxides (including lipid hydroperoxides and products of lipid peroxidation) [183]. 
Both endogenous compounds and xenobiotics may form epoxides, which may 
undergo conjugation with GSH [52]; 
GST 
-C-C- + GSH - -C-C-
'cf HO SG 
although the GST isoenzymes vary in their specific activities with any particular 
epoxide. This reaction may have considerable toxicological significance since a 
proportion of human subjects lack the isoenzyme (transferase µ) which has the 
highest specific activity with the mutagenic arene oxides such as benzo(a)pyrene-
4,5-oxide [315,316]. 
An important physiological function of transferases which contain subunits 1, 2, 5 
or 7 is thought to be their GSH peroxidase activity towards organic peroxides [97]. 
This peroxidase activity is distinct from that of the selenium-linked GSH 
peroxidase found in many tissues, and can be distinguished from the latter by the 
inability of the GSTs to catalyse the reduction of hydrogen peroxide [230]. In the 
equations below the initial reaction is catalysed by the transferases, and the second 
proceeds non-enzymatically, resulting in the formation of oxidised glutathione 
(GSSG) [147]; 
ROOH + GSH 
[GS-OH] + GSH 
GST ROH + [GS-OH] 
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Products of lipid peroxidation, such as cholesterol a-oxide [193] and activated 
alkenes, for example the hydroxyalkenals [8], are substrates for those GSTs which 
exhibit peroxidase activity; 
R-CH-CH=CH-CHO + GSH 
I 
GST 
R-CH-CH-CH - CHO 
I I 2 
OH OH SG 
The primary GSH adduct shown above can be subsequently transformed to a cyclic 
hemimercaptal derivative [180]. An important biological function of the GSTs may 
therefore be the protection of membranes from damage by the process of lipid 
peroxidation [152,201,285]. 
Subunit 1 of the transferases catalyses the GSH-dependent isomerisation about 
certain double bonds. An example is the conversion of ~5-androstene-3,17-dione 
to ~4-androstene-3, 17-dione, shown below; 
GST 
While GSH is not consumed in this reaction, it is thought that an intermediate 
GSH-adduct exists, which splits to yield GSH and the thermodynamically stable 
steroid isomer [148]. 
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Some prostaglandins have been shown to be substrates for the GSTs [47,179], and 
some GST isoenzymes (particularly those belonging to class Mu) are also capable 
of catalysing the conversion of the epoxide derivative of arachidonic acid, 






?"' , .... COOCH3 
~ H ··s , /Gly 
,,Cys 
'YGlu 
The enzyme was therefore thought to play a role in the biosynthesis of 
leukotrienes, which are directly responsible for in vivo inflammatory effects. 
However, Soderstrom et al. [273] have shown using mouse mastocytoma cells that 
the activity of microsomal and cytosolic GSTs towards leukotriene A4 is too low to 
account for in vivo leukotriene C4 formation [273]. Instead, a distinct membrane-
bound enzyme, leukotriene C synthase, has been found to be primarily responsible 
for leukotriene C4 biosynthesis. 
Although the GSTs are normally considered to be enzymes of detoxification, they 
appear to have a role in the bioactivation of certain precarcinogens, principally the 
vicinal dihaloethanes, such as ethylene dibromide (EDB). Widely used as a grain 
fumigant, industrial solvent and anti-knock petroleum additive, EDB has been 
shown to be both mutagenic and carcinogenic [233,324]. Considerable concern has 
been expressed over EDB residues in foodstuffs as well as over occupational 
exposure to the chemical. 
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The compound is converted in a OST-catalysed reaction to a OSH adduct that 
irreversibly binds to DNA (214,303]. A general scheme for the proposed formation 
of reactive intermediates from the reaction of EDB (and other dihaloalkanes) with 
OSH is shown below. OST-catalysed conjugation of EDB with OSH gives rise to 
half-sulphur mustard compounds with the subsequent production of reactive 
episulphonium ions (303]. There is evidence that the major DNA adduct formed in 
rat liver is S-[2-(N7-guanyl)ethyl]glutathione (158]. 
GST 
Br ""vBr + GSH ------ GS""v8r 
EDS 













Androgen-repressed DNA-binding proteins which are present at interchromatinic 
regions of the cell nucleus have been identified as OST subunits 3 and 4 (27,51]. 
The possibility exists that some OSTs (themselves under negative regulation by 
androgens) may exert control over organ growth through modulation of nuclear 
events related to the production, processing, or transport of RNA (51]. 
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1.4 KINETICS AND CATALYTIC MECHANISM 
1.4.1 Catalytic Site 
The specificity of the GSTs for GSH as the thiol substrate is extremely high. In 
addition to GSH, the only substrates capable of binding to the GSH site of the 
transferases are a small number of GSH-analogues such as homoglutathione (in 
which ,8-alanine replaces glycine) and -y-glutamylcysteine [53,54,107,145,276]. 
Several other thiols small enough to fit into the active-site do not have catalytic 
activity (105,107,145,147,326], although Principato et al. (229] have shown that one 
of these thiols, 2-mercaptoethanol, can serve as a substrate in the presence of a 
non-substrate GSH analogue, S-methylglutathione. In view of this, it has been 
suggested that the peptide portion of GSH induces a conformational change in the 
protein to an active state in which catalysis may occur (229]. GSH would therefore 
have two functions - to induce a catalytically active protein conformation and 
provide the thiol group for the reaction (229]. Such conformational changes, 
induced by GSH or by other substances, have been proposed as an explanation for 
the non-hyperbolic steady-state kinetics of the transferases (see Section 1.4.2) 
(179,229]. 
The active-site of the transferases is thought to have reasonably wide space 
available in the vicinity of the sulphur atom of the bound GSH, due to the 
similarity in binding properties of the GSH and S-alkylglutathione affinity 
matrices (179]. The three charged groups of the GSH molecule are thought to bind 
to oppositely charged amino acid side chains at the binding site for GSH (known 
as the G site) on the enzyme [179]. It has been shown using inhibitors and 
protective agents that several different functional groups are required for catalytic 
activity. These may include the thiol, amino and guanidino groups of the protein, 
although partial modification of the protein thiols is possible without loss of 
catalytic activity [49,179]. Awasthi et al. (15], working with human GST isoenzyme 
l/J, have shown that a functional histidine residue at or near the GSH binding site is 
essential for catalytic activity. Hydrogen bonds are probably also formed between 
the two peptide bonds of GSH and suitable groups in the protein (179]. 
In contrast to the very strict requirements for binding to the GSH site, the adjacent 
acceptor substrate binding site of the transferases appears to be much less specific. 
A large variety of substrates, ranging in size and shape from iodomethane to 
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steroids and polycyclic hydrocarbons, bind to the active-site. The acceptor 
substrate binding site may be expected to be hydrophobic in nature [137], since a 
prerequisite for substrate binding to the site appears to be the possession of a 
hydrophobic region [148]. 
While compounds such as maleic acid, L-cystine and N-N-diacetyl-L-cystine 
were not substrates for the transferases, uncharged analogues of these same 
compounds (maleylacetone, L-cystine dimethyl ester and N-N-diacetyl-L-
cystine dimethyl ester) were substrates [148]. The hydrophobic nature of the 
analogues apparently enhanced their ability to act as substrates [39]. A series of 
S-(n-alkyl)-glutathione derivatives with substituents of varying chain length have 
been used to probe the acceptor binding site on transferases 3-3 and 3-4 [12]. 
The inhibitory potency of these compounds increased with substituent chain 
length, providing further evidence of the hydrophobic nature of the acceptor 
binding site, named the H-site (179]. In addition, the binding of bilirubin to GST 
1-2 is associated with the quenching of intrinsic tryptophan fluorescence, and the 
only tryptophan residue in the polypeptide is situated in the H-site [223]. 
The H-site of the transferases shows varying degrees of stereoselectivity, 
depending upon the isoenzyme and substrate. It is thought that although the 
H-site is capable of accommodating a wide variety of chemical moieties, the 
scissile bond of the electrophilic substrate may have strict stereochemical 
requirements with respect to binding to the sulphur atom of GSH and to the 
catalytic groups of the enzyme (179]. 
Varying degrees of enantioselectivity have been demonstrated for purified 
transferase isoenzymes 1-1, 3-3, 3-4 and 1-2 using chiral substrates [175,176]. 
In the conjugation of GSH and arene oxide substrates, isoenzymes 3-3 and 4-4 
from rat liver showed a pronounced preference for the stereocentre of R-absolute 
configuration on the electrophilic substrate (54,59,71,80]. Cobb et al. [59] found 
that transferase 3-4 showed more stereoselectivity with phenanthrene 9, 10-oxide 
than did transferases 3-3 and 1-2. 
Further evidence for the importance of stereospecificity comes from the finding 
that transferase 3-3 is able to metabolise BSP, while transferases containing 
subunit 4 are not (and are in fact inhibited by the compound) (179,325]. However, 
the binding stoichiometry and affinity for BSP are not significantly different for 
subunits 3 and 4. Therefore the topological orientation of BSP when bound to 
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subunit 4 seems to be inadequate for catalysis. 
Although most studies have been on the rat transferases, investigations with the 
human GST isoenzymes have also shown qualitative variations in their degree of 
stereospecificity [179,238]. The near-neutral transferase µ shows high preference 
for (-)4R,5S benzo(a)pyrene 4,5-oxide, yielding a 4S,5S GSH conjugate. The 
basic transferases have a similar, but less pronounced, preference, whereas the 
transferase 7r primarily yields the two 4R,5R GSH conjugates. Human GST µ is 
highly stereoselective for reaction of GSH with (R)-configured oxirane carbon 
atom of the polycyclic arene oxides studied [80]. However, high preference for 
GSH reaction with (S)-configured oxirane carbon occurs with human placental 
GST 7r [80] ( as well as with rat kidney and spleen cytosol [79]). 
The functional properties of different GST isoenzymes appear to reflect the 
structure of their respective active-site regions [62]. It has been suggested that GST 
isoenzymes from different species may therefore have appreciable differences in 
the topography of their active-sites, and that stereoselectivity with epoxide 
substrates might complement existing methods for the functional characterisation 
of different isoforms of GST [81]. It has been found, for rat [34] and elasmobranch 
[87] transferases at least, that the stereospecifity of the isoenzymes towards 
polycyclic arene oxides may be predicted from their subunit compositions and is 
not dependent on subunit-subunit interactions. 
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Figure 1.4 shows two alternative models for the localization of the two active-sites 
of a dimeric GST molecule. Kinetic and equilibrium binding studies indicate that 
each of the two enzyme subunits contains a complete active-site ( composed of both 
the GSH binding site and the hydrophobic binding site) that is topologically 
independent of the second subunit ( as opposed to the concept of shared catalytic 
sites formed at the interface of the two subunits) [63,132,179]. It has been 
suggested that the ability to predict the kinetic behaviour of heterodimeric GST 
isoenzymes from the kinetic properties of the parent homodimers (see Section 
1.1.1.1) seems to exclude the possibility of a shared active-site built by residues 
from two adjacent subunits [63]. However, the subunits are thought to be mutually 
dependent for maintaining the correct polypeptide folding for a catalytically active 




Figure 1.4 : Alternative Models of the Topology for the Two Active 
Sites of a Dimeric GSH S-Transferase Molecule 
The topology to the right appears excluded by kinetic and equilibrium binding data 
(see Section 1.4.1). From reference 179. 
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1.4.2 Kinetic Mechanism 
Detailed investigations of the kinetics of GST have only been performed for a few 
isoenzymes. The most extensive studies have been done with rat liver isoenzyme 
3-3, which is fortunate since the contributions of two non-identical subunits need 
not be considered [179]. 
Using the substrates GSH and 1,2-dichloro-4-nitrobenzene (DCNB), two 
different laboratories reported similar kinetic data for isoenzyme 3-3 [12,132,215] 
although each ascribed different interpretations to their findings. Convex-up 1/v vs 
1/[S] plots, analogous to those seen when a mixture of e~mes with different Km 
values act on the same substrate, were observed when the concentration of GSH 
was varied at constant DCNB concentration [12,215,179]. The deviations from 
Michaelis-Menten kinetics remained even with rigorously purified isoenzyme, 
which implied that they were not caused by inhomogeneous enzyme preparations. 
Furthermore, when the concentration of DCNB was varied at constant GSH 
concentration, the resultant biphasic plots showed the opposite sign of curvature to 
that expected for a mixture of enzymes individually obeying the Michaelis-Menten 
equation [132,133,179]. 
Nonhyperbolic substrate-rate saturation curves are often indicative of co-
operativity, where the Km of the system may alter with changing substrate 
concentration [138]. However, equilibrium binding studies using GSH and the 
GSH·CDNB conjugate, S-(2,4-dinitrophenyl)glutathione, showed that two 
binding sites are present on each enzyme molecule, but did not indicate deviations 
from a simple hyperbolic binding saturation curve [135]. This appeared to exclude 
co-operative interactions (as described by Huang et al. [122]) between two non-
identical ligand binding sites of an enzyme molecule as a cause for the non-
Michaelian kinetics [179]. For a dimer which has two non-co-operative binding 
sites, the microscopic rate constants for the binding of a ligand to a subunit are 
always the same irrespective of the occupancy of the other subunit [135]. The 
possibility of subunit interaction during catalysis was investigated further by use of 
the distinct substrate specificities of rat transferase subunits 1, 2, 3 and 4 [63]. 
These studies demonstrated that the kinetic properties of the heterodimeric 
isoenzymes could be predicted from their corresponding homodimers and 
confirmed the kinetic independence of the transferase subunits. 
A further possible cause of non-hyperbolic kinetics was thought to be partial 
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inhibition ( entailing alternative reaction pathways) by ethanol, the solvent used to 
dissolve the electrophilic substrate; this type of inhibition would introduce higher 
degree terms into the rate equation [134). However, non-specific inhibition was 
observed experimentally, and the non-hyperbolic kinetics remained even with 
extrapolation to zero ethanol concentration [134). Since measured reaction rates 
were found to be proportional to the enzyme concentration [13), association-
dissociation of the enzyme was also eliminated as a possible explanation. It was 
therefore concluded that the explanation for the apparently unusual rate behaviour 
of this homodimeric isoenzyme must be sought in kinetic effects [63). 
Based on kinetic and product inhibition data, Pabst et al. [215) proposed a hybrid 
kinetic mechanism in which the concentration of the acceptor substrate governs 
the flux ratio of two alternative reaction pathways. At concentrations of GSH 
greater than approximately 0.1 mM, an ordered sequential mechanism prevailed, 
with GSH binding first and then the electrophilic substrate (with the GSH still 
bound to the enzyme). The order of addition with high GSH is derived from the 
finding that the product is competitive with GSH and non-competitive with DCNB 
[215). At concentrations of GSH below about 0.1 mM, the reaction followed a 
ping-pong mechanism, with the electrophilic substrate leaving before the GSH 
bound to the enzyme [39,215). 
In accordance with a prediction of the general rate equation for this mechanism, 
V (Eqn. 1) 
where Vi(i = 1-3) and KjU = 2-7) are constants and A and B are substrate 
concentrations [179), the breakpoint in the biphasic double-reciprocal plot for 
GSH saturation was found to shift to lower GSH concentrations as the 
concentration of the electrophilic substrate was lowered [138]. Under physiological 
conditions ( 1-10 mM GSH) the ordered sequential mechanism would 
predominate [137,215]. 
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On the basis of kinetic and binding data, Mannervik and his co-workers [12,132] 
suggested a steady-state random sequential mechanism to explain their non-
Michaelian kinetic data. This mechanism, in which either substrate may bind first 
and both substrates bind before any product is released, is shown below, 




P = Conjugate 
where E = enzyme, B = DCNB, A = GSH and P = the GSH · DCNB conjugate. 
The observed non-linearity in the kinetic plots was thought to be due to product 
inhibition, not to a complex kinetic mechanism (132]. 
In its simplest form, the steady-state random sequential mechanism has the rate 
equation: 
V = (Eqn. 2) 
where Vi(i = 1-3) and KjU = 1-7) are constants, but are not equated, in terms of 
their elementary rate constant composition, with the coefficients Vi and Kj of 
Eqn. 1 (179]. 
Stereochernical investigations of the enzyme-catalysed reaction have helped to 
clarify the kinetic mechanism of the GSTs. A ping-pong reaction should show a 
double ( or even number of) displacement(s), and retention of the stereochernical 
configuration on formation of the GSH adduct [39]. On the other hand, a 
sequential mechanism would result in a single ( or odd number of) displacement(s), 
with inversion of configuration at the reaction site [39,179]. Abdel-Monem and 
co-workers [176,237], using chiral (1-haloethyl)benzenes and 2-halooctanes as 
substrates for transferases 3-3 and 1-2, observed inversion of configuration of 
the S-3 stereoisomer at the benzylic carbon atom. A single ( or odd-numbered) 
displacement was observed at both low and high GSH concentrations, thus 
favouring a random sequential kinetic mechanism over a ping-pong model (39]. 
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Mannervik and colleagues, in order to discriminate between these rival models, 
performed an analysis of both their own initial rate data and those of Pabst et al. 
(215] using non-linear regression methods [178,184]. This discrimination was based 
on the criteria detailed by Mannervik (177], and included an assessment of the 
'goodness of fit' of the model rate equations to the experimental data. 
Because the constants in multi-parameter models such as Eqn. 1 are highly 
correlated through the variance-covariance matrix, it was impossible to obtain 
accurate estimates for individual constants (63]. Use was therefore made of the 
asymptotic properties of the rate equations (177]. At sufficiently low 
concentrations of A and B the terms containing second-power concentration 
factors become negligible. Under these conditions Eqn. 1 degenerates to: 
VAB 
V = (Eqn. 3) 
K" A + K" ' B + AB 
and Eqn. 2 to: 
VAB 
v= (Eqn. 4) 
K' + K"A + K" ' B + AB 
where 
{K,. K1JS } V = V/D, K' K/D, K" ID, v1 
{K,- K1JS } / D, K''' 
v1 
and 
I , + v2 { K1JS } + V3 { K,K, } D = - IS IS v1 v1 v1 v1 
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The results of the analysis showed that the K1 term was required for a good fit of 
the rate equation to the experimental data (in both the complete as well as the 
degenerate rate equations), and that Eqn. 4 fitted the data better than Eqn. 3 at 
low substrate concentrations [184]. This was also found to be the case when the 
original initial rate data of Pabst et al. [215] were similarly analysed [184]. 
Mannervik concluded that this finding ruled out a reaction scheme involving a 
ping-pong branch, since any such scheme could never yield a constant term in the 
rate law [179]. 
Further evidence in support of a steady-state random sequential mechanism has 
come from double inhibition experiments involving S-substituted GSH derivatives 
with GST 3-3 [133]. 
A random sequential mechanism has also been proposed for isoenzyme 1-1, 
based on kinetic and binding studies involving a spin-labelled product analogue 
[249], and for isoenzyme 4-4, in studies involving product inhibition and 
alternative substrates [53,54 ]. An acidic GST isoenzyme isolated from human liver 
also demonstrated non-hyperbolic kinetics, although the enzyme preparation was 
apparently not homogeneous [159]. Non-linear kinetics have also been observed 
for the human erythrocyte GST enzyme with respect to both GSH and CDNB 
[118]. 
Still apparently unresolved, however, was the belief that none of the simple 
classical mechanisms explained the higher-degree dependence of velocity on 
substrate concentration observed in the absence of inhibitors [133]. Several 
alternate mechanisms and modifications to the steady-state mechanism were 
investigated in an attempt to explain the apparently anomalous non-hyperbolic 
kinetics of GST 3-3 for the conjugation of DCNB and GSH. Explanations have 
included the superimposition of product inhibition on the steady-state mechanism 
[132,133], and the suggestion that the basic sequential model may be overlaid with 
the kinetic complications inherent in an 'enzyme memory' mechanism involving 
GSH-induced slow transitions [ 179] ( discussed further in Section 4.5). Mannervik 
[63] has suggested that the only remaining explanation for the non-Michaelian rate 
behaviour appears to be an enzyme memory mechanism involving slow conforma-
tional changes of the protein between kinetically stable states. Conformational 
changes have also been invoked by Radulovic and Kulkarni [232] to explain the 
observed non-Michaelian behaviour of human placental GST using ethacrynic acid 
as the substrate. 
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1.5 NON-SUBSTRATE LIGAND BINDING 
Early investigators identified a protein in rat liver cytosol that bound a number of 
hydrophobic compounds [154,197], and this protein was termed 'ligandin' in view 
of its broad affinity for non-substrate ligands (171 ]. Later, a ESP-binding ligandin 
in hepatic cytosol was found to possess GST activity (146], and immunochemical 
studies established that transferase 1-2 and ligandin were one and the same 
protein (106]. It is now known that the majority of GSTs in both rat and human 
tissues are able to reversibly bind a variety of non-substrate ligands, including a 
number of endogenous ligands, such as haem and bilirubin (136,155]. 
The methods used to measure non-substrate ligand binding to the GSTs have been 
reviewed by Boyer (39]. These include circular dichroism, equilibrium dialysis and 
fluorescence spectroscopy. Because the binding characteristics of the transferases 
for different ligands can vary considerably under different conditions, such 
variables must be taken into account when comparing the results of different 
binding studies [ 41 ]. 
The binding of a number of non-substrate ligands has been investigated and some 
of the reported binding constants for the GSTs are shown in Table 1.10. The 
inhibitory effect (150 values) of non-substrate ligands on the CDNB-conjugating 
activity of the transferase subunits has been used to discriminate between the 
various classes of rat [114,281,325] and human [280,281] isoenzymes (see Section 
1.1.1.1). 
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1.5.1 Physiological Significance of Binding 
The GSTs may function as intracellular transport and storage proteins, perhaps by 
increasing the solubility of non-polar endogenous compounds and xenobiotics and 
therefore facilitating their cytosolic transport between intracellular membranes 
[39]. This suggestion is supported by a mathematical model [291], although some 
doubt has been cast on the ability of the transferases to remove membrane-
associated molecules [ 43]. This would make facilitation of ligand transport by the 
transferases dependent on the rates of desorption of ligand into the cytosol, which 
are thought to vary considerably [39,43]. 
The correlation between hepatic ligandin levels and the hepatic uptake of organic 
anions suggested that the transferases may also play a part in the hepatic and renal 
uptake and excretion of organic anions [43]. However, increasing the intrahepatic 
ligandin concentration did not influence the rate of influx of bilirubin into the 
hepatocyte [323]. Scriven et al. [250] have suggested that human GSTs may only 
play a minor role in bile acid transport in vivo. 
Because of the poor aqueous solubility of haemin (see Section 1.7) it has been 
suggested that the GSTs may be involved in the intracellular solubilisation of 
haemin, in much the same manner as serum albumin is thought to function 
extracellularly [110,136]. The affinity of the GST isoenzyme from human 
erythrocytes for haemin was found to approximate that of bovine serum albumin 
for the same compound [110] and in addition, haemin has been found to be the 
only non-substrate ligand which binds with high affinity to the human GSTs [284]. 
The binding of haem to the transferases has not been studied extensively, although 
a specific role for the GSTs in haem transport from mitochondria has been 
suggested [110,124,306]. Consistent with this suggestion, the protein responsible for 
haem transfer from the mitochondria to apocytochrome b 5 has been isolated and 
identified as a cytosolic GST [253]. 
Rat liver GSTs containing subunits 3 or 4 have been shown to bind dexamethasone 
and corticosterone with greater affinity than putative glucocorticoid receptors 
[120,121], suggesting a potential role for these transferases in intracellular steroid 
hormone transport. 
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1.5.2 Stoichiometry of Binding and Relationship Between Binding and 
Catalysis 
In many early studies, it was suggested that non-substrate ligand binding occurred 
at the catalytic site, since ligands were competitive inhibitors of the reactions 
catalysed by the transferases [37,150,293]. Although competitive inhibition has 
been observed in subsequent investigations for several substrates and transferases, 
other combinations displayed complex inhibition patterns [312]. These results have 
provided evidence for other binding sites distinct from the catalytic site. However, 
the relationship between the non-substrate ligand binding site(s) and the acceptor 
substrate site is still unresolved and is therefore of considerable interest. 
In addition to the complex non-competitive inhibition patterns described above, 
there is other experimental evidence in support of non-substrate ligand binding 
sites which are distinct from the enzyme active-site. For example, blocking the 
binding of bilirubin to ligandin with dimethylsuberimidate did not decrease 
enzymic activity, implying that the bilirubin binding site and active-site are discrete 
entities [30]. Transferase 2-2 and to a lesser extent, transferase 1-2 have also 
been shown to retain catalytic activity in the presence of bound non-substrate 
ligand [39,41,307,311]. 
Furthermore, inhibition by non-substrate ligands has been shown to be dependent 
on incubation conditions, for example, bilirubin is a much less effective inhibitor of 
transferase 1-2 at pH 7.4 than at pH 6.5 [307]. Boyer et al. [41] also observed less 
inhibition at higher pH values when transferases 1-2 and 2-2 were incubated 
with a variety of non-substrate ligands, although the inhibition of transferase 1-1 
was the same over the entire pH range. The observed inhibition in both studies 
could not be explained simply by a pH-induced loss in enzyme affinity for the non-
substrate ligands, but was consistent with the formation of different ternary 
enzyme-substrate• inhibitor conformers at different pH values [39,307]. The 
conformers formed at pH 6.5 had little enzymic activity, while those formed at pH 
7.5 retained significant catalytic activity. Allosteric modifications of the 
isoenzymes, which may differentially affect substrate binding, are thought to 
explain these findings [311]. 
In addition, some non-substrate ligands, notably 2,4,5-trichlorophenoxyacetic acid 
and several other phenoxyherbicides, have been found to reversibly activate rather 
than inhibit the activity towards CDNB of GSTs 2-2 and 1-2 [310,311]. 
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Therefore, evidence for distinct binding sites for non-substrate ligands includes the 
retention of enzymic activity in the presence of some bound non-substrate ligands, 
the formation of catalytically active enzyme· substrate· inhibitor complexes at high 
pH values, and the fact that some non-substrate ligands stimulate rather than 
inhibit enzyme activity. 
The stoichiometry of non-substrate ligand binding to the GSTs is still unresolved, 
but indications are that the number of binding sites may vary for different 
isoenzyme/non-substrate ligand combinations. Based on patterns of inhibition by 
non-substrate ligands, Vander Jagt and colleagues [304,306,307] have proposed 
that GSTs from rat and human liver contain at least two binding sites for non-
substrate ligands, one specific for bilirubin and the other(s) capable of binding a 
number of non-substrate ligands. A bilirubin binding site that was distinct from the 
catalytic site was also reported for human placental GST, after bilirubin was found 
not to inhibit the activity of the enzyme even at concentrations sufficiently high to 
quench most of the protein fluorescence [308]. The GSTs of human liver and 
placenta bind both bilirubin and haematin at sites distinct from the catalytic site 
[145,304,306-308]. Interestingly, this property of unique binding sites for bilirubin 
and haematin is also shared by human serum albumin [305]. 
The nature of the binding of bilirubin to subunits 1 and 2 is still uncertain. Some 
investigators found that transferase 1-1 bound, with high affinity, two molecules 
of bilirubin per enzyme molecule [30-32]. Since transferase 2-2 lacked a high 
affinity bilirubin site, and transferase 1-2 was found to have only one such site, the 
high affinity bilirubin binding site was apparently situated on subunit 1 [150,155]. 
Similar findings were reported for the binding of lithocholic acid to transferases 
1-1 and 1-2 [116,282,283]. Other binding studies are at variance with these 
conclusions, for reasons which are not clear. A single binding site was found for 
bilirubin [ 40,49], BSP [ 40] and oestrone sulphate [ 49] on transferase 1-1. A single 
binding site has also been reported for five transferases (1-1, 1-2, 3-3, 3-4 and 
4-4) with bilirubin, haematin and BSP [277]. If the transferases have only one 
binding site for non-substrate ligands, then either the site may not reside on a 
specific subunit but may be formed by subunit interaction [37,40,49,191] or binding 
of the first non-substrate ligand molecule may prevent binding of the second [39]. 
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1.5.3 Covalent Binding 
In addition to the reversible binding of the non-substrate ligands, a number of 
compounds (including carcinogenic aminoazo dyes and polycyclic hydrocarbons) 
covalently bind to the transferases [137]. This 'suicide inhibition' may be an 
additional protective mechanism for the cell, in which the transferases act as 
scavengers of potentially harmful electrophiles [139,272]. 
1.6 BIOLOGICAL REGULATION 
A complex regulatory mechanism to control the expression of GSTs is thought to 
exist, resulting in the observed variations in the distribution of GST isoenzymes 
and their different substrate specificities (for a review, see reference 222). 
Differences in GST distribution and activities, both between foetal and adult rats 
and between male and female rats, have been reported (reviewed in 179). Some 
studies have described the hypothalamic and pituitary modulation of the gonadal 
control of GST in rat liver [166,179]. The marked induction of placental GST in 
preneoplastic tissue (see Section 1.1.2) and the resultant resistance to some 
cytotoxic drugs has been the subject of considerable research. There is also 
evidence that interferon is an endogenous inducer of the placental GST, although 
links between the anti-cancer activity of the interferons and the GSTs remain 
speculative [2]. 
Glutathione S-transferase activity can be induced by several classes of 
compounds, and isoenzyme patterns may also be altered [78,137,179,222,313]. 
Phenobarbital and 3-methylcholanthrene both induce levels of subunits 1 and 3 in 
rat liver, as do food additives such as butylated hydroxyanisole [70,75,77,101, 
224,263]. Divergent regions of three cDNA clones have been used to demonstrate 
induction by phenobarbital of levels of the mRNAs corresponding to rat subunits 
1, 2 and 3 [224 ]. Such changes have potential importance in the toxic consequences 
of xenobiotic metabolism. 
1.7 MICROPEROXIDASE-8 : A MODEL COMPOUND FOR STUDIES OF 
HAEM/PROTEIN INTERACTIONS 
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Haemin (ferriprotoporphyrin IX) is one of the most physiologically important non-
substrate ligands of the GSTs (see Section 1.5.1) and although a number of studies 
of its interaction with the enzyme have been published [110,277,306], the kinetics 
of the interaction have not been described. In addition to its physiological 
significance, haernin is an attractive candidate for a kinetic study of non-substrate 
ligand/GST interaction, since perturbation of the intense Soret peak of the 
metalloporphyrin on interaction with proteins facilitates monitoring of the binding 
reaction at low enzyme and ligand concentrations. 
One of the factors which complicates investigations of haem/protein interactions is 
the poor solubility of haemin in aqueous solutions. Haemin precipitates from 
aqueous acidic and neutral solutions, and exists as a mixture of monomeric hydroxy 
and dimeric µ-oxo forms in aqueous alkaline solutions, even at sub-micromolar 
concentrations [11,110]. Several approaches, such as the use of detergents or 
aqueous/non-aqueous solvent mixtures, have been used to overcome the problems 
of haemin aggregation [11]. However, the ligand-binding behaviour of haernin can 
be altered by the nature and concentration of these detergents and non-aqueous 
solvents [11]. 
A possible alternative to the use of haernin per se entails the utilisation of water-
soluble haempeptide fragments of cytochrome-c as model compounds for mono-
meric haernin. Several of these haempeptides ( the microperoxidases) can be 
obtained by enzyrnic degradation of cytochrome-c, with each haempeptide 
retaining different numbers of amino acid residues from the parent compound ( see 
Figure 1.5). 
Microperoxidase-8 (MP-8) is the ferrihaem-c containing octapeptide derived from 
cytochrome-c. Amino acid residues 14 to 21 of cytochrome-c are retained and 
the haem moiety remains covalently linked by thioether bridges to Cys-14 and 
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Cys-21 [302]. In aqueous solution at pH 5-8, it is thought that the ferric ion of 
MP-8 is six-coordinate with His-18 and that a water molecule is axially ligating 
positions 5 and 6 [109]. MP-8 has been found to be monomeric at micromolar/ 
submicromolar concentrations at pH 7 in aqueous solution [11]. This important 
property has facilitated the use of MP-8 as a chemical model for both the 
cytochrome P-450 enzymes [3,4], and the activation of hydrogen peroxide by the 
peroxidases [22]. 
Dr Paul Adams, of this university, has proposed that the microperoxidases may 
also prove valuable as sterically-hindered model compounds for investigating the 
mechanism of interactions of monomeric haemin with haem-binding proteins in 
aqueous solution. We have therefore recently investigated the interaction of 
MP-8 with two such proteins, human serum albumin [6] and apo-myoglobin 
(Adams, Goold & Thumser, unpublished results). Although details of these 
investigations are not given in this thesis since they are outside the immediate 
scope of this study, some of this work has been recently accepted for publication 
[6], and is included as Appendix 1. These studies have already confirmed that 
MP-8 may indeed be a valuable mechanistic analogue of monomeric haemin and 
accordingly, they have now been extended here to the GSTs, another important 
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Figure 1.5 : The Haem-Peptides from Cytochrome-c 
The numbering of the amino acid residues refers to the original protein sequence of 
horse-heart cytochrome-c. Adapted from Reference 21. 
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1.8 OBJECTIVES OF THIS STUDY 
This investigation is broadly concerned with aspects of the kinetics, binding and 
inhibition of the GSTs, a group of multifunctional enzymes of drug and xenobiotic 
metabolism (reviewed in this chapter). Both the steady-state kinetics of the GST-
catalysed conjugation reaction and the kinetics of binding of substrates and non-
substrate ligands to the enzyme have been investigated and are reported here. 
One of the primary objectives of this study was to confirm the biphasic kinetics 
previously reported [12,132,215] for the conjugation of GSH and DCNB by GST 
isoenzyme 3-3 and to propose an explanation for the apparently unusual steady-
state kinetics (see Section 1.4.2). The kinetics of the conjugation of CDNB and 
GSH by GST 3-3 and of DCNB by GST 3-4 were also investigated. Details of 
these studies are given in Section 3.3. 
In order to carry out steady-state kinetic studies with a high degree of accuracy and 
reproducibility, a preliminary optimisation of the GST assay system was 
performed. Factors investigated included the selection and suitability of 
spectrophotometric instrument, choice of solvent for CDNB and DCNB, the order 
of addition of reagents, and the linearity of initial rates in the standard GST assay. 
These preliminary experiments are described in Sections 3.1. 
The isoenzymes which have to date been subjected to the most detailed steady-
state kinetic analysis, 3-3 and 3-4, both belong to class Mu of the GSTs. 
Therefore, it was decided to isolate representative homodimeric isoenzymes from 
the other two classes of GST (Alpha and Pi) and to characterise their kinetic 
mechanism, in order to determine whether other classes of GST exhibit similar 
biphasic kinetics. The GST isoenzymes selected for study were human placental 
GST 7T (Class Pi) and rat liver GST 2-2 (Class Alpha). The results of these steady-
state kinetic studies are reported in Section 3.3. 
It was originally thought that the non-Michaelian kinetics observed with rat liver 
GST 3-3 might be caused by co-operative binding between the enzyme subunits 
[138]. However, this possibility seems to have been excluded by equilibrium 
dialysis studies of the binding of the substrate GSH to isoenzyme 3-3 [135] (see 
Section 1.4.2). In order to investigate the possibility of co-operativity between the 
subunits of human placental GST, a similar equilibrium dialysis study of GSH 
binding to GST 7T was performed (these results are presented in Section 3.4). 
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Ethylene dibromide reportedly binds to DNA irreversibly in a reaction catalysed 
by GST when they are incubated together at 37°C for 2 hours [127]. These results 
were re-evaluated here in view of the observation in this laboratory that EDB 
irreversibly inhibited selected GST isoenzymes [131]. In these experiments 
( described in Section 3.1), it was hoped to show that this irreversible inhibition is a 
factor in determining the extent of DNA binding by EDB in vivo. 
As described in Section 1.5.1, one of the most biologically significant of the non-
substrate ligands of the GSTs is haemin. In this investigation, an attempt has been 
made to kinetically characterise the interaction of haemin with human placental 
GST using microperoxidase-8 (MP-8), a sterically hindered analogue of proto-
porphyrin IX. Unlike haemin, MP-8 remains monomeric in aqueous solution at 
experimentally useful concentrations, facilitating its use as a chemical model for 
monomeric haemin (see Section 1.7). 
Conventional methods for the preparation of MP-8 are time-consuming (8-10 
days) and result in relatively poor yields of a product that is only approximately 
90% pure. Although a recent HPLC-based method [4] has enabled the preparation 
of MP-8 of higher purity in a shorter time, a requirement for MP-8 of still higher 
purity in kinetic studies (such as those of this investigation) prompted attempts 
here to further optimise the preparative schedule for the haempeptide ( described 
in Section 3.5). 
Investigations to date into the interaction of non-substrate ligands with the GSTs 
have been almost exclusively thermodynamic in nature, despite the fact that such 
studies do not permit unambiguous mechanistic interpretation when taken in 
isolation (see Section 4.7). In this study, the kinetic mechanism of the interaction 
of MP-8 and GST was investigated both by examining the inhibition by MP-8 of 
the steady-state GST-catalysed conjugation between GSH and CDNB (Section 3.7) 
and by direct observation and analysis of the time-course of the binding process 
(Section 3.6). The latter technique represents the simplest and most direct 'extra-
thermodynamic' method for obtaining information on the ligand/protein 
interaction. By using MP-8 in this novel manner, it was hoped to obtain 
unambiguous information on steric aspects of the haemoprotein binding site(s) 
and their spatial relationship to the catalytic site of the enzyme. The results of 
these investigations are described in Sections 3.6 and 3.7. 
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2. EXPERIMENTAL METHODS 
2.1 MATERIALS AND GENERAL METHODS 
Reagents and solvents were obtained from the sources shown in Table 2.1. 
Reagents were analytical grade wherever possible. Water was double-distilled in 
glass. 
Buffers were prepared with double-distilled water, degassed and adjusted to the 
correct pH value at the temperature of use. Measurements of pH and ionic 
strength were made with a GK 2501C combination glass electrode on a 
Radiometer model I0N83 ion meter (Radiometer, Copenhagen, Denmark), 
calibrated against commercial pH standard buffers. 
2.2 ASSAYS FOR GSH S-TRANSFERASE ACTIVITY 
The activity of GST toward various substrates was determined spectrophoto-
metrically by monitoring the rate of formation of product. The wavelength used 
was the maximum of the difference spectrum between the starting assay mixture 
and the product [107]. Table 1.9 summarises the more frequently used spectro-
photometric methods, details of which are found in several references [39,104, 
107,137]. The cumene hydroperoxide assay was performed according to the 
procedure of Reddy et al. [235]. Some detail is given here for the CDNB and 
DCNB assays since these were the basis of the kinetic studies, and were 
considerably modified for use with the Multistat centrifugal analyser. 
All GSTs conjugate CDNB with GSH, and this 'universal' substrate forms the basis 
of the standard spectrophotometric assay for GST activity (see Section 1.2.1). The 
activity of GST toward CDNB was assayed in this study by modification of the 
method of Habig et al. [107]. Assays were either performed in a Beckman 
UV-5230 spectrophotometer or in a Multistat III Plus centrifugal analyser 
(Instrumentation Laboratory, Lexington, MA), which facilitated the performance 
of more assays in a shorter time than possible in conventional spectrophotometers. 
This was especially important for the kinetic investigations undertaken, where any 
time-dependent loss of enzyme activity should be minimised. The small cuvette 
Table 2.1 Sources of Reagents and Solvents Used 
REAGENT SOURCE 




Albumin (bovine serum) Miles 
Albumin (human serum) Sigma 
Ammonium bicarbonate Merck 
Ammonium hydroxide Merck 
Ammonium persulphate BDH 





Bio-Rad protein assay dye Bio-Rad 
I3romophenol blue Merck 
CDNB Merck 
C\11-Cellulose (CM-52) Whatman 
Chloroform Merck 
Cit ric acid May & Baker 
Copper sulphate Merck 
Cumene hydroperoxide Fluka 
Cytochrome c (horse heart type Ill) Sigma 
DCNB EGA 
Diethyl ether BDH 
1.2-Dimethoxyethane Merck 
Dimethyl sulphoxide Merck 
Dipotassium hydrogen phosphate Merck 
5,5'-Dithiobis(2-nitrobenzoic acid) Merck/Sigma 
Dithiothreitol BDH/Sigma 
DNA (calf thymus) Sigma 
EDTA BDH 
l.2-Epoxy-3-(p-nitrophenoxy)propane Sigma 
Ethacrynic acid Sigma 
Ethanol (SVR; Absolute) Merck/BDH 
Ethanolamine BDH 
Ethr.1ene dibromide BDH 
[U- 4C]EDB (radiochemical purity >98%) Amersham 
Folin-Ciocalteau's phenol reagent Merck 
1-Globulin (bovine) Bio-Rad 
Glycerol BDH 
Trypsin (bovine pancreas type I) Sigma 
Afrox. Cape Town, RSA 
Aldrich Chemicals, Milwaukee, WI, USA 
Amersham International pie, Buckinghamshire, UK 
BDH Chemicals, Poole. UK 
Bio-Rad Laboratories, Munich, FRG 
Calbiochem-Behring, La Jolla, CA. USA 
EGA Chemie, Steinheim, FRG 
Fluka, Buchs, FRG 





S]GSH (radiochemical purity >99.8%) 
GSH Reductase 




























Sodium dihydrogen phosphate 
Sodium dithionite 
Sodium dodecyl sulphate 






Merck Chemicals, Darmsdadt, FR 
Miles Laboratories, USA 
New England Nuclear, Boston, Mass, USA 
Pharmacia, Uppsala, Sweden 
Radiometer, Copenhagen, Denmark 
Riedel-de-Haen, Seelze-Hannover, FRG 
Sigma Chemical Co. St Louis, MO, USA 












































volume (200 µl) enabled economical usage of the enzyme preparation, and the 
centrifugal mixing method allowed absorbance measurements from as little as 
3 seconds after the initiation of the reaction. The centrifugal analyser also 
provided controlled temperature conditions (30.0 ± 0.1 ° C) and enabled more 
precise and reproducible absorbance/tirne measurements than possible using 
conventional manual spectrophotometric methods. 
Twenty cuvettes of 0.50 ± 0.010 cm pathlength are contained in each disposable 
Multistat rotor. Each cuvette consists of two chambers, separated by an internal 
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Figure 2.1 : Multistat Centrifugal Analyser Rotor 
Reagents were added to the inner and outer cuvette compartments as shown in rotor 
cross-section (A-B), with order of addition as numbered. 
The CDNB solution was pipetted into the outer chamber of each cuvette, and the 
enzyme solution into the inner chamber. Immediately prior to analysis, the GSH 
solution was added to the same cuvette compartment as the CDNB. After a short 
incubation period during which the assay temperature was attained, the rotor was 
accelerated to 4 000 rpm and was then briefly stopped (0.5 sec) causing thorough 
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mixing of the reactants. The reaction was therefore initiated by the addition of 
enzyme to the other reactants. Centrifugation then resumed at 1 000 rpm while the 
analyser measured the absorbances of all cuvettes essentially simultaneously. The 
centrifugal analyser used a quartz tungsten light source and narrow bandpass 
340 run optical filter. 
Absorbances were measured at 5 second intervals for a total period of 60 seconds, 
commencing 3 seconds after initial mixing. Initial rates were determined by linear 
least squares regression of these time/absorbance values. Velocities are in 
nmol/min/ml except where otherwise indicated. 
Because GSH reacts at a finite rate with CDNB (and other substrates) in the 
absence of enzyme, non-enzymatic reaction rates, obtained under identical 
conditions of ionic strength, pH and temperature as the enzymic rates, served as 
controls for the spontaneous 'background' rates. Relevant background rates were 
subtracted from enzymatic rates in all cases. 
Stock solutions of GSH were prepared in 0.1 M potassium phosphate (pH 6.5), 
readjusted to pH 6.5 with 1 mM KOH and kept under nitrogen in an ice-bath to 
prevent oxidation. Oxidised glutathione (GSSG) is an inhibitor of several of the 
GST isoenzymes [39]. Because of its limited aqueous solubility, CDNB was first 
dissolved in dimethyl sulphoxide (DMSO), and then diluted with the buffer used in 
the assay (0.1 M potassium phosphate (pH 6.5)), to make a premixed stock 
solution. This technique was employed in order to avoid the precipitation of 
CDNB on the walls of the cuvette. This has been observed when addition of 
CDNB solutions in organic solvent is made directly to the assay system [39]. 
Photosensitive solutions containing CDNB were kept in foil-covered amber vials to 
minimise light degradation. In the standard assay, the final concentration of GSH 
and CDNB used was 1 mM, and the final concentration of DMSO in the reaction 
mixture was 2% (v /v). Although substrate concentrations varied in the steady-state 
kinetic experiments, the DMSO component of the solvent was always kept 
constant at 2% (v /v). 
The assay using DCNB as substrate was performed in the same manner as the 
CDNB assay, the only difference being that the assay was performed at pH 7.5 (see 
Table 1.9). 
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2.3 PRELIMINARY EXPERIMENTS 
After the standard assay volume had been scaled down to 200 µl for the centrifugal 
analyser, the assay conditions were optimised and the suitability of the instrument 
confirmed. For CDNB and DCNB, the change in absorbance has been found to be 
a linear function of enzyme concentration and of time for at least 3 min when the 
rate of absorbance change was limited to less than 0.05 units per minute (for a 
pathlength of 1 cm) [104]. Experiments were performed to confirm the linearity of 
the enzymic reaction in the standard assay (1 mM GSH; 1 mM CDNB) with time 
and enzyme concentration, and the photometric linearity of the instrument was 
checked with potassium dichromate standards. Periodically, control enzyme 
preparations having independently determined ~A340/min/ml values were used to 
monitor the performance of the CDNB and DCNB assays. 
The time course experiments were performed with both CDNB and DCNB with 
rat liver GST mix (Sigma), .rat liver cytosol, and purified rat liver isoenzyme 3-4, 
human lung basic, acidic and near-neutral isoenzymes as well as human placental 
isoenzyme n. Initially, readings were taken at 10 sec intervals for 3 min, since 
previous reports had indicated that the reaction appeared linear for at least 3 min 
[104,107]. Also tested were 10 sec intervals for 10 min and 3 sec intervals for 1 min. 
Absorbance/time data were fitted to straight-lined and quadratic functions and 
each tested for randomness by a runs test [279]. The effect of bovine serum 
albumin (120 µM) on the linearity of the standard assay was also investigated. The 
linearity of the standard CDNB and DCNB assays was studied using enzyme 
solutions ranging from 0.5-8 times the concentration which resulted in a rate of 
absorbance change of about 0.025 units (for a pathlength of 0.5 cm). 
Background rates were also investigated to determine the best method to correct 
for non-enzymic conjugation rates. The results of these latter experiments were 
also checked using a carefully calibrated Varian Techtron 635 UV-vis spectro-
photometer with precise temperature control (± 0.02°C), as a standard kinetic 
instrument. 
It is generally considered that solvent concentrations should be kept as low as 
possible to minimise solvent effects on the enzyme [39,104]. It has been shown that 
ethanol inhibits the GSTs at concentratipns of greater than 1 % (v /v) [39], although 
ethanol is still the most frequently used solvent used for CDNB and DCNB in the 
GST assay. Ethanol concentrations of less than 4-5% (v /v) are usually 
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recommended in the standard assay [9,104,107,186,249], although concentrations 
as high as 10% have been used [12). Other organic solvents have been found to be 
less inhibitory to the transferase activity of rat liver cytosolic fraction, at least when 
used as vehicles for DCNB [7). The effects of various organic solvents on the 
activity of the purified transferase isoenzymes used in this study towards both 
CDNB and DCNB were investigated. CDNB and DCNB assays were performed 
with different solvents ( ethanol, acetone, DMSO, 1,2-dimethoxyethane or 
tetrahydrofuran) at concentrations of 0.3-4.5% (v /v). 
The order of addition of reagents to the assay system was investigated since 
preincubation with GSH prior to assay has been reported to activate the enzyme 
[150). Such effects could be significant in kinetic experiments, and must also be 
considered when using certain enzyme preparations, such as rat liver cytosolic 
fraction and the commercially available rat liver GST (Sigma), which both contain 
varying amounts of GSH. Assays were performed at different CDNB concentra-
tions with 1 mM GSH added either to the same cuvette compartment as the 
enzyme, or to the compartment containing the CDNB. The purified isoenzyme 
preparations used (Sigma rat liver GST and rat liver isoenzyme 3-3) were dialysed 
overnight against buffer containing no GSH, to remove any residual GSH present. 
Unpublished observations in this laboratory have indicated that the activity of 
various GST dilutions was greater when water, rather than 0.1 M potassium 
phosphate (pH 6.5) buffer, was used as a diluent. Equivalent dilutions (1/10) were 
therefore prepared in both diluents, using human placental GST, and tested for 
activity after standing on ice for one hour. 
In order to confirm the suitability of the instrument and the reproducibility of 
previous work done in this laboratory, on the reversible inhibition and activation of 
rat hepatic GSH S-transferases by ethylene dibromide [130), these experiments 
were repeated. 
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Inskeep and Guengerich [127) have reported that EDB bound irreversibly to DNA 
in a reaction catalysed by GSTs when they were incubated together at 37 ° C for 
2 hours. These results were re-examined and the conditions of the incubation 
reproduced in view of the observation in this laboratory that EDB irreversibly 
inhibited selected GST isoenzymes [131). Incubations were performed at 37°C in 
polycarbonate centrifuge tubes (Eppendorf, Hamburg, FRG) containing 100 µl 
0.1 M Tris.HCl (pH 7.7), 0.2 mg DNA, 2 mM (or 15 mM) GSH, 5 mM EDB and 
0.4 mg rat liver GST mix (Sigma). The GST activity of the incubation mixture was 
determined at intervals, up to two hours. 
An attempt was also made to assess the binding of [14C]-EDB to DNA under 
these incubation conditions, using four different GST sources (Sigma rat liver GST 
mix, and three GST isoenzymes from human lung - see Section 2.4 ). Incubations 
were performed as described above ( at 2 mM GSH), although only 15 µg of each 
GST was used per experiment, due to the limited availability of the purified 
isoenzymes. The specific radioactivity of the [14C]-EDB used in the incubations 
was 185 MBq/mmol (5 mCi/mmol). The incubations were terminated by the 
addition of 50 mM Tris.HCl buffer (pH 7.7) containing 15 mM sodium citrate and 
1 % (w /v) SDS, and the content of protein, DNA and DNA-bound [14C]-EDB 
were then determined. EDB-bound DNA was purified by extraction with an equal 
volume of a saturated aqueous phenol (twice), after which the aqueous 
supernatant was extracted with an equal volume of chloroform:isoamyl alcohol 
(24:1). Several extractions using diethyl ether were used to remove excess EDB, 
and residual ether was removed under vacuum. 
DNA was determined by the fluorometric Hoechst 33258 assay described by 
Cesarone et al. [50], using a Perkin-Elmer LS-5 Fluorimeter. Protein 
determinations were by the Bio-Rad dye-binding method, using bovine -y-globulin 
as the standard. In order to measure DNA-bound [14C]-EDB, 20 µl aliquots of the 
incubation mixture were added to 5 ml of Beckman RV liquid scintillation cocktail 
and radioactivity was determined using a Packard TriCarb 4640 liquid scintillation 
counter. The results of all the preliminary experiments are presented in 
Section 3.1. 
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2.4 GSH S-TRANSFERASE ISOENZYME PURIFICATIONS 
The rat liver isoenzymes 3-3 and 3-4 used in this study had been purified and 
characterised earlier by others in this laboratory, according to a method described 
previously [131]. Essentially, the method used was similar to that of Guthenberg 
and Mannervik [99], and employed S-hexylglutathione affinity chromatography 
and chromatofocusing to isolate the isoenzymes. Human lung acidic, basic and 
near-neutral isoenzyme samples were the gift of Ms A Corrigall, UCT Department 
of Medicine. The methods used in this investigation to isolate human placental 
GST n and rat GST 2-2 are described below. 
The protein concentrations of cytosolic tissue fractions were determined by the 
method of Lowry et al. [173], while the Bio-Rad assay (based on the dye-binding 
method of Bradford [45]) was used for subsequent purification steps. The Bio-Rad 
microassay (for protein concentrations in the range 1-20 µg) was performed 
according to the manufacturer's instructions. For both methods of protein 
determination, bovine -y-globulin was used as the standard. Activity towards CDNB 
was used to monitor GST throughout the purifications and this activity, together 
with those towards other substrates, were determined as described in Section 2.2. 
SDS-PAGE was performed by the method of Laemmli [164], using molecular 
weight standards (BDH) to determine the homogeneity and apparent M, of the 
isoenzyme preparations. The results of the purifications are found in Section 3.2. 
2.4.1 Purification of Human Placental GSH S-Transferase n 
GSH S-transferase n was isolated from human placental tissue by affinity 
chromatography and HPLC, essentially according to the method of Radulovic and 
Kulkarni [231,232] with several modifications, as detailed below. 
Placentae were collected from non-smoking women at the time of elective 
Caesarean deliveries at Groote Schuur Hospital, Cape Town, within 30 min of 
parturition and were maintained at 4 ° C thereafter. The placental tissue was 
cleared of amniotic membranes, and approximately 150 g of tissue was cut into 
small pieces, washed copiously with cold 50 mM Tris (pH 7.4 at 4°C) to remove 
residual blood, minced and homogenised in approximately 750 ml of the same 
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buffer. The cytosol was centrifuged at 12 250 g for 20 min in a Beckman 12-21 
centrifuge (JA14 rotor), and the supernatant was filtered through cheesecloth to 
remove floating lipid material. The supernatant was then centrifuged at 100 000 g 
for 60 min in a Beckman L8-70 centrifuge (50.2 Ti rotor). 
Epoxy-activated Sepharose 68 (Sigma) was derivatised with GSH by the method of 
Simons and Vander Jagt [257,259]. Supernatant containing approximately 400 U of 
enzyme activity was added to a beaker containing the GSH-affinity gel, 
equilibrated with 50 mM Tris buffer (pH 7.4 at 4°C), and gently stirred for 5-10 
min. The coupled gel was then poured into a column (2.2 x 13 cm), which was 
washed through with the same buffer until protein (Ai30) was no longer detected 
in the effluent. The GST activity was eluted from the matrix with 50 mM Tris 
containing 10 mM GSH (pH 9.6 at 4 °C), and collected in 1 ml fractions. The flow 
rate was maintained at 0.5 ml/min throughout. Fractions with GST activity were 
pooled, concentrated using an Amicon PlO membrane to a protein concentration 
of 0.5-10 mg/ml, and then adjusted to pH 7.4 with 1 M KH2P04. The pooled GST 
was dialysed overnight against 10 mM potassium phosphate buffer (pH 6.0) 
containing 10 mM GSH before anion exchange HPLC. 
A Beckman gradient control HPLC system ( comprising two model 1 lOA pumps, a 
model 420 controller and a model 163 variable wavelength detector set at 280 nm) 
was used in conjunction with a Spectra Physics SP4290 electronic integrator. 
In initial purifications, a Beckman DSK SBW anion exchange column was 
employed, although later the Synchrom AX-300 (Synchrom, Lafayette, IN) became 
the column of choice. The mobile phase consisted of a 5.5 mM citrate/potassium 
phosphate buffer t (pH 5.85) containing 1 mM dithiothreitol (DTT) and 10 mM 
GSH (Buffer A), and Buffer A containing 400 mM KCl (Buffer B). Two different 
but rapidly inter-convertible charge isomers of GST 7r may be obtained, depending 
on the GSH concentration in the mobile phase of the HPLC step [232]. The use of 
10 mM GSH, as in this study, results in the purification of human placental GST 
primarily as conformer A(± 96% of recovered GST activity) [232]. All buffers for 
HPLC were degassed and filtered (0.22 µm) before use. 
t 19.7 ml of 25 mM citric acid & 30.3 ml of 50 mM dibasic potassium 
phosphate/100 ml 
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The enzyme solution was filtered (Millipore Millex GV 0.22 µm) before 500 µl 
(approximately 0.45 mg protein) aliquots were injected onto the column. Elution 
gradient was as follows: buffer A (1 ml/min) for 5 min; the percentage of buffer B 
was increased to 7.5% over 3 min and then to 100% over 1 min. At 16 min, the 
percentage of buffer B was decreased to zero over 2 min (1.5 ml/min), followed by 
re-equilibration with buffer A for 25 min. Fractions (1 ml) containing GST activity 
towards CDNB were pooled and dialysed overnight against 10 mM potassium 
phosphate buffer (pH 7.4) containing 1 mM DTT, to remove the GSH, before 
storage at 77 K. 
2.4.2 Purification of Rat Hepatic GSH S-Transferase 2-2 
This isoenzyme was selected for study because it is a homodimeric representative 
of the Alpha class of GSTs, for which detailed kinetic investigations have not yet 
been performed. Initially, attempts were made to isolate 2-2 from rat adrenal 
tissue, where it is the predominant GST isoenzyme (151]. The purification method 
used for adrenal tissue was analogous to that described below for isolating 2-2 
from rat liver, except where otherwise specified. 
Since isoenzyme 2-2 has been reported to be readily isolated using CM-cellulose 
chromatography (39], this step was central to the chosen purification method. A 
GSH-affinity column preceded the anion-exchange step, in order to remove non-
GSH-specific proteins. The GSH-affinity step was modified from that described by 
Boyer et al. [ 40]. 
Male Long-Evans rats (180-200 g) were permitted free access to water and Epol 
laboratory chow (protein min 20%; fat 2.5%; fibre 6%; calcium 1.4%; phosphorus 
0.7%) obtained from Epol Ltd., Goodwood, Cape, RSA. 
Two animals were sacrificed by cervical dislocation, and their livers immediately 
excised and maintained at 4 ° C thereafter. Approximately 19 g of tissue was cut 
into small pieces, washed copiously with 25 mM sodium phosphate buffer (pH 9.4) 
to remove residual blood, minced and homogenised in the same buffer (± 25% 
homogenate). In the adrenal purification, one hundred rats were sacrificed to 
obtain 9 g of tissue. The cytosol was centrifuged at 12 250 g for 20 min in a 
Beckman L8-70 centrifuge, and the supernatant carefully removed without 
disturbing the floating lipid material. The supernatant was then centrifuged at 
100 000 g for 60 min in the same centrifuge. 
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The GSH-affinity matrix was prepared as described earlier (Section 2.4.1). The 
supernatant from the previous step was poured through Whatman No. 1 filter 
paper into a beaker containing the GSH-affinity gel, equilibrated with 25 mM 
sodium phosphate buffer (pH 9.4). The slurry was gently stirred for 5-10 min. The 
coupled gel was then poured into a column (1 x 13 cm), which was then washed 
through, as soon as the gel had settled, with 25 mM sodium phosphate buffer 
containing 150 mM NaCl (pH 9.4) until protein (Azs0) was no longer detected in 
the effluent (about four column volumes). The GST activity was eluted from the 
matrix with 25 mM sodium phosphate buffer containing 150 mM NaCl & 100 mM 
GSH (pH 9.4 ), and collected in 1 ml fractions. The flow rate was maintained at 
0.5 ml/min throughout. Fractions with GST activity were pooled and dialysed 
overnight against 10 mM potassium phosphate buffer (pH 6.0). 
Twenty grams of CM-Cellulose (Whatman CM-52) was prepared according to 
the manufacturers' instructions (method B), poured into a column (1.5 x 20 cm) 
and equilibrated with 10 mM potassium phosphate buffer (pH 6.0; µ = 0.1). Care 
was taken to ensure that the pH of the loaded and effluent buffer was the same to 
ensure thorough equilibration. The pH and ionic strength of the enzyme sample 
were corrected (if necessary) before application onto the column, and the gel was 
then rinsed with one column volume of the same buffer. The transferase 
isoenzymes were eluted with a 24 hr linear gradient of Oto 75 mM KCl in 10 mM 
potassium phosphate buffer (pH 6.0), using LKB Bromrna (Ultrograd 11300) 
gradient mixing apparatus. The flow rate was 0.5 ml/min, and 2.5 ml fractions were 
collected. Care was taken not to stop the flow through the column for more than 
30 sec at any one time during the sample loading or buffer changing operations, to 
prevent local effects at the interfaces. 
The active fractions were separately pooled and dialysed overnight against 10 mM 
potassium phosphate buffer containing 1 mM DTT (pH 7.4), to remove GSH 
before storage at 77 K. 
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2.5 STEADY-STATE KINETIC STUDIES 
2.5.1 Initial Velocities in the Absence of Products 
The steady-state kinetic experiments of Pabst et al. [215] using transferase 3-3 and 
DCNB were repeated. Similar studies were conducted with isoenzymes 3-3 and 
CDNB, and 3-4 with DCNB. The activity of the GST isoenzymes toward DCNB 
and CDNB was determined using the centrifugal analyser as described in 
Section 2.2. All solutions were prepared freshly each day, and isoenzymes (stored 
at 77 K) were thawed when required and allowed to stand for a fixed period of 
time prior to use. Grouped kinetic assays were designed to be performed on one 
day, using one enzyme sample. The enzyme sample was checked for any loss of 
activity after the experiment, and all enzymic assays were completed before the 
control non-enzymic reactions were begun. 
Among the substrates commonly used to characterise the GSTs, the compound 
which has the highest specific activity with human placental GST is CDNB 
[100,232]. The steady-state kinetics of this isoenzyme were therefore investigated 
with this substrate. In order to determine the optimum range of substrate 
concentrations for the estimation of the kinetic parameters ( and to ensure that the 
breakpoint in the expected biphasic kinetics was evident), a number of preliminary 
experiments were performed using different concentration ranges of GSH and 
CDNB. The ranges initially used were based on previously reported values of the 
apparent kinetic constants [16,100,186,216]. Once suitable ranges were 
determined, initial rate measurements were performed over an eight by eight 
matrix with respect to the concentrations of GSH (0.04-1 mM) and CDNB 
(0.1-1 mM) (192 data points). The steady-state kinetics of isoenzyme 2-2 using 
CDNB. as substrate were investigated in a similar manner. The results of the 
steady-state studies using GST 1r and GST 2-2 are found in Sections 3.3.2 and 
3.3.4, respectively. 
The activity toward CDNB was determined using the centrifugal analyser as 
described in Section 2.2. DMSO was used as the solvent for CDNB, with the final 
DMSO concentration constant in all assays at 2% (v /v). Assays were performed in 
triplicate. 
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For visual assessment, the data were plotted according to the Lineweaver-Burk 
method, and approximate values of the apparent Km and V max for each substrate 
were obtained from the various plots and replots [252]. However, final parameter 
estimation was always carried out using non-linear least-squares optimisation. 
Non-linear least squares regression analyses were performed by the iterative 
method of Duggleby [82] using the software package Enzfitter (Elsevier-BIOSOFf) 
[167]. The initial parameter estimates required for the iterative process were either 
obtained from replots of the data, or were calculated by the computer program. 
Throughout this thesis, where a factor is indicated in the label of a figure axis, this 
is the number by which the values given on the axis must be multiplied to give the 
actual values observed. 
2.5.2 Initial Velocities in the Presence of Product 
The products of the reaction of GSH and CDNB are the conjugate, S-(2,4-
dinitrophenyl)glutathione, and chloride ion. No inhibition by chloride, at 
concentrations of up to 0.1 M, has been observed towards rat liver GST 3-3 
[132,215] or GST 1-1 [249]. The inhibition of human placental GST and rat liver 
GST 2-2 by 0.1 M chloride (as KCl) was investigated in the standard CDNB 
assay. 
The inhibition of placental GST 1r by the CDNB 0 GSH conjugate (see Section 2.5.3 
for method of preparation of the conjugate) was investigated with a five by five 
matrix of concentrations of GSH (0.15-1 mM) and CDNB (0.3-1 mM). Each 
point in the matrix was assayed in the absence of conjugate and at 35, 65 and 
100 µM conjugate (300 data points). The GST assays were performed in the usual 
manner (see Section 2.2), and the inhibitor was added to the outer cuvette 
compartment, immediately prior to the addition of GSH (see Figure 2.1). The 
experimentally observed pattern of inhibition by the conjugate with respect to each 
substrate determined the choice of rate equations selected to model the initial 
velocity data in the presence of the conjugate. Estimates of the parameters of the 
rate equations were obtained from the various plots and secondary plots as 
described by Segel [252]. The experimental protocol for product inhibition studies 
using rat liver GST 2-2 was similar to that described for the human placental 
isoenzyme. The results of both these investigations are described in the Sections 
3.3.3 and 3.3.5. 
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2.5.3 Synthesis of S-(2,4-Dinitrophenyl)glutathione 
The product of the enzymatic conjugation of CDNB and GSH, S-(2,4-dinitro-
phenyl)glutathione, was synthesised and purified by the method of Schramm et al. 
(249]. 
Ten rnrnol of CDNB was suspended in 30 ml 50% (v /v) ethanol in water. Ten 
rnrnol of GSH was added in portions over a 40 min period to the solution, while 
stirring continuously. After each addition of GSH, 2.5 M NaOH was used to return 
the pH to the range 7-8. The progress of reaction was monitored by following the 
drop in pH and increase in A340 due to the formation of S-(2,4-dinitro-
phenyl)glutathione. 
When the reaction was completed, the volume was reduced by about 50% under 
vacuum using a Corning rotary evaporator. Unreacted CDNB was removed by 
three extractions with ethyl ether. Ethanol was added to the aqueous solution to 
give a faintly turbid solution, and the reaction mixture was stored at 2 ° C for 48 
hours. 
The oily prec1p1tate, containing S-(2,4-dinitrophenyl)glutathione and some 
unreacted GSH, was dissolved in water and loaded onto a 2.5 x 30 cm Sephadex 
G-50 column, equilibrated with water. Fractions (2 ml) containing the clearly-
visible yellow band were collected and assayed for GSH. Glutathione was 
determined by the 5,5' -dithiobis(2-nitrobenzoic acid) (DTNB) assay (303]: a 0.1 
ml sample was added to 1.5 ml 0.5 mM DTNB in 0.1 M phosphate buffer pH 6.5, 
and mixed thoroughly. After 5-30 min at room temperature, the absorbance at 
412 nm was measured. Fractions which were free of GSH were then pooled and 
lyophilised. A quantitative solution of this material dried to constant weight gave 
the expected absorbance at 343 nm, consistent with the absence of CDNB and 
GSSG. 
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2.5.4 Model Fitting and Discrimination Between Rival Models 
Alternative mathematical models were fitted to the experimental data by the 
BMDP AR (derivative-free) and BMDP3R Gauss-Newton non-linear least squares 
regression analysis subroutines of the BMDP statistical package (University of 
California, Los Angeles). 
The regression function Y minimised for each model was 
n 
y = :Z: w-(v--v' -)2 
1 1 1 
i= 1 
where vi and v' i are the experimental and predicted velocities, respectively, wi is a 
weighting factor, n is the number of measurements and vi-v' i is the residual in the 
ith point. An analysis of the error structure of the experimental data showed that 
variance increased with velocity but not necessarily in proportion to it; the inverse 
of the predicted variance (from regression analysis) at any observed experimental 
velocity was therefore used as a weighting factor at that point [91,212]. 
The adequacy of fit of a model was determined by the examination of parameter 
values, residuals, and the residual sum of squares, and discrimination between 
models was based on the criteria of Garfinkel et al. [90,91] and Mannervik [177]. In 
general, a good model should converge to meaningful parameter values with low 
standard deviations, and have a low residual sum of squares. The resultant 
residuals should have a normal distribution with a mean of zero, and should lack 
correlation with any of the dependent or independent variables. 
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2.6 EQUILIBRIUM BINDING OF GSH TO HUMAN PLACENTAL GST 1r 
Equilibrium dialysis was used to evaluate the binding of GSH to human placental 
GST. The method was similar to that used for GST 3-3 [135], with modifications 
as described below. 
Equilibrium dialysis cells were formed by sealing 0.5 ml of 10 µM human placental 
GST in a short length of prepared 10 mm dialysis tubing (Sigma, St.Louis, MO), 
and then submerging these cells in 1 ml aqueous GSH. The dialysis tubing was 
prepared according to the manufacturers' instructions. The buffer used for both 
enzyme and GSH, 50 mM sodium phosphate buffer (pH 7.3), was prepared 
anaerobically and contained 0.25 mM dithioerythritol (to prevent oxidation of 
GSH during equilibration [135]). 
Seven different GSH concentrations (5-190 µM) were used. The concentration of 
radiolabelled GSH was kept constant (0.01 µM) in each cell, and the total 
concentration and specific activity of the ligand was varied by addition of 
unlabelled GSH. The specific activity of the undiluted [35S]-GSH was 
2.42 TBq/mmol (65.4 Ci/mmol) at the time of use. 
The [35S]-GSH concentration was determined before equilibration, which took 
place over 16 hr with shaking (12 rpm) at 25°C under anaerobic conditions. On 
equilibration, triplicate determinations of [35S]-GSH were performed using 0.1 ml 
aliquots taken from both compartments of the dialysis cells. Aliquots were added 
to 5 ml of Beckman RV liquid scintillation cocktail and radioactivity was 
determined using a Packard TriCarb 4640 liquid scintillation counter. To obtain 
stable counts of radioactivity, the sulphydryl groups of GSH were blocked by the 
addition 10 mM N-ethylmaleimide to the scintillation vials before counting [ 135]. 







Kd + [GSH] 
= number of moles of GSH bound per mole of enzyme, = number of binding sites, 
= concentration of free GSH, 
= average dissociation constant, 
using non-linear least squares regression [167]. The results of this equilibrium 
binding study are presented in Section 3.4. 
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2.7 OPTIMISATION OF THE PREPARATION OF MP-8 
Spectrophotometric studies were performed using a Varian Techtron 635 dual 
beam UV /visible spectrophotometer, calibrated for absorbance linearity and 
accuracy at 402 nm using the p-nitrophenoxide anion [4]. HPLC studies were 
performed at room temperature using a Spectra Physics SP-8700 system with both 
analytical and semi-preparative Microbondpak C18 columns. Eluates were 
monitored at 395 nm (for haem) or 225 nm (for peptide). HPLC buffers were as 
follows: buffer A, 0.1 % trifluoroacetic acid in deionised water; buffer B, 0.1 % 
trifluoroacetic acid in acetonitrile/deionised water (60/40 v/v). Elution was 
performed at a flow rate of 2 ml/min and gradients were either isocratic 
(50% A/50% B) or as specified below. Columns were washed with 100% 
acetonitrile. 
2.7.1 Preparation of MP-8 
Preparation of high purity MP-8 was essentially according to the method of 
Adams et al. [4]. The modifications to the published method, which are detailed 
below, arose from the optimisation of the MP-8 preparative schedule which was 
performed as part of this study (Section 2.7.2). 
Two hundred milligrams of horse heart cytochrome-c was dissolved in 4 ml 
deionised water, and 5.5 mg pepsin (in 100 µl deionised water) was added. The pH 
of the stirred solution was lowered to 2.0-2.1 with 2 M HCl and the mixture was 
incubated for 15 min at 40 ± 0.05 ° C. A further 5.5 mg pepsin (in 100 µl deionised 
water) was then added and incubation carried out for 2 hours at 40°C. The pH of 
the reaction mixture was adjusted to 5 with concentrated ammonium hydroxide 
solution, and solid ammonium sulphate was added to the stirred solution on ice. 
When the first traces of cloudiness were noted, saturated ammonium sulphate 
solution was added dropwise to completely precipitate haem-containing material 
(leaving a colourless supernatant). The dark red precipitate was pelleted by 
centrifugation, drained thoroughly and redissolved in 0.5 ml deionised water. The 
pH was adjusted to 8.5 with concentrated ammonium hydroxide and the sample 
incubated at 40°C for 5 minutes. Trypsin (7.5 mg in 400 µl deionised water) was 
added with stirring, and the reaction was incubated for a further 20 minutes at 
40°C. 
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The concentrated MP-8 solution, approximately 95% pure in terms of haem-
peptide at this stage, was further purified by affinity chromatography to remove 
trypsin and MP-11-derived tripeptide [321]. The sample was poured onto a 
bovine serum alburnin/CNBr-activated Sepharose 4B affinity column (1 x 10 cm), 
prepared according to the manufacturer's directions. The column was washed with 
five column volumes of 0.05 M ammonium bicarbonate (pH 7.5), before elution 
with 0.8 M ammonium hydroxide. Fractions containing the clearly-visible red band 
were collected and lyophylised. 
Further purification of the MP-8 was performed by HPLC using buffers A and B 
above (43-55% buffer B over 12 minutes) on a semi-preparative reversed-phase 
C18 column. Prior to use in kinetic and binding studies, 1 mg samples of the 
lyophylised MP-8 preparation were routinely repurified (to remove trace amounts 
of MP-11) by analytical HPLC on an C18 column. This resulted in a product in 
which no impurities could be detected at either 395 nm (haem) or 225 nm 
(peptide). 
2.7.2 Kinetics of MP-11 Formation from Cytochrome-c 
In a recently published optimised preparative schedule for MP-8 [4], the peptic 
digestion of cytochrome-c is performed at 26 ° C and requires 8-10 hours for 
completion. In order to further refine the preparation of MP-8, the peptic digest 
(described above) was performed at 40°C and the conversion of cytochrome-c to 
MP-11 was monitored by analytical HPLC. Immediately prior to the second 
addition of pepsin, and at 30 minute time intervals thereafter, 1 µl samples were 
withdrawn from the incubation and diluted into 50 µl buffer A at 0°C. 
These samples were injected onto an analytical HPLC column, and eluted 
isocratically (50% A/50% B) for 10 minutes, followed by a gradient increase to 
100% B over 10 minutes. The results of this kinetic study are described in 
Section 3.5. 
2.8 INTERACTION OF HUMAN PLACENTAL GST 7r AND MP-8 
The methods of preparation of both human placental GST 7£ and MP-8 have been 
described earlier in this chapter (Sections 2.4.1 and 2.7.1). 
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The interaction of monomeric MP-8 and GST were first examined by measuring 
the spectral and difference spectral changes observed on mixing, using an Hewlett 
Packard 8450A Diode Array Spectrophotometer. The kinetics of the reaction were 
then followed, utilising the decrease in A396nm' under pseudo-first-order conditions 
([MP-8] > > [GST]) at 22.5 ± 0.02°C. Kinetic studies were performed using a 
Varian Techtron 635 dual beam UV /visible spectrophotometer. This instrument 
was selected because of its exceptional photometric stability ( drift after 2 hours 
stabilisation was less than 1 x 10-4 AU /h at 396 nm) and low noise level ( < 2 x 10-4 
AU peak to peak), factors which are of the utmost importance when carrying out 
multiphasic kinetic studies over small total absorbance changes ( < 0.1 AU 
396 nm). The reaction temperature in the cuvette was controlled to± 0.02°C using 
a Colora circulating heater/ cooler bath. 
Each reaction was initiated by the addition of a fixed amount of enzyme 
(2 x 10-8 M) to solutions of varying concentration of MP-8 (lo-7 to 10-6 M), 
equilibrated for 5 min in 10 mM potassium phosphate buffer (pH 7.0). For some 
reactions, the GST was preincubated with bilirubin (15 µM) or GSH (1 mM) for 
15 minutes prior to the addition of the enzyme to the MP-8. Other kinetic runs 
were performed in the presence of 1 mM CDNB, which was added immediately 
prior to the initiation of the reaction. 
The absorbance/time data were digitised prior to numerical analysis using Enzfitter 
[167]. Data were fitted to either single exponential (Abs = A + Be-k*t) or 
biexponential (Abs = A + Be-k~t + ce-k; t) functions, and the statistical adequacy 
of the least-squares fits was assessed as described in Section 2.5.4. The results of 
these investigations are found in Section 3.6. 
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2.9 THE INHIBITION OF HUMAN PLACENTAL GST 1r BY MP-8 
In order to further elucidate the spatial relationship between the binding site(s) 
and the catalytic site of the enzyme, the inhibition by MP-8 of the steady-state 
GST-catalysed conjugation between GSH and CDNB was investigated. Prepara-
tion of human placental GST and MP-8 was as detailed above, and the GST assay 
(activity towards CDNB) was performed as described in Section 2.2. 
The time-dependent inhibition of the enzyme-catalysed conjugation of CDNB and 
GSH was monitored during the incubation of 0.4 µM MP-8 with 0.1 µM GST at 
25 ± 0.02°C in 0.1 M potassium phosphate buffer (pH 6.5). Following initiation of 
the incubation, aliquots of the reaction mixture were assayed for enzyme activity 
with CDNB at various time intervals. Control incubations (no MP-8 present) 
were performed and the results of these were subtracted from those in the 
presence of inhibitor. 
In addition, the effect of MP-8 on the steady-state kinetics of the enzyme-
catalysed conjugation of GSH and CDNB was investigated. At each of several 
MP-8 concentrations (0, 0.5, 2 and 5 µM), assays were performed with either a 
fixed CDNB concentration (1 mM) and varying GSH (0.15 - 1 mM), or a fixed 
GSH concentration (1 mM) and varying CDNB (0.4 - 3 mM). Assays were 
performed as described in Section 2.5, except that 5% v /v DMSO (final) was used 
in the experiments at fixed GSH concentration, to accommodate relatively high 
CDNB concentrations. MP-8 was preincubated with the enzyme (20 nM) for 15 
minutes prior to assay, allowing time for the reaction to proceed essentially to 
completion. The results of these studies are presented in Section 3.7. 
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3. RESULTS 
3.1 PRELIMINARY EXPERIMENTS 
The use of a centrifugal analyser in this investigation permitted the assessment of 
the linearity of initial rates for the GST-catalysed conjugation of GSH and CDNB 
from effectively zero reaction time (see Figure 3.1). The residuals that resulted 
from a fit of the initial rate data over 0-60 seconds to a straight-line function were 
randomly scattered about the mean (m = 2; n = 3; runs = 6), while systematic 
non-randomness was observed for the data over a 0-180 seconds period (m = 8; 
n = 11; runs = 3). Fitting the 0-180 seconds data of Figure 3.1 to a quadratic 
function resulted in a random distribution of residuals. Curvature was always 
evident 50-70 seconds after the initiation of reaction with all the rat and human 
GST isoenzymes used. Rates at 2 and 3 minutes were 90% and 83% of the initial 
rate (see Figure 3.1). Consequently, initial rates were measured over the first 
60 seconds of the reaction, during which time the reaction was apparently linear 
(r ~ 0.999). Albumin (120 µM) diminished but did not eliminate the curvature of 
the absorbance versus time plots over 180 seconds (see Figure 3.1 and Discussion). 
Using the centrifugal analyser, the enzymatic reaction rate of the GST isoenzymes 
investigated was found to be a linear function of enzyme concentration for 60 
seconds after initiation, when the rate of absorbance change was limited to a less 
than 0.15 per minute (for a pathlength of 0.5 cm). The centrifugal analyser was 
found to give a photometrically linear response over the range of absorbance 
values of the dichromate concentrations investigated. 
Because the 0-60 second time period was found to be insufficient for the 
determination of non-enzymic reaction rates, these were measured at 30 second 
intervals over 5 minutes. Background rates were found to be uniformly linear over 
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Figure 3.1 : Linearity of CDNB Assay with Time 
Data shown are for rat liver GST 3-3, although similar results were observed with the other rat and human GST isoenzymes studied. In both the standard assay (0) and when 
120 µM bovine scrum albumin was added (•) , GSH and CDNB were both 1 mM. The 
straight line represents the tangent to Lhe initial rate. Inset shows another data set, 
generated under similar conditions, over 10 min (time axis in seconds). 
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Figure 3.2 : The Effect of Solvent on the DCNB Assay 
The different solvents used as the vehicle for DCNB were ethanol (•), THF (D), acetone (•), DMSO (~) and DME (Iii..). The data shown are for human placental GST 7£, with 1 mM GSH and 0.1 mM DCNB. Solvent concentrations are expressed as final percentages (v/v). The percentage activity is that remaining of the enzymic activity at the lowest concentration of each solvent (taken to be 100%). 
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The effects of various organic solvents, used as vehicles for substrates in the 
CDNB and DCNB assays, on the activity of purified human placental GST are 
shown in Figure 3.2. The previously reported inhibition of rat liver cytosolic GST 
activity by ethanol [7,134] was confirmed for the purified isoenzymes studied, and 
was found to be concentration dependent. All the other solvents tested were less 
inhibitory than ethanol, and activity towards CDNB seemed to be affected by 
solvent choice to a lesser extent than DCNB. Both Acetone and D MSO were 
approximately equivalent, in that no inhibition of CDNB activity, and only slight 
inhibition of DCNB activity (94% at 4.5 % v /v for rat liver isoenzyme 3-3) was 
observed. DMSO was used as the vehicle for CDNB and DCNB in all further 
studies, at a concentration of 2% (v /v). 
The GST activity of both the purified isoenzyme 3-3 and the commercial rat liver 
GST mixture was enhanced (by between 8 and 22%) when GSH was added to the 
cuvette compartment containing the enzyme sample, even though the two were 
added only 1-2 minutes before assay. When the GST was prepared in buffer 
containing 0.1 mM or 0.5 mM GSH, and allowed to stand for 5 minutes before 
assay, the activities were 108% and 114%, respectively, of that of controls prepared 
in buffer without GSH. Consequently, all assays were initiated by the addition of 
enzyme, as described in Section 2.2, in order to minimise the effects of the variable 
enzyme activation by GSH. 
Despite the observation in this laboratory that the act1v1ty of several rat and 
human GST preparations seemed greater when water, rather than 0.1 M potassium 
phosphate buffer (pH 6.5), was used as a diluent, no significant difference was 
' observed in the activity of human placental GST when the enzyme was prepared in 
either diluent. Dilutions were therefore prepared in phosphate buffer. 
The unusual pattern of inhibition and activation of hepatic GSTs by ethylene 
dibromide (EDB) that has been previously reported from this laboratory [130] was 
confirmed using the present assay system. As shown in Figure 3.3, EDB inhibited 
GST activity at lower CDNB concentrations and activated the same at higher 
CDNB concentrations. A possible mechanistic model for this mixed inhibition has 
been proposed [130]. 
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Figure 3.3 : Inhibition and Activation of GST 3-3 by EDB 
GSH concentration was 1 mM in all assays. Concentrations of CDNB were 0.027, 0.032, 
0.049, 0.097 and 0.259 mM. EDB was dissolved in ethanol at either 6 mM (0) or 
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The Variation in GST Activity During Incubations of EDB with DNA 
GST activity was monitored with CDNB at various times during a 2 hour incubation 
(37°C) of Sigma rat liver GST mixture (0.2 mg), DNA (0.2 mg), EDB (5 mM) and either 
2 mM (0) or 15 mM (•) GSH. The percentage activity is that remaining of the enzymic 
activity at time zero (taken to be 100%). Data represent the means of triplicate 
determinations with controls subtracted. The lines drawn are those predicted by fitting the 
data to the equation A = Ai + Ad e-kr, using non-linear least squares regression analysis. 
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In the presence of EDB, a gradual loss of activity over 2 hours was observed for 
the commercial rat liver GST mixture at both 2 mM and 15 mM GSH (see Figure 
3.4 ). The loss of activity followed pseudo-first-order kinetics, with rate constants at 
both 2 mM and 15 mM GSH in close agreement (2.25 x 10-3 ± 2.54 x 10-4 s-1 and 
1.64 x 10-3 ± 3.42 x 10-4 s-1, respectively). The extent of the activity loss was greater 
in the presence of EDB plus 2 mM GSH than EDB plus 15 mM GSH. This may be 
related to the finding that GSH concentrations above 10 mM resulted in less EDB 
binding to DNA than GSH concentrations of 2 mM [127]. The implications of this 
inhibition for GST-mediated toxicity of EDB is discussed in Section 4.2. 
The results of the experiments to determine the GSH-mediated binding of 
[14C]-EDB to DNA, using four different GST sources, are shown in Table 3.1. 
The neutral human lung GST exhibited the highest activity of those isoenzymes 
studied. The activities of the human GSTs are considerably greater than the values 
previously reported for rat isoenzymes [ 127]. 
Table 3.1: GSH-Mediated DNA-Binding of EDB 
Catalysed by Different GST Isoenzymes 
GST Isoenzyme 
per mg DNA 
Sigma Rat Liver Mix 
Human Lung Acidic 
Human Lung Neutral 
Human Lung Basic 
pmol EDB bound 
4713 ± 133 
3683 ± 184 
5164 ± 535 
2206 ± 49 
Incubations (100 µl) containing 0.2 mg DNA, 2 mM GSH, 
5 mM [14C)-EDB (specific activity 185 MBq/mmol) and 
15 µg GST were at 37 ° C. Each value is the mean ± SD of 
duplicate determinations. 
72 
3.2 GSH S-TRANSFERASE ISOENZYME PURIFICATIONS 
3.2.1 Purification of Human Placental GSH S-Transferase 7r 
Table 3.2 summarises the results of a typical purification of human placental GST 
by the method described in Section 2.4.1. The elution profile of the GSH-affinity 
column ( depicted in Figure 3.5) indicates that a large amount of non-GST protein 
was efficiently eliminated by this step; no significant GST activity was found in the 
protein-containing effluent prior to elution. The results achieved by GSH-affinity 
chromatography (specific activity of 98.4 µmol/min/mg, 94% recovery and 364-
fold purification) are comparable with those of previous workers who have used 
this technique to purify human placental GST [231,232,308]. 
A typical chromatographic profile for the HPLC separation obtained using the 
Synchrom AX-300 column is shown in Figure 3.6. Approximately 97% of the 
recovered activity was present in the major peak (retention time 5.68 min), while 
other peaks represented 2% (RT 3.7 min) and 1 % (RT about 12 min) of the 
activity. This profile is similar to the corresponding profiles of Radulovic and 
Kulkarni [231,232]. It was found necessary to equilibrate the column extensively 
between runs for good profile reproducibility. 
The presence of a single band on SOS-PAGE with approximate subunit apparent 
M, 21 500 (Figure 3.7) suggested that the enzyme had been purified to 
homogeneity. The specific activities of the placental GST isoenzyme were as 
follows: CDNB, 133; DCNB, 0.06; cumene hydroperoxide, 0.04; and ethacrynic 
acid, 1.3. These values are in good agreement with previously published specific 
activities [100,186,308]. 
Table 3.2: Summary of Human Placental GST Purification 
Volume of Protein Total Specific Purification Step Fraction Concentration Activityt Activity Yield Factor 
(ml) (mg/ml) (1,1mol/min) (1,1mol/min/mg) (%) Fold 
Supernatant 263 6.99 493.13 0.27 100 1 Affinity Chromatography 47 0.10 462.30 98.36 94 364 Ultrafiltration 3.4 0.91 312.03 100.85 63 374 HPLC 19.5 0.10 259.45 133.05 53 493 












































































































































































































































































































































































































































































































































































































































3.2.2 Purification of Rat Hepatic GSH S-Transferase 2-2 
Although GST 2-2 is the predominant isoenzyme in rat adrenal gland [ 151], the 
total recovery of GST activity from this tissue was found to be too low for practical 
enzyme isolation ( data not shown). It was decided to purify GST 2-2 from rat 
liver, where the overall GST content is much greater, even though GST 2-2 
represents proportionally less of the total tissue GST activity. 
Table 3.3 summarises the results of a purification of GST 2-2 from rat liver. The 
GSH-affinity column resulted in a 17-fold purification, with a recovery of 53.7% 
total initial activity. The elution profile of the separation on the CM-cellulose 
column, shown in Figure 3.8, was comparable to previously reported 
CM-cellulose elution patterns which were run under similar conditions [103,108]. 
The first peak of GST activity (labelled X), which passed through in the eluant 
volume, comprised the anionic transferase isoenzymes, which do not bind to 
CM-cellulose. The last peak eluted (peak 5) corresponded to transferase 2-2 in 
terms of elution position and substrate specificities. The intermediate peaks, which 
were not characterised fully, were not well separated (see Figure 3.8 and the gel in 
Figure 3.7), and probably represented overlapping activities of GSTs 4-4, 5-5, 
3-4, 1-2 and 3-3. However, since GST 2-2 is clearly separated from the other 
isoenzymes by CM-cellulose chromatography [39], the other GST activities were 
not of great concern. 
The results of SDS-PAGE (Figure 3.7) suggested that GST 2-2 had been purified 
to homogeneity (homodimer with approximate subunit apparent M, 24 500). The 
specific activities of GST 2-2 were as follows: CDNB, 18.2; DCNB, 0.01; cumene 
hydroperoxide, 6.7; and ethacrynic acid, 0.6, in good agreement with previously 
published values [9,40]. 
Table 3.3 : Summary of Rat Liver GST 2-2 Purification 
Volume of Protein 
Step Fraction Concentration 
(ml) (mg/ml) 
Supernatant 9 22.78 
Affinity Chromatography 
& Dialysis 19 2.26 
























Figure 3.7 : SDS-Polyacrylamide Gel Electrophoresis of GSTs 
The GSTs were purified and analysed by SDS-PAGE as described in the text. Proteins 
were applied to the gel as follows: Channel S - protein standards with M values of 14 300, r 28 600, 42 900, 57 200, 71 500, & 85 800. Channels 1 to 5 contain GST peaks 1 to 5 from 
CM-cellulose column chromatography of rat liver (see text and Figure 3.8). Channel 6 
contained GST 'Jr, from HPLC column of the purification of human placental GST, and 
channel 7 contained the newly available (and recently discontinued) commercial 
preparation (Sigma) of human placental GST. Approximately 10 µg of each protein was 
applied to the gel. Approximate M values for GST isoenzymes 2-2 and 7r were 24 500 r 
and 21 500, respectively. 
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Figure 3.8 : CM-Cellulose Chromatography of Rat Liver GST 
A 24 hour linear KC! gradient (0-75 mM) was used to elute transferase activity from a 
CM-cellulose column (1.5 x 20 cm). The flow rate was 0.5 ml/min, and 2.5 ml fractions 
were collected. GST activity is in µmol/min/ml. 
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3.3 STEADY-STATE KINETIC STUDIES 
3.3.1 Rat Liver GST Isoenzymes 3-3 and 3-4 
Families of non-linear concave-down plots were found for the conjugation of 
CDNB by isoenzyme 3-3 and of DCNB by isoenzyme 3-4 when initial rates were 
measured over extended substrate ranges (Figures 3.9 and 3.10). Although 
sufficient data for detailed mechanistic modelling were not collected, the general 
rate equation for a steady-state random sequential mechanism (Eqn. 5 of Table 
3.4) was found to be capable of fitting the data. Although at best two parameters 
were redundant in the model it provided a better fit, by the criteria of Mannervik 
[177] for goodness of fit and discrimination between rival models, than the 
branched reaction scheme of Pabst et al. [215] or the rapid equilibrium random Bi 
Bi mechanism. 
The non-linear concave-down double-reciprocal plots of kinetic data for the GSTs 
are consistent with negative co-operativity. In phenomenological terms [ cf. 249], 
the kinetics of the metabolism of DCNB and CDNB by rat liver GST 3-3 and of 
DCNB by GST 3-4 exhibit negative co-operativity: Hill plots generated from the 
data of Pabst et al. [215] and the data from Figures 3.9 and 3.10 exhibit Hill 
coefficients ( average napparent values) of 0.65-0.80 (Figure 3.11 ). Since linear 
equilibrium binding Scatchard plots for GSH have been reported for GST iso-
enzymes 1-2 and 3-3 [135,292], and for human placental GST (see Section 3.4), 
it appears that the negative co-operativity of the GSH S-transferases is kinetically 

















Figure 3.9 : Reciprocal Plot of Initial Rate Qata for Rat Liver 
GST3-3 and CDNB. 
With CDNB as the varied substrate, GSH concentrations were (•) 0.05, (0) 0.15 and 
(X) 1 mM. Velocities are expressed in nmol/min/ml. Enzyme concentration was 0.1 µM. 
Data points represent the means of triplicate determinations. Lines drawn are those 
predicted by fitting the data to a steady-state random sequential Bi Bi mechanism using 
the BMDP program. 
120 





Figure 3.10 : Reciprocal Plot of Initial Rate Data for Rat Liver 
GST 3-4 and DCNB. 
With GSH as the varied substrate, DCNB concentrations were (•) 0.2, (0) 0.4 and 
(X) 0.6 mM. Velocities are expressed in nmol/min/ml. Enzyme concentration was 0.2 µM. 
Data points represent the means of triplicate determinations. Lines drawn are those 
predicted by fitting the data to a steady-state random sequential Bi Bi mechanism using 
the BMDP program. 
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The apparently anomalous biphasic kinetics observed previously for GST 3-3 with 
DCNB [132,215], and in this investigation for GST 3-3 with CDNB and GST 3-4 
with DCNB, are discussed in Section 4.3. This discussion includes a demonstration 
that the basic steady-state random sequential Bi Bi mechanism under initial rate 
conditions is the simplest mechanism consistent with and sufficient to explain the 















Figure 3.11 : Hill Plot of Rat Liver GST Activity 
Isoenzyme 3-3 for variable CDNB concentration, at 0.05 mM GSH (•); isoenzyme 3-4 for 
variable GSH concentration at 0.2 mM DCNB (0). 
3.3.2 Human Placental GST 7T • Initial Velocities in the 
Absence of Products 
79 
In preliminary experiments, double-reciprocal plots of initial velocity data were 
linear over a 103-fold range of GSH (1 µM - l mM) at concentrations of CDNB 
ranging from 0.1-1 mM. Subsequently, initial rate measurements performed over 
an eight by eight matrix with regard to the concentrations of GSH (0.04-1 mM) 
and CDNB (0.1-1 mM) (192 data points) gave rise to linear double-reciprocal plots 
versus both substrates (Figure 3.12). 
Initial estimates of Km app and V max app were obtained from the double-reciprocal 
plots and refined by non-linear regression analysis. Replots of the slope and 
intercept versus the reciprocal of the concentration of the alternate substrate 
(Figure 3.13) provided estimates of other parameters. These initial parameter 
estimates were used in further data analysis by non-linear regression (BMDP AR). 
The results of fitting five rate equations to the initial rate data are shown in Table 
3.4. Included therein are the rate equations, the calculated parameter values and 
assessments of goodness of fit. In general, a good model should exhibit proper 
convergence to meaningful parameter values with low standard deviations, a 
random distribution of residuals which lack correlation with the variables, and a 
small residual sum of squares [177]. The velocities predicted by fitting the rate data 
to Eqn. 4 with the BMDPAR program were used to generate the lines in Figures 
3.12 and 3.13. 
When the initial rate data were fitted to the two rate equations for a rapid 
equilibrium ordered bireactant system (Eqns. 1 and 2), only the function describing 
a kinetic system with GSH binding first gave a reasonable fit to the data 
(Table 3.4 ). The alternative model exhibited standard deviations for two 
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Figure 3.12: Reciprocal Plots of Initial Rate Data in the Absence 
of Product for Human Placental GST. 
(a) With CDNB as the varied substrate, GSH concentrations were (D) 0.04, (•) 0.07, 
(0) 0.1, (•) 0.15, (Ll) 0.2, (.All) 0.3, (.c.) 0.5, (•) 1 mM. (b) With GSH as the varied substrate, 
CDNB concentrations were (D) 0.1, (•) 0.2, (0) 0.3, (•) 0.4, (Ll) 0.55, (.All) 0.7, (.c.) 0.85, 
(• ) 1 mM. Velocities are expressed in nmol/ min/ml. Enzyme concentration was 2 nM. 
_Data points represent the means of triplicate determinations. Lines drawn are those 
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The steady-state ordered Bi Bi mechanism (Eqn. 3) cannot be distinguished from a 
rapid equilibrium random mechanism by computer modelling since the rate 
equations are identical where Kia = KA' ~ = aKA and KmB = aKB (see Table 
3.4 ). Therefore, these models give equivalent fits to the data [252]. Both models 
rapidly converged to the lowest residual sum of squares and mean square error 
values and gave meaningful parameter values with low standard deviations. These 
values were close to the estimates obtained from the plotted data (Table 3.4, and 
Figures 3.12 and 3.13). Very similar parameter values and error estimates were 
obtained when no weighting procedure was used in fitting the data to the rapid 
equilibrium random mechanism ( data not shown). 
Modelling the steady-state random Bi Bi mechanism (Eqn. 5) resulted either in 
convergence with a larger residual sum of squares than the rapid equilibrium 
random model (Eqn. 4, Table 3.4 ), or in a smaller residual sum of squares but no 
convergence and a non-random distribution of residuals. All attempts to fit the 
steady-state model resulted in several redundant parameters (parameters with 
values of zero or not significantly different from zero). 
The kinetic data were best fitted by the rapid equilibrium random equation or the 
equivalent steady-state ordered mechanism. This model exhibited the lowest 
residual sum of squares, meaningful parameter values with low standard deviations 
and a random distribution of residuals. 
3.3.3 Human Placental GST 7f - Initial Velocities in the 
Presence of Product 
The products of the reaction of GSH and CDNB are the conjugate, S-(2,4-
dinitrophenyl)glutathione, and chloride ion. As previously reported for GST 
isoenzymes 3-3 [132,215] and 1-1 [249], no significant inhibition of human 
placental GSH S-transferase by chloride ion was apparent at concentrations of up 
to 0.1 M (data not shown). The finding that chloride ion was too weak an inhibitor 
for product inhibition studies [132,215,249] was therefore confirmed. 
The initial rate data for the inhibition of GST 7f by the conjugate were plotted as 
double-reciprocal plots with varying substrate concentration at fixed co-substrate 
concentration. The families of lines on each plot represent different inhibitor 
concentrations; two examples are shown in Figure 3.14. Replots of the slope versus 
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Figure 3.14 : Reciprocal Plots of Initial Rate Data in the Presence 
of the Conjugate - Human Placental GST. 
(a) With CDNB as the varied substrate at a fixed GSH concentration of 0.33 mM. 
(b) With GSH as the varied substrate at a fixed CDNB concentration of 0.55 mM. 
In both plots, concentrations of the conjugate were (•) 0, (D) 35, (•) 65, and (0) 100 µM. 
Velocities are expressed in nmol/min/ml. Enzyme concentration was 10 nM. Data points 
represent the means of triplicate determinations. Lines drawn are those predicted by 
fitting the data to a rapid equilibrium random Bi Bi mechanism with a dead-end 






































































































































































































































































































































































































































































horizontal-axis intercepts (the Ki~(;e values t) of the slope replots (i.e. Figures 
3.15a and b) versus the concentration of co-substrate were also constructed 
(Figures 3.15c and d). The conjugate showed mixed-type inhibition towards CDNB 
(Figure 3.15a). The K~ /
1
CDNB increased linearly with increasing GSH concen-1s ope 
tration (Figure 3.15c), indicating that saturation with GSH overcomes the 
inhibition by the conjugate. The conjugate was a competitive inhibitor toward 
GSH (Figure 3.15b). The hyperbolic increase in the K~/GSH with increasing 
CDNB concentration (Figure 3.15d) indicates that the 
15
~ci~jugate remains a 
competitive inhibitor at all concentrations of CDNB. 
An analysis ( described in Section 4.4) of the observed pattern of product inhibition 
allowed the elimination of several bireactant mechanisms from further 
consideration, and determined the selection of two rate equations for modelling 
the initial velocity data in the presence of the conjugate. Both of these rate 
equations describe rapid equilibrium random systems, one without dead-end 
complexes, and the other with a catalytically inactive enzyme· CDNB · conjugate 
complex. Table 3.5. shows the results of fitting the product inhibition data to these 
equations (Eqns. 6 and 7, respectively). Estimates of the parameters of the rate 
equations were obtained from the various plots and secondary plots as described 
by Segel (252]. 
The equation which includes the dead-end complex, and consequently the 
additional parameter 'Y, provided a superior fit to the data by all statistical criteria. 
The velocities predicted by fitting the rate data to Eqn. 7 with the BMDP AR 
program were used to generate the lines in Figures 3.14 and 3.15. 
tKi~f~e is the apparent inhibitor constant expressing the effect of P on the slope of 
the 1/v versus 1/(A] plots. The latter is indicated as slope1/A· The apparent 















































































































































































































































































































































































































































































































































































































































































































































































3.3.4 Rat Liver GST 2-2 - Initial Velocities in the 
Absence of Products 
88 
The results of the initial rate measurements performed using GSH and CDNB as 
substrates for GST 2-2 are shown as double-reciprocal plots versus both substrates 
in Figure 3.16. The 1/V versus 1/[GSH] plot (Figure 3.16b) was clearly biphasic 
( concave-down), as observed for GST isoenzymes 3-3 and 3-4, although the 
degree of curvature was not as great as for those isoenzymes. Even more slight was 
the curvature of the 1/V versus 1/[CDNB] plot (Figure 3.16a). Replots, 
corresponding to those for human placental GST 71" in Section 3.3.3, are shown in 
Figure 3.17. 
Table 3.6 shows the results of fitting five rate equations to the initial rate data. 
Using the statistical criteria described already (Section 2.5.4 ), the general rate 
equation for a steady-state random sequential mechanism (Eqn. 5 of Table 3.6) 
was found to be superior to the rapid equilibrium random Bi Bi mechanism (Eqn. 
4 of Table 3.6) and the other bireactant models. The alternative models were 
excluded on the basis of lack of convergence, large residual sum of squares values, 
non-random residual distribution and/or parameter values with high standard 
deviations. The velocities predicted by fitting the rate data to Equation 5 with the 
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Figure 3.16 : Reciprocal Plots of Initial Rate Data in the Absence 
of Product for Rat Liver GST 2-2. 
(a) With CDNB as the varied substrate, GSH concentrations were (D) 0.04, (•) 0.07, (0) 
0.1, (•) 0.15, (LI) 0.2, (""') 0.3, (Ll) 0.5, (•) 1 mM. (b) With GSH as the varied substrate, 
CDNB concentrations were (D) 0.1, (•) 0.2, (0) 0.3, (•) 0.4, (Ll) 0.55, (""') 0.7, (Ll) 0.85, 
(•) 1 mM. Velocities are expressed in nmol/min/ml. Enzyme concentration was 0.14 µM. 
: D_ata points represent the means of triplicate determinations. The lines drawn are those 
predicted by fitting the data to Equation 5 of Table 3.6, by non-linear least squares 
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3.3.5 Rat Liver GST 2-2 - Initial Velocities in the 
Presence of Product 
92 
The initial rate data were plotted as for the human placental GST isoenzyme (two 
examples are shown in Figure 3.18). Although the reciprocal plots were non-linear, 
the conjugate showed apparent mixed-type inhibition towards both substrates. 
No attempt was made to model the product inhibition data, because of the 
complex nature of rate equations describing steady-state bireactant systems in the 
presence of the products of the enzymic reaction [252]. However, the data for each 
varied substrate concentration at fixed co-substrate concentration were found to fit 
the general rate equation for hyperbolic mixed-type inhibition, as predicted for the 
random Bi Bi mechanism [252]. The non-hyperbolic kinetics observed for GST 






















Figure 3.18 : Reciprocal Plots of Initial Rate Data in the Presence of the Conjugate - Rat Liver GST 2-2. 
(a) With CDNB as the varied substrate at a fixed GSH concentration of 0.5 mM. (b) With GSH as the varied substrate at a fixed CDNB concentration of 0.8 mM. In both plots, concentrations of the conjugate were (•) 0, (D) 35, (•) 65, and (0) 100 µM. Velocities are in nmol/min/ml. Enzyme concentration was 0.2 itM. Data points represent the means of triplicate determinations. Lines drawn are those predicted by fitting the data to an equation describing hyperbolic mixed-type inhibition [252), using the BMDP program. 
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3.4 EQUILIBRIUM BINDING OF GSH TO HUMAN PLACENTAL GST 1r 
A Scatchard plot of the results of the equilibrium binding studies performed with 
GSH and human placental GST (Section 2.6) is shown in Figure 3.19. The straight-
line graph indicates hyperbolic ( i.e. non-co-operative) binding of the substrate to 
GST, and binding to identical and independent sites. A stoichiometry of two 
molecules of ligand (n = 1.92 ± 0.07) per molecule of enzyme was apparent, with 
an average Kd value of 33.84 ± 1.71. These results are consistent with the 
hyperbolic binding isotherm and stoichiometry of two reported for rat liver GST 
3-3 [135], although a single binding site per dimer of rat liver GST 1-1 was found 
for a spin-labelled GSH analogue [249]. The reported Kd (28 µM) for this latter 
isoenzyme was close to that observed in this investigation (33 µM), while the 
dissociation constant for GST 3-3 was 10 µM [135]. 
0.04 
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Figure 3.19: Equilibrium Binding of [35S]GSH to Human Placental 
GST 7r by Equilibrium Dialysis 
The enzyme concentration was 10 µM, and equilibration was at 25 ° C for 16 hrs in 50 mM 
sodium phosphate buffer (pH 7.3). Data represent the means of triplicate determinations. 
The line drawn is that predicted by fitting the data to the Scatchard equation, using non-
linear least squares regression analysis (with the outlying point shown excluded). GSH had 
an average dissociation constant (Kd) of 33.4 ± 1.71 µM, with a binding stoichiometry of 









3.5 OPTIMISATION OF THE PREPARATION OF MP-8 
The effect of temperature on the kinetics of the peptic digestion of cytochrome-c 
was investigated (Section 2.7). It is clear from analytical HPLC of the incubation 
mixture (Figure 3.20a) that performing the peptic digestion at 4Q°C significantly 
reduced the incubation time, from about 8-10 hours required previously at 26°C 
[ 4 ], to less than 2 hours. Furthermore, contamination by the other haem-containing 
peptides was reduced. Figure 3.20b shows the reduction in contamination by non-
haem peptides that resulted from the inclusion of an ammonium sulphate precipi-
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Figure 3.20 : Optimisation of Peptic Digestion of Cytochrome-c 
to MP-11 
(a) Conversion of cytochrome-c (dashed line, at t = 0) to MP-11 (solid line) by pepsin 
digestion for 2 hours at 40 ± 0.05 ° C and pH 2.1. Inset to Figure 3.20a shows the kinetics 
of formation of MP-11 from cytochrome-c. The point at which the second addition of 
pepsin occurred is arrowed. (b) Removal of non-haem peptides (shaded) by quantitative 
ammonium sulphate precipitation (at pH 5) of MP-11. The dashed line shows the 
position at which MP-11 elutes at 396 nm. In both (a) and (b) the HPLC gradient was 









3.6 INTERACTION OF HUMAN PLACENTAL GST 1r AND MP-8 
Figure 3.21 shows the spectral and difference spectral changes observed on 
incubation of 0.5 µM MP-8 and 0.02 µM human placental GST for 10 minutes. 
Addition of GST to the MP-8 solution typically resulted in a quenching (by about 
50% after complete reaction) of the MP-8 Soret peak at 396 nm, although no shift 
in the peak maximum was observed. 
The kinetics of quenching were shown to follow a biexponential time course. A 
representative trace, generated by the addition of 0.02 µM GST to an MP-8 
solution (0.35 µM) , is shown in Figure 3.22a. Figure 3.22b depicts the digitised data 
from Figure 3.22a modelled by a biexponential function. The inset to Figure 3.22b 
demonstrates the inability of a single exponential function to adequately describe 
the data. Table 3.7 shows the parameter values obtained when many more points 
from the experimental trace in Figure 3.22 were included in the biexponential fit. 
Since the parameter values were closely similar whether 4 7 or 250 points were 
included in the data analysis, no advantage was gained by the inclusion of as many 
as 250 data points in the fit. Figure 3.23 demonstrates the applicability of a 
biexponential model over a range of MP-8 concentrations. In all cases, only a 
biexponential function adequately modelled the kinetic data, with respect to the 
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Figure 3.21 : Spectral Changes for MP-8/GST Interaction 
Spectral (a) and difference spectral (b) changes observed on incubation of 0.5 µM MP-8 
with human placental 0.02 µM GST at 22.5 ± 0.02 ° C and pH 7.00. The quenching shown 
( approximately 10% after 10 minutes) attains a final value of about 50% when the 



























Figure 3.22 : Kinetics of the Interaction of Human Placental GST 
and MP-8 
(a) Absorbance/time trace describing the interaction of MP-8 (0.35 µM) and human 
placental GST (0.02 µM) (decrease in A
3
%nm). Reaction was performed at 22.5 ± 0.02°C 
in 10 mM potassium phosphate buffer (pH 7.00). (b) Biexponential fit to the data of a) . 
Line drawn in main plot is that predicted by fitting the data to the biexponential function A A kl •t k2*t f1Ar + UAf. + /iA.
5
e· . The resultant parameter values are shown in Table 3.7 
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Figure 3.23 : Interaction of Human Placental GST with Varying Concentrations of MP-8 
Biexponential modelling of the absorbance/time data for the interaction of human placental GST (0.02 µM) and a range of MP-8 concentrations (0.25 (0), 0.35 (D), 0.5 (•), 0.7 (ti.), and 1 µM (•), respectively). All reactions were performed at 22.5 ± 0.02°C in 10 mM potassium phosphate buffer (pH 7.00). Lines drawn are those predicted by fitting the data to the biexponential function~+ tiAf-kl"t + M
5
e-k2"t. The data show clearly that a biexponential model is applicable over the whole MP-8 concentration range employed. 
Table 3.7: Kinetic Parameters for the Interaction of MP-8 and Human Placental GST 
Parameter Fit A(± S.D.) Fit B (± S.D.) 
~ 4.62 X 10-2 ± 1.41 X 10-3 4.63 X 10-2 ± 7.19 X 104 
Mr 2.34 X 10-2 ± 4.53 X 104 2.19 X 10-2 ± 2.26 X 10-4 
k • 
1 5.42 X 10
4 ± 8.80 X 10-5 5.25 X 10-4 ± 4.49 X lQ-5 
M 
s 
2.32 X 10-2 ± 1.26 X 10-3 2.45 X 10-2 ± 5.78 X 10-4 
kz• 3.65 X 10-3 ± 1.88 X 104 3.56 X 10-3 ± 8.22 X 10-5 
The kinetic parameters above are those predicted by fitting the data shown 
in Figure 3.22 to the biexponential function: ~ + Mf-kl*t + M
5
e-k2"t. 
Only 47 points on the curve were included in fit A, while 250 points were used in fit B. 
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The biexponential fits to the data yielded pseudo-first-order rate constants (k1 * 
and~*) for the fast and slow phases of the process, respectively, as well as values 
for the contributions of each phase (f = fast and s = slow) to the total (T) 
absorbance change (tAf(ast)' tAs(low)' and tAr(otal)• respectively). When the 
values of k1;/ are plotted against MP-8 concentration (Figure 3.24 ), a straight-
line dependence of the individual rate constants on MP-8 concentration is 
observed. Figure 3.25 shows the change, with increasing MP-8 concentration, in 
the relative proportion of the total displacement occupied by the fast phase. A 
mechanistic interpretation of these results is proposed in Section 4.7. 
Preincubation of the GST with bilirubin (15 µM) for 15 minutes prior to addition 
to MP-8 completely eliminated the slow phase of the kinetic binding curve, which 
became monophasic. Figure 3.26 shows a typical trace obtained after preincuba-
tion with bilirubin ( data plotted as a first-order kinetic process) with a logarithmic 
plot of the data inset. The addition of 1 mM CDNB to the enzyme immediately 
prior to initiation of the kinetic run completely eliminated the fast binding phase 
(Figure 3.27 and inset), while in the presence of 1 mM GSH, the kinetics of the 
MP-8/GST interaction remained biphasic in nature (Figure 3.28). These results 






Figure 3.24 : Variation of k1* and~* with MP-8 Concentration 
The pseudo-first-order rate constants for the fast and slow phases of the interaction 
between GST (0.02 M) and MP-8 were evaluated by non-linear regression at a number 
of MP-8 concentrations (0.3-111M). The straight lines were fitted to the data by the 
method of least-squares. Evaluation of the apparent rate constants was possible from the 
slopes and intercepts of these plots (see text). 
1 
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Figure 3.25: Variation of A.. with MP-8 Concentration 
The relative absorbance change due to the fast phase (Ar = AA.cf (Mr+ AA.s)) is shown 
for a range of MP-8 concentrations up to 1 µM. The open circles (0) refer to data 
obtained at 22.5° C (± 0.02 ° C), while the filled circles(•) represent data from preliminary 
experiments conducted at room temperature (20-25 ° C), which were therefore not 
included in the kinetic analysis. 
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Figure 3.26 : Effect of Bilirubin on the Interaction of MP-8 and GST 
Kinetic trace describing the interaction of MP-8 and human placental GST after preincubation of the enzyme with 15 µM bilirubin for 15 minutes prior to addition of 
MP-8. The data now show adherence to a single first-order kinetic process over > 95% of the reaction extent. Inset shows a logarithmic plot of the data. Concentrations of MP-8 
and GST were 0.35 µM and 0.02 µM, respectively, and reaction ( decrease in A
396
nm) was performed at 22.5 ± 0.02 ° C in 10 mM potassium phosphate buffer (pH 7.00) . 
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Figure 3.27 : Effect of CDNB on the Interaction of MP-8 and GST 


























Figure 3.28 : Effect of GSH on the Interaction of MP-8 and GST 
Kinetic trace describing the interaction of MP-8 and human placental GST after 
preincubation of the enzyme with 1 mM glutathione for 15 minutes prior to addition of 
MP-8. The inset demonstrates the inadequacy of a single exponential for modelling the 




3.7 THE INHIBITION OF HUMAN PLACENTAL GST 1r BY MP-8 
The time-dependent inhibition of human placental GST by MP-8 is depicted in 
Figure 3.29. The decrease in enzyme activity towards CDNB followed a pseudo-
first-order rate law, with a rate constant (kobs) of 2.3 (± 0.4) x 10-3 s·1, determined 
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Figure 3.29 : Time-Dependent Inhibition of Human Placental GST 
by MP-8 
The time-dependent inhibition of the enzyme-catalysed conjugation of CDNB and GSH 
was followed by incubation of 0.4 µM MP-8 with 0.1 µM GST at 25 ± 0.02°C in 0.1 M 
potassium phosphate buffer (pH 6.5). The results of control incubations (no MP-8 
present) were subtracted. The line shown is that predicted by the fit of a first-order rate 
equation to the pooled data from three separate experiments. The first-order rate 
constant, determined by non-linear least squares regression, was 2.3 (± 0.4) x 10·3 sec·1. 
-
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Figure 3.30 depicts the effect of MP-8 on the steady-state kinetics of the GST-
catalysed conjugation of GSH and CDNB. The inhibition of GST by MP-8 at 
constant CDNB and varying GSH was apparently of the mixed type (Figure 3.30a), 
although the inhibition was too slight for further analysis. Preincubation of GST 
with MP-8 resulted in mixed-type inhibition of the enzyme with respect to CDNB 
also (Figure 3.30b ). The straight-line replots of the 1/v-axis intercepts and slopes 
( of Figure 3.30b) versus MP-8 concentration shown in Figure 3.31 confirm that 
the inhibition is of the linear mixed-type (scheme shown in Section 4.8) [252]. 
The value of Ki (0.34 µM), determined from the slope versus MP-8 concentration 
replot, allowed a value for a to be determined using the intercept versus MP-8 
concentration replot. The value thus calculated for a (3.54) was in good agreement 
with the value (3.03) determined from the intersection point of the primary 
reciprocal plot (Figure 3.30b ). All the parameter values evaluated from these plots 
for the linear mixed inhibition mechanism are shown in Table 3.8. The data of 
Figure 3.30b were also subjected to a Dixon-type analysis, which gave results in full 
agreement with the alternative (Lineweaver-Burk) analysis. Figure 3.32 shows 
replots of the Dixon plot slopes and intercepts according to a linear mixed-type 
inhibition mechanism, and the parameter values derived from the Dixon analysis 
are included in Table 3.8 for comparison. Also shown in Table 3.8 are the values of 
Ks and Ki for the data of Harvey and Beutler [110], for human erythrocyte GST 
(see discussion in Section 4.8). 
Table 3.8 : Parameters for Linear Mixed Type Inhibition of Human 
Placental GST by MP-8 
Ks K 
I 
(M x 10"3) (M x 10-6) 
Direct Replot 0.73 (± 0.2) 0.33 ( ± 0.05) 3.5 (± 0.4) 
Dixon Analysis 1.3 (± 0.3) 0.51 (± 0.04) 2.2 (± 0.5) 
Dixon Analysis of 0.77 0.1 
Data of Ref. 110* 
*For human erythrocyte GST p. 



























Figure 3.30 : Inhibition of Human Placental GST by MP-8 
105 
(a) With GSH as the varied substrate at a fixed CDNB concentration of 1 mM. 
(b) With CDNB as the varied substrate at a fixed GSH concentration of 1 mM. 
In both plots, enzyme concentration was 20 nM and MP-8 concentrations were (•) 0, 
(D) 0.5, (• ) 2 and (0) 5 µM. Velocities are expressed in nmoljmin/ml. Data points 
represent the means of triplicate determinations. Lines are those predicted by non-linear 
regression of the experimental data. Inset to (b) shows the region of intersection of the 
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(a) 1/V vs [MP-8]. (b) KCDNB /V . Concentrations are µM for MP-8 max app app max app and mM for substrate. In Figure 3.31b, the point representing an MP-8 concentration of 
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zero uses the accurate value of KCDNB calculated in the full kinetic analysis reported in 
Section 3.3.2 (Table 3.3). Derived steady-state parameters for the linear mixed-type 
inhibition scheme (see text) are shown in Table 3.8. Lines are generated by linear 

























Figure 3.32 : Slope and Intercept Replots of Dixon Plots for Data of 
Figure 3.30b 
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The straight line is predicted for mixed-type inhibition with the species ESI catalytically 
inactive. Steady-state parameters for the linear mixed-type inhibition scheme obtained 




4.1 OPTIMISATION OF GST ASSAY FOR KINETIC STUDIES 
In order to optimise the GST assay system prior to detailed kinetic studies, a 
number of preliminary experiments were performed. These included investigations 
of the choice of solvent for CDNB and DCNB, the order of addition of reagents, 
and the linearity of initial rates in the standard GST assay. 
Integral to this optimisation was the selection of the centrifugal analyser as the 
spectrophotometric instrument of choice. More conventional spectrophotometers 
are limited by several factors in investigations of this nature, where a large number 
of assays (up to 600 per experiment) must be performed in as short a time as 
possible to minimise time-dependent enzyme activity losses. The ability of the 
centrifugal analyser to process 20 cuvettes si.multaneously, as well as the 
elimination of the need to wash out and dry cuvettes at intervals, reduced the 
overall experimental time considerably. In addition, economical use of the purified 
isoenzymes was facilitated by the small cuvette volume (minimum volume of 
150 µl). The centrifugal mixing method allowed absorbance measurements from as 
little as 3 seconds after the initiation of the reaction (in contrast to the variable 
and sometimes considerably longer times of manual mixing methods). More 
precise absorbance measurements and temperature control (30.0 ± 0.1 ° C) than 
permitted by other available instruments were possible with the Multistat. 
Using the centrifugal analyser, it was possible to assess the linearity of initial rates 
for the reaction from effectively time zero. The results of this investigation 
(Section 3.1) indicate that initial rates are not linear for as long as previously 
thought; in fact curvature is evident after only 1 minute (Figure 3.1). For accurate 
kinetic studies with GST isoenzymes, initial rates should therefore be measured 
using data obtained over the first 60 seconds of the reaction only. Using manual 
mixing methods, the time taken between initiation of the reaction and recording of 
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the reaction rate is operator-dependent and variable, and may encroach 
substantially on the first 60 seconds of reaction. The centrifugal analyser is 
therefore well suited to kinetic studies of the transferases, since mixing is 
automated and measurements are always taken from 3 seconds after initiation of 
the reaction. 
One possible cause of the curvature observed after 60 seconds, which is diminished 
in the presence of albumin (see Section 3.1), may be irreversible inhibition of GST 
activity by CDNB [61]. Incubation of CDNB with a mixture of rat liver GST 
isoenzymes resulted in a time-dependent pseudo-first-order loss of activity (kobs = 
2.5 x 10-3 s-1) [61, Sikakana et al., unpublished results]. The extent of this 
inhibition was dependent on CDNB concentration (150 = 0.3 mM), and was not 
reversed on removal of CDNB by either dialysis or Sephadex G-75 chromato-
graphy. CDNB has also been reported to covalently bind to and irreversibly inhibit 
rat liver GSTs 1-2 and 3-3 [136,215]. 
Previous reports [150,179] of an increased enzymic activity in assays performed 
after preincubation of GST preparations with GSH have been confirmed in this 
study (see Section 3.1). This activation by GSH may well have introduced 
uncertainty into the results of some previous kinetic studies [132,184], where GST 
was preincubated for 5 minutes at 30°C with GSH, at each of the varying GSH 
concentrations used. In order to minimise the possible variable activation of the 
enzym_e that could result from this phenomenon, the enzyme (in buffer) was always 
added alone to the inner cuvette chamber of the Multistat rotor (see Figure 2.1) in 
these kinetic studies. The other reactants were added (in the order shown in 
Figure 2.1) to the outer chamber, and the reaction was initiated by the addition of 
enzyme. 
Some commonly used solvents have profound substrate-dependent effects on 
various enzymatic reactions in vitro [7]. For example, ethanol, the most commonly 
used solvent for CDNB and DCNB in the GST assay, has been shown to reversibly 
inhibit GST activity towards these halo-aromatic substrates at solvent 
concentrations greater than 1 % (v/v) [39,134]. Despite this, some GST assay 
methods [9,104,257] have recommended ethanol concentrations as high as 5% for 
substrates with limited aqueous solubility. 
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Using mathematical modelling of limit-velocity values obtained by extrapolating 
ethanol concentrations to zero, Jakobson et al. (134) have concluded that inhibition 
by ethanol was not the cause of the non-hyperbolic kinetics observed for GST 
isoenzyme 3-3. However, it is generally held that solvent concentration in enzyme 
assays should be kept as low as possible in order to minimise solvent effects on the 
enzyme and that these effects should be investigated for each enzyme/substrate 
combination prior to any detailed kinetic studies (7,39). Although the 
concentration of ethanol in some early initial velocity studies [132,184] was kept 
constant at 3% (v/v) because of this fact, considerable inhibition was observed at 
that concentration in the present investigation (see Figure 3.2). 
This study has also demonstrated that DMSO is considerably less inhibitory than 
ethanol towards GST activity (Figure 3.2) and is thus a more suitable solvent for 
both CDNB and DCNB for the GST isoenzymes of this investigation. The concen-
tration of DMSO in these kinetic studies was limited to 2% (v /v), at which no 
significant inhibition was observed (Figure 3.2). Therefore, the contribution of 
solvent effects could be eliminated from the mechanistic interpretation of the 
kinetic data. 
In view of the findings of these preliminary experiments, the standard assay 
conditions were reassessed and relatively stringent conditions imposed with respect 
to solvent choice, order of addition of reactants, linearity of reaction with time, 
etc., to ensure accurate initial rates, a particularly relevant requirement for 
mechanistic studies of the GSTs. 
4.2 THE REVERSIBLE AND IRREVERSIBLE INHIBITION OF GSTs BY 
ETHYLENE DIBROMIDE 
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The experiments to reproduce work previously performed in this laboratory on the 
reversible inhibition and activation of the GSTs by EDB [130] successfully 
confirmed the suitability of the centrifugal analyser for kinetic studies on the 
transferases (Figure 3.3). A mechanistic interpretation of this work has already 
been proposed [130] and therefore the results of those experiments are not 
discussed further here. 
Inskeep and Guengerich [127] reported that both GSH and GST were necessary 
for the irreversible binding of [14C]-EDB to DNA to occur in vitro. Although no 
binding of EDB to DNA was observed when GSH was absent, GSH concentrations 
of greater than 10 mM resulted in less EDB binding to DNA than GSH concentra-
tions_ of 2 mM [127]. Inskeep and Guengerich [127] concluded that the extent of 
DNA binding by EDB and other dihaloethanes in vivo may be the net result of a 
complicated balance between the detoxicating and activating processes of GSH 
r 
conjugation. The results of the present investigation (Section 3.1) suggest that 
another factor in this balance which has not been previously considered may be 
irreversible inhibition of GST activity by EDB. This irreversible inhibition of the 
GSTs by EDB may be a further example of the demonstrated ability of these 
enzymes to sequester potentially toxic compounds [39,155]. 
Pseudo-first-order inhibition of GST activity by EDB has been observed previously 
in this laboratory, for both rat liver GST 3-3 and a mixture of rat cytosolic GSTs 
[131 ]. In the present investigation, measurements of GST activity at various time 
intervals has confirmed this inhibition occurs for human placental GST under the 
incubation conditions of Inskeep and Guengerich [127]. The observed pseudo-first-
order rate constants in the presence of 2 mM or 15 mM GSH (2.25 x 10-3 and 
1.64 x 10-3 s-1, respectively) were in good agreement with that previously reported 
for the inhibition of a mixture of rat liver cytosolic GSTs by EDB (2-2.6 x 10-3 s-1) 
[131]. Although the first-order rate constants for the loss of activity of human 
placental GST 7r were similar at both GSH concentrations, the extent of inhibition 
was greater at 2 mM (see Figure 3.4). This phenomenon may be related to the 
finding that GSH concentrations of greater than 10 mM resulted in less EDB 
binding to DNA than GSH concentrations of 2 mM [127], and may well be 
accounted for by the partial protection of GST from inactivation that is observed 
on preincubation with GSH [61,131,308] (see also Section 4.5). 
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One passing point of interest concerns the observation of Inskeep and Guengerich 
[127] that GST 1-2 and Sigma rat liver GST mix were equivalently effective in 
producing binding of EDB to DNA. This may well be accounted for, at least in 
part, by a report that the commercial preparation is primarily composed of 
isoenzyme 1-2 [23 7] 
The ultimate toxicity of EDB in vivo may be the net result of several processes, 
including activation to a DNA-binding GSH adduct by at least some GST iso-
enzymes, irreversible binding of EDB to these isoenzymes (both inhibiting the 
metabolic activation of the precarcinogen and sequestering the compound), the 
physiological concentration of GSH and other GST-independent processes of 
activation and detoxication. 
4.3 THE SIMPLEST STEADY-STATE RANDOM SEQUENTIAL BI BI 
MECHANISM ADEQUATELY EXPLAINS THE NON-HYPERBOLIC 
KINETICS OF THE GSTs. 
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"The kinetic mechanism of the glutathione S-transferases is controversial. The 
uncertainty reflects, in large part, the non-linear behaviour of the kinetic data 
obtained with purified glutathione S-transferases." This is how Boyer and Kenney 
[39] described the kinetics of the GSTs in their recent major review of the subject. 
In his review of the same year [179], Mannervik concluded " ... virtually all GSH 
transferases studied in detail display distinct deviations from Michaelis-Menten 
rate-behaviour when the concentration of GSH is varied. Thus, it seems likely that 
the basic sequential model is overlaid with the kinetic complications arising from 
an enzyme memory mechanism involving GSH-induced slow transitions. Further 
investigations are necessary to evaluate this suggestion". 
The non-hyperbolic kinetics of the GSTs were first observed in early studies of the 
conjugation of GSH and DCNB by rat liver GST 3-3 (reviewed in Section 1.4.2). 
Families of concave-down reciprocal plots were also observed in this investigation 
for the conjugation of ODNB by isoenzyme 3-3 (Figure 3.9) and of DCNB by 
isoenzyme 3-4 (Figure 3.10) and for the conjugation of CDNB by rat liver 
GST 2-2 (Figure 3.16). 
The reported data for GST 3-3 and DCNB are generally thought to fit the steady-
state random sequential Bi Bi model best [39,179,184]. Although sufficient data for 
detailed mechanistic modelling were not collected in this study for GSTs 3-3 and 
3-4, and although the contributions of the different subunits of the heterodimer 
cannot be overlooked, it was found that this model was also capable of fitting the 
data for both these isoenzymes (Section 3.3.1). The initial velocity data collected in 
this investigation for GST isoenzyme 2-2 were considerably more substantial than 
those for GSTs 3-3 and 3-4, and these too were found to be best described by 
the steady-state random model. In fact, where Mannervik and Askelof [184] 
reported one redundant parameter when their data were fitted to this model, no 
redundant parameters were found in this study with the data for GST 2-2 (see 
Table 3.6). The observed pattern of inhibition by the CDNB-GSH conjugate (see 
Section 3.3.5) also supported a steady-state random mechanism for GST 2-2. 
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The kinetic, equilibrium binding and product inhibition data for GSTs 3-3, 3-4 
and 2-2 therefore appear to favour a steady-state random sequential mechanism. 
However, over the years, several models have been proposed to account for the 
apparent deviations from Michaelis-Menten kinetics of GST 3-3 (these are 
reviewed in Section 1.4.2) [39,179]. These suggestions have included subunit co-
operativity [63], steady-state mechanisms of differing degrees of complexity [132], 
and the superimposition of product inhibition [132,133] or enzyme memory [179] 
on the latter. As recently as 1988, GSH-induced conformational transitions have 
been invoked to account for the non-hyperbolic steady-state kinetics of the GSTs 
[229]. 
As described m Section 1.4.2, no evidence has been found for co-operative 
interactions between the subunits of the dimeric GST isoenzymes studied, 
apparently eliminating negative co-operativity as a possible cause of the non-
linearity (see also Section 4.4) [63,135,179,292]. 
A steady-state random mechanism involving kinetically significant enzyme. product 
complexes was proposed by Jakobson et al. [132]. They demonstrated that although 
the classical rate equation for a steady-state random mechanism fitted the data for 
GST 3-3 satisfactorily, their more complex model (which included > 10 para-
meters and terms of 4th degree in concentration of each substrate) fitted the data 
with a lower residual sum of squares. Despite the admission that this model was 
considerably overdetermined (having several redundant parameters and many 
other parameters with standard deviations of 100% ), they concluded that this 
model best described the kinetic mechanism of GST 3-3 [132]. 
It is demonstrated here that the simplest steady-state random sequential Bi Bi 
mechanism, in the absence of products, is consistent with and sufficient to explain 
the non-hyperbolic kinetics of GST 3-3. Neither more complex steady-state 
mechanisms nor the superimposition of product inhibition or enzyme memory on 
the basic steady-state random sequential mechanism are necessary. 
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The simplest steady-state random sequential mechanism, as applied by Mannervik 
and Askelof [184] to GST 3-3 in the absence of Pander, is shown below, 
E + P + Cl-
E = Enzyme 
B=DCNB 
A=GSH 
P = Conjugate 
(1) 
where E = enzyme, B = DCNB, A = GSH and P = the GSH · DCNB conjugate. 
The rate equation corresponding to this mechanism is: 
v= (Eqn. 1) 
where Vi (i = 1-3) are constants containing ET, and Vi and Kj U = 1-7) are 
combinations of the rate constants shown in scheme (1) [184]. 
For fixed concentrations of DCNB, Eqn. 1 simplifies to: 
iA2 + jA 
V = 
k + 1A2 + mA 
(Eqn. 2) 
where i = V2B, j = V1B + V3B
2, k = K1 + ~B + K5B
2, 
1 = K4 + K6B, and m =Ki+ B + K7B2 [85,221,252]. 
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An analogous expression can be derived for constant concentrations of GSH. 
These simplified rate equations (like Eqn. 2) are 2/1 functions, i.e., in reciprocal 
form ( after dividing through by A 2) 1 / A 2 appears in the numerator and 1 / A 
appears in the denominator [252]. Both the reciprocal equation (Eqn. 3) derived 
from Eqn. 2 and the first derivative of the reciprocal form (Eqn. 4) are shown 
below. 
1/v = 
k/A2 + 1 + m/A 
i + j/A 
dy kjx2 + 2kix + (im - jl) 
= 
dx (i + jx)2 
where y = 1/v and x = 1/ A. 
(Eqn. 3) 
(Eqn. 4) 
The presence of squared terms in the rate equations means that the steady-state 
random mechanism predicts non-linear reciprocal plots with either substrate 
[58,85,221,252]. In fact, several distinct types of non-hyperbolic kinetics can be 
obtained in the steady-state random system (where E, EA, EB, A and B are not at 
equilibrium and k5 of scheme ( 1) is greater than any of the other forward rate 
constants). For example, plots of v versus substrate concentration may exhibit zero, 
one, or even two inflection points if one route to EAB is kinetically more 
favourable than another [85,86,221,252]. 
Only under certain conditions, such as with saturating substrate concentrations or 
where special relationships exist between the kinetic parameters and the constant 
concentration of one substrate (see Section 4.4 ), will Eqn. 2 simplify so that linear 
double-reciprocal plots are obtained for the simplest steady-state random Bi Bi 
mechanism [58,85,252]. , 
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The required conditions for concave-down double-reciprocal plots are met when 
jl/im, ki/mj, i2k/j(mi - jl) and K6A
2/m are all less than unity for fixed DCNB 
concentrations (or if the equivalent conditions hold for fixed GSH concentrations) 
[85,252]. Using the reported values of Vi and Ki for the metabolism of DCNB by 
GST 3-3 [184], which provided a good fit to the experimental data, it can be 
shown that Eqn. 2 predicts concave-down double-reciprocal plots over the whole 
range of substrate concentrations used experimentally ( data not shown). 
Conditions for linearity of the double-reciprocal plots would only be met, using 
these Vi and Ki values, at very much lower concentrations of GSH (~ 2 µM) or 
DCNB ( < 5 µM) or at saturating concentrations of either substrate. 
Using the converged values of Vi and Ki for the metabolism of CDNB by GST 2-2 
(Table 3.6) it was also found that concave-down double-reciprocal plots are 
predicted over the whole range of substrate concentrations used experimentally 
(data not shown). As was the case for the reported values of Vi and Ki above [184], 
conditions for linearity of the double-reciprocal plots would only be met at very 
much lower concentrations or at saturating concentrations of either substrate. 
As mentioned above, although concave-down reciprocal plots are consistent with 
negative co-operativity, hyperbolic binding isotherms have been reported for the 
equilibrium binding of GSH to GST isoenzymes 1-2 and 3-3 [135,292]. 
Contributions from co-operative subunit interactions cannot be completely ruled 
out, though the binding studies do not support this possibility. It therefore appears 
that the negative co-operativity of the GSTs is kinetically generated via the 
branched pathway of scheme (1). In theory, kinetically generated negative co-
operativity disappears as the concentration of the fixed substrate becomes high 
enough to essentially force the reaction into an ordered mechanism (see Section 
4.4 ). It was not possible to observe such a trend in this investigation because of the 
limited solubility of DCNB and CDNB in aqueous solution. The trend might 
however be observable with GSH concentrations in the range of 100 - 1000 mM. 
Generally, in steady-state bisubstrate systems in which there is a preferred (but not 
exclusive) kinetic pathway to a ternary complex, there is no need to assume 
subunit-subunit interactions or ligand-induced conformational changes in order to 
explain sigmoidal responses [252]. This is because the complexities inherent in 
bisubstrate enzymic reactions can adequately account for 'allosteric' phenomena 
. without necessarily involving protein-protein interactions. The non-hyperbolic 
kinetics of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthetase of 
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Rhodomicrobium vannielli [141] and phosphofructokinase of E. coli [85] have also 
been interpreted in terms of such a kinetic model. This kinetic explanation for 
non-hyperbolic kinetics is not valid for rapid equilibrium systems (where the 
breakdown of EAB is rate-limiting), nor for systems in which either both routes to 
EAB are equally favourable or in which A and B add in an obligate order [252]. 
As Segel [252] has emphasised, "the possibility that a sigmoid velocity curve arises 
as a consequence of a random path to the central complex should be considered 
seriously by investigators dealing with 'allosteric' bireactant or terreactant 
enzymes." 
In conclusion, the simplest steady-state random sequential Bi Bi mechanism is 
consistent with and is sufficient to explain the reported non-hyperbolic kinetics of 
GST 3-3 [184] and those observed here for GSTs 3-3, 3-4 and 2-2. This is the 
simplest mechanism consistent with all the kinetic, equilibrium binding and 
product inhibition data. Therefore, invoking Occam's razor t, neither more 
complex steady-state mechanisms nor the superimposition of product inhibition or 
enzyme memory on a steady-state random sequential mechanism are required to 
explain the non-hyperbolic kinetics. 
twilliam of Occam's (1280-1349) dictum - Entia non sunt multiplicanda practer 
necessitatem. 
4.4 A RAPID EQUILIBRIUM RANDOM SEQUENTIAL BI BI MECHANISM 
FOR HUMAN PLACENTAL GLUTATHIONE S-TRANSFERASE 
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For human placental GST 7r, double-reciprocal plots of initial rate data were linear 
over wide concentration ranges of both substrates (Section 3.3.2). This is in 
contrast to the initial rate data for rat liver isoenzymes 3-3 and 3-4 with CDNB 
and DCNB, which exhibit concave-down double-reciprocal plots (Section 4.3). 
The intersecting initial velocity patterns shown in Figure 3.12 indicate that the 
kinetics of human placental GST 7r are consistent with a sequential mechanism, 
with both substrates adding to the enzyme before products are released [252]. This 
is in agreement with the available kinetic and stereochemical data for the 
interaction of GST isoenzymes with all substrates studied [175,179,249]. Although 
this pattern distinguishes the kinetic mechanism from a Ping-Pong system, in which 
one product leaves before the second substrate binds to the enzyme (and parallel 
lines are observed), these plots do not yield information on whether an ordered or 
random addition and release of reactants occurs [252]. 
The inhibition of GST 7r by the products of the enzymic conjugation reaction, was 
also investigated (Section 3.3.3). Initial rate data both in the absence and presence 
of the CDNB • GSH conjugate were fitted by non-linear least squares regression 
analysis to several rate equations describing bisubstrate mechanisms. Since the 
rapid equilibrium random mechanism was the simplest one consistent with all the 
kinetic experimental data for GST 7r, the kinetic constants are interpreted in terms 
of this mechanism. For example, since both the plots in Figure 3.12 intersect below 
the 1/[Substrate ]-axes, the binding of either substrate decreases the affinity 
(dissociation constant) for the other substrate by a factor a (i.e., a > 1), and the 
apparent K value for the varied substrate increases as the concentration of fixed 
substrate increases [252]. 
The linear double-reciprocal plots of substrate saturation are consistent with rapid 
equilibrium random substrate addition, and this model also provided the best fit to 
the experimental data (Table 3.4 ). Since steady-state initial rate equations for a 
random bisubstrate mechanism contain squared terms with respect to each 
substrate [252], biphasic plots would be expected at the unsaturating experimental 
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. substrate concentrations (see Section 4.3). It must be noted, however, that both a 
steady-state random mechanism and a steady-state ordered mechanism may also 
give rise to straight-lined double-reciprocal plots [252], and therefore such plots 
may not be good criteria for discriminating between steady-state and rapid 
equilibrium substrate interactions (see below). 
In addition to the linear initial velocity plots, the experimentally observed pattern 
of inhibition by the CDNB-GSH conjugate also indicated that the placental 
isoenzyme was not adequately described by the steady-state random mechanism 
which best fits GST 3-3 (see Section 3.3.3). For a steady-state random sequential 
Bi Bi mechanism, at fixed unsaturating substrate concentrations, 1/V-axis 
intercept replots should be hyperbolic, and slope replots would be more complex 
functions of the product inhibitor concentrations [252]. 
Although a rapid equilibrium ordered system with GSH binding first gave a 
reasonable fit to the data (Table 3.4 ), this mechanism could be eliminated on the 
basis of the characteristics of the reciprocal plots in the absence of inhibitors and 
also by the product inhibition pattern. In a rapid equilibrium ordered system with 
GSH binding first, the family of lines in the 1/v versus 1/[CDNB] plots (at fixed 
GSH concentrations) should intersect on the 1/v axis and above the horizontal axis 
[252]. This pattern of competitive activation by GSH is a method of distinguishing 
a rapid equilibrium ordered system from the rapid equilibrium random and steady-
state ordered or random reactions [252]. The observed pattern of product 
inhibition is also inconsistent with that expected for a rapid equilibrium ordered 
mechanism (see Table 3.5). 
Although a steady-state ordered Bi Bi mechanism could not be excluded by the 
initial velocity data in the absence of product ( see above), and could not be 
distinguished from a rapid equilibrium random Bi Bi mechanism by computer 
modelling (see Section 3.3.2), the two mechanisms can be differentiated by product 
inhibition studies [252]. In a steady-state ordered Bi Bi system, the K~ /
1
GSH is 1s ope independent of CDNB concentration, and both slope and K~/
1
GSH replots would 1s ope reflect this constant value (252]. However, the experimental value of K~ /
1
GSH was 
1s ope observed to vary with CDNB concentration (Figure 3.15d), which is characteristic 
of a rapid equilibrium random mechanism where -y ;. 1. 
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The product inhibition data suggest that the mechanism may be a random one in 
which the interconversion of central complexes is largely the rate-limiting step 
(rapid equilibrium random), and in which at least one dead-end complex may 
form, namely that between enzyme, CDNB and the CDNB • GSH conjugate, as 
shown below [252], 
Kp KA 
EP ~ p + E + A 
.,__ 
EA --, --, 
+ + + 
B B B (2) 
IKsH KeH .«:a Ji IKp kp 
EBP ~p +EB+ A ~ EAB --t E +P+Q 
where E = Enzyme, B = CDNB, A = GSH, P = Conjugate, and Q = Chloride. 
In this scheme, the binding of the conjugate to the enzyme does not competitively 
exclude CDNB, and the formation of a catalytically inactive ( dead-end) 
enzyme· CDNB • conjugate complex is possible. Binding of the conjugate to the 
enzyme changes the dissociation constant for CDNB by a factor, -y, which results in 
the mixed-type inhibition observed in the 1/v versus 1/[CDNB] plots at varying 
conjugate concentrations and fixed GSH concentrations (see Figure 3.14). The 
binding of the conjugate is competitive with respect to GSH, and saturating GSH 
concentrations overcome inhibition by the conjugate. Saturation with CDNB will 
not reverse the inhibition by the conjugate, since some conjugate and CDNB can 
still bind to the enzyme to form the inactive enzyme• CDNB • conjugate complex. 
Therefore the conjugate remains a competitive inhibitor with respect to GSH at all 
CDNB concentrations. 
Although the product inhibition data and the results of the computer modelling 
are consistent with this model, they provide only indirect evidence of the existence 
of a dead-end complex. Confirmation might be obtained experimentally by 
measurement of the binding of radiolabelled CDNB to GST 7r in the presence of 
the conjugate. If radiolabelled CDNB binds to the enzyme in the presence of the 
conjugate, this would provide direct evidence for the existence of an 
enzyme· CDNB • conjugate complex. 
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The evaluation of reports that other GST isoenzymes exhibit hyperbolic kinetics 
with CDNB and other substrates [107,177,249] is restricted by the use of limited 
ranges of substrate concentrations. It is known that the non-linearity of reciprocal 
plots may be difficult to observe over narrow ranges of substrate concentrations, 
and most kinetic studies have employed too narrow a range of substrate concentra-
tions to establish whether the kinetics are truly hyperbolic or non-hyperbolic. 
For example, Schramm et al. [249] proposed a rapid equilibrium random 
mechanism for rat liver isoenzyme 1-1, on the basis of linear double-reciprocal 
plots over a fivefold range of concentrations for both substrates. Their initial rate 
measurements were performed over a five by five matrix with regard to the 
concentrations of GSH (0.1 - 0.5 mM) and CDNB (0.2 - 1 mM). Over a similar 
GSH concentration range (0.15 - 1 mM), the kinetics of isoenzyme 3-3 with 
DCNB would also appear to be linear [215]. However, over a 67-fold GSH range 
(0.015 - 1 mM) the non-linear kinetics of isoenzyme 3-3 become apparent, with 
the discontinuity at about 0.1 mM GSH [215]. In contrast, the double-reciprocal 
plots for human placental GST 7T in this investigation were linear over a 103-fold 
range of GSH concentration and a tenfold CDNB range. 
As mentioned above, straight-lined double-reciprocal plots do not necessarily 
preclude a steady-state random sequential mechanism. If assumptions are made 
concerning the relative significance of various ternis, the rate equation for a 
steady-state random mechanism (Eqn. 1) will simplify, so that linear double-
reciprocal plots are obtained [58,252]. Theoretical analysis of the rate equation has 
identified several sets of such conditions [58,252]: 
1. If one substrate is saturating, the reaction flux is via one pathway to EAB and 
the randomness disappears, thereby essentially forcing the reaction to a 
steady-state ordered mechanism. 
2. If both routes to EAB are approximately equally favourable, departure from 
linearity may be impossible to detect. The curvature of the reciprocal plot 
will occur close to the 1/v axis and the system will appear to be rapid 
equilibrium random. 
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3. At very low concentrations of the variable substrate, Eqn. 2 reduces to 
1/v = k/UA) + m/j and the curve approaches a linear asymptote. 
4. Linear double-reciprocal plots occur over a wide range of DCNB or GSH 
concentrations if the first derivative (Eqn. 4) is invariant for all 
concentrations of variable substrate, i.e. if i2k = j(im - jl). Under these 
conditions, the second derivative of the reciprocal form, i.e., 
d2y 
dx2 
2 {i2k - j(im - jl)} 
= 
(i + jx)3 
(Eqn. 5) 
where y = 1/v and x = 1/ A, is zero. 
For favourable reactions, isotope exchange may provide a means to determine 
whether or not a random system is rapid equilibrium [252]. If the interconversion 
of central complexes is the sole rate-limiting step, then all exchanges in a given 
direction must proceed at the same rate at any given set of reactant concentrations, 
since they are all limited by the flux through this step [93,252]. The kinetic 
mechanisms of both yeast hexokinase [242] and E. coli galactokinase [93] have 
been shown to be truly steady-state random, although the initial velocity and 
product inhibition patterns are fully consistent with the rate equation derived for 
the rapid equilibrium random model. In both cases, the exchange along one 
pathway was found to be at least double the exchange along the alternative route 
[242], indicating the presence of a kinetically preferred pathway (see Section 4.3). 
Isotope exchange may in some cases also be able to discriminate between a steady-
state ordered Bi Bi and a steady-state random Bi Bi mechanism [252]. For both 
liver [58,256] · and yeast [256] alcohol dehydrogenase, all the kinetic data were 
consistent with a steady-state ordered mechanism, until isotope exchange revealed 
that the mechanism was random. Since the reaction catalysed by the GSTs is very 
exothermic and is considered to be irreversible for practical purposes [132], 
isotope exchange studies are unsuitable for further elucidation of the kinetic 
mechanism. 
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It is evident then that reaction kinetics adequately described by the rapid 
equilibrium random model may in fact represent a more complex mechanism in 
unusual cases [57]. Specifically, differences in the relative significance of various 
terms may account for the apparent difference in kinetic mechanism for the rat 
liver and human placental GST isoenzymes. 
The phenomenon of isoenzymes from different sources exhibiting different kinetic 
mechanisms is not without precedent [157]. For example, lactate dehydrogenase of 
rabbit skeletal muscle cytosol has an ordered sequential Bi Bi mechanism, whereas 
the rnitochondrially-bound isoenzyme exhibits non-hyperbolic kinetic behaviour 
[172]. Differences in kinetic mechanism have been described for the alcohol 
dehydrogenases from different sources [36,56,208,244]. Pig heart mitochondrial 
malate dehydrogenase operates via an ordered mechanism at pH 8, yet becomes 
partly random at pH 9 [56]. In contrast to the kinases mentioned earlier (which 
were truly steady-state, although fully consistent with the rapid equilibrium 
random model), isotope exchange revealed that creatine kinase from rabbit 
skeletal muscle has a truly rapid equilibrium random mechanism, with all 
exchanges occurring at equal rates under different conditions [56]. Furthermore, 
arginine kinase from Australian crayfish and nucleoside diphosphokinase from 
human erythrocytes both exhibit ping-pong mechanisms, as do hexokinases from 
mammalian brain and muscle [56]. 
In summary, although a more complex steady-state random mechanism cannot be 
unequivocally excluded, the rate equation describing the rapid equilibrium random 
model accurately predicts all the experimental findings. As is usual in such cases, 
the general principle of interpreting the data by the simplest consistent model is 
applied, and therefore it is entirely appropriate to interpret the initial velocity data 
in terms of this model [93,242,249,252]. 
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The straight-lined Scatchard plot (Figure 3.19) indicates hyperbolic (i.e. non-co-
operative) binding of the substrate to GST, and binding to identical and 
independent sites [252]. This binding study is fully consistent with a rapid 
equilibrium random sequential Bi Bi mechanism, and also with the equivalent 
steady-state mechanism. These results are also consistent with the hyperbolic 
binding isotherm and the stoichiometry of two reported for rat liver GST 3-3 
[135], also obtained using equilibrium dialysis. A single binding site per dimer of 
rat liver GST 1-1 was found for a spin-labelled GSH analogue, using electron 
paramagnetic resonance spectroscopy [249]. The reported Kd (28 µM) for this 
latter isoenzyme was close to that observed in this investigation (33 µM), while the 
dissociation constant for GST 3-3 was 10 µM [135]. 
One interpretation of the non-linearity of the double-reciprocal plots observed 
with GST 3-3 has been to postulate the existence of negative co-operat1v1ty 
between subunits, although this is not supported by much of the binding data (see 
Section 1.4.2). While the binding studies with human placental GST 71", in which 
only a single substrate (GSH) was used, might not detect negative co-operativity 
caused by the binding of the substrate in the presence of the co-substrate, the 
linear plots of substrate saturation observed for this isoenzyme do not call for 
explanation in terms of co-operative interactions. The finding of a hyperbolic 
binding isotherm for GSH with GST 71", which has a rapid equilibrium random 
mechanism, gives indirect evidence for the unlikelihood of negative co-operativity 
between the subunits of GSTs generally. As demonstrated here, it is conceivable 
that a steady-state random mechanism could simplify to a rapid equilibrium model 
by alterations in rate constants, however it seems unlikely that negative co-
operativity should be important in the mechanism of some GST isoenzymes, but 
not of others. 
4.5 ACTIVE-SITE SOLVATION CONTRIBUTES SIGNIFICANTLY TO 
INACTIVATION OF THE GSTs. 
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An important aspect of GST chemistry is the fact that the isoenzymes are 
inactivated to varying extents, both reversibly and irreversibly, by several non-
substrate ligands and highly reactive substrates/ co-substrate conjugates 
(61,131,308,309]. Examples of the time-dependent inactivation of GST activity 
have been documented for GST isoenzymes from rat (61,131,307] and human liver 
(258], human placenta (227,308] and human erythrocytes (110]. The presence of 
GSH [61,131,308] or a variety of proteins [304] has been found to protect or 
partially protect the GSTs from time-dependent inactivation. 
Vander Jagt and co-workers [304] explained this phenomenon by proposing that, in 
the presence of any of a variety of inhibitors, GSTs of rat and human liver exhibit 
conformational changes which are both time- and concentration-dependent, and 
which may lead to inactivation of the enzyme [258,304]. Foreign proteins (and 
GSH) are able to interact with the enzyme, preventing or partially preventing it 
from adopting an inactive conformation, and resulting in the formation of different 
active conformations of GST, each showing distinct specific activities depending on 
the nature of the protein (304 ]. These 'protein-protein interactions' are apparently 
weak (occurring without the formation of stable complexes) and non-selective, 
since almost any protein (including the enzyme itself) is able to participate in 
them. Furthermore, the foreign protein is only able to prevent the inhibitor 
exerting its conformational effect on the enzyme if the protein is added prior to the 
enzyme adopting the inactive conformation, or during the time of the conforma-
tional changes. Vander Jagt and colleagues [304] described these protein-protein 
interactions as a form of 'enzyme memory', involving the transmission of 
information through macromolecular interactions, with each conformation 
reflecting the prior history of events involving interaction of inhibitor, GST and 
foreign protein. 
The kinetic complications inherent in an 'enzyme memory' mechanism have 
subsequently been used to explain the apparent deviations of GST 3-3 from 
Michaelis-Menten rate behaviour [179], although the discussion in Section 4.3 has 
shown that the imposition of enzyme memory on the basic steady-state random 
sequential model is not necessary. The finding that incubation with GSH enhanced 
the activity of purified GSTs (12,132,150] has also been related to the kinetically 
stable activity states of the 'enzyme memory' mechanism (179]. 
I. 
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In this laboratory, a number of studies of the time-dependent inactivation of GSTs 
from rat liver and human placenta have been performed (see Table 4.1). During 
the course of these investigations, we have observed that a further type of 
inactivation, which does not appear to have been previously characterised, occurs 
on dilution of concentrated stock solutions of GST in buffer. We have proposed 
(Adams, Goold & Sikakana, unpublished results) that this type of inhibition, which 
follows pseudo-first-order kinetics, with a rate constant of 0.0025 s-1 at 25°C 
(pH 6.5) and does not proceed to 100% inactivation, is the result of salvation of 
the hydrophobic active-site of the enzyme. 
The studies conducted in this laboratory [131, Table 4.1 ], as well as results 
compiled from a survey of the literature [61,110,227,308], have revealed that a 
first-order inactivation of GST - with a rate constant close to that observed for 
dilutional inactivation above - was widespread over a range of GST isoenzymes 
and inactivating agents in unrelated experiments (summarised in Table 4.1). 
In this thesis, examples of this first-order inactivation phenomenon may be found 
in the time-dependent inhibition of human placental GST activity by MP-8 
(Section 3.7) and in the inhibition of Sigma rat liver GST by EDB (Section 3.1). 
The first-order rate constant was 2.2 (± 0.4) x 10-3 s-1 for the former, and 
1.64-2.25 x 10-3 s-1 for the latter. 
The remarkable constancy of the inactivation rate constant in all these cases, 
together with the fact that the various inactivating agents affect the extent of 
inactivation but not the rate constant for the process, suggests that these 
compounds are not inactivating agents per se. They merely facilitate an increase in 
the extent of salvation by increasing the degree to which water can penetrate the 
hydrophobic active-site. The resultant loss of hydrophobicity (which would differ in 
extent, depending on the nature and concentration of inhibitor) would determine 
the activity loss of the enzyme preparation. 
Table 4.1 : The Pseudo-First-Order Rate Constants for Irreversible Inactivation 
of a Range of GSTs 
Inactivating Agent GST Isoenzyme 
CDNB (1 mM) Human Placental 71' 
CDNB (1 mM EDTA), 30°C Human Placental 71' 
CTX (1 rnM EDTA), 30°C Human Placental 71' 
Solvent (1 mM EDTA), 30°C Human Placental 71' 
Solvent Human Placental 71' (Sigma) 
CDNB (1 mM) Human Placental 71' (Sigma) 
Solvent Human Placental 71' ( this prep) 
CDNB (0.8 mM) Human Placental 71' ( this prep) 
CDNB (1.2 mM) Human Placental 71' ( this prep) 
MP-8 (0.4 µM) Human Placental 71' ( this prep) 
CDNB (0.5 mM), 37°C Human Erythrocyte p 
CDNB (1.2 mM) Human Acidic Lung GST 
EDB (37 mM) 3-3 (Rat Liver) 
Solvent 3-4 (Rat Liver) 
CDNB (1.2 mM) 3-4 (Rat Liver) 
CDNB (1.2 mM) 3-4 (Rat Liver) 
EDB (37 mM) Rat Liver GST Mix (Sigma) 
EDB (5 mM) Rat Liver GST Mix (Sigma) 
CDNB (1.2 mM) Rat Liver GST Mix (Sigma) 
t Adams, Goold & Sikakana, unpublished results 
•Sikakana et al., unpublished results 
Mean kb 
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CTX - cefataxine; EDB - Ethylene dibromide; Solvent - phosphate buffer pH 6.5, µ = 0.1. 
Except where otherwise noted, T = 25 ° C. Standard deviations on the above rate constants 
are of the order of ± 15%. 
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We have also proposed (Adams, Goold & Sikakana, unpublished results) that the 
observed partial protection of GST from this type of inactivation by preincubation 
with GSH [61,131,308 (and in this thesis, Sections 3.1 and 3.7)] is caused by the 
tripeptide physically blocking the approach of water molecules into the catalytic 
centre. Similarly, the differing degrees of protection of GST activity observed on 
preincubation with foreign proteins ( or with higher concentrations of enzyme) 
[304] are explicable in terms of the preservation, to varying extents, of the 
hydrophobic nature of the enzyme active-site by localised interactions in the 
environment of the site. The concentration-dependence of this protection, the 
finding that no stable enzyme· inhibitor· protein complexes are observed [304], and 
the fact that protection is only afforded the enzyme if the protein is added prior to 
the inactivating agent, are all fully consistent with the proposed solvational 
inactivation of the GSTs. In addition solvational inactivation adequately accounts 
for the observed irreversiblity of the inhibition of GST activity by CDNB 
[61,136,215,304] and EDB [131], previously attributed to stable conformational 
states [61,304] or covalent binding [61,131]. 
The pH-dependence of the inhibition of GSTs by non-substrate ligands has been 
explained in terms of the allosteric formation of different enzyme· substrate. 
inhibitor conformers at different pH values [39,311]. It may be speculated that 
changes in pH create perturbations in the hydrophobicity of the enzyme active-site, 
which result in different degrees of solvation inactivation ( this hypothesis is under 
investigation in this laboratory). 
Independent confirmation of the role of dilutional inactivation in the mechanism 
of human placental GST has been obtained in the studies, reported in this thesis, 
of the binding kinetics of the interaction between GST 7r and MP-8 (see Section 
4.7). 
While solvation of the active-site provides a simple alternative explanation for a 
number of the observed phenomena concerning the type of inactivation of GST 
described here, it does not preclude the existence of other types of enzyme 
inactivation (such as that caused by cross-linking at sulphydryl groups), which may 
occur in addition to solvation inactivation. 
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4.6 OPTIMISATION OF THE PREPARATION OF MP-8 
The preparation of MP-8 from cytochrome-c using proteolytic enzymes has 
undergone several improvements in recent years. In general terms, however, the 
procedure involves the cleavage of cytochrome-c by peptic digestion to produce 
the haem undecapeptide (MP-11), which is then further degraded to the haem 
octapeptide (MP-8) by tryptic digestion. Conventional methods for the prepara-
tion of MP-8 require extensive column chromatography, are time consuming and 
result in relatively poor yields (:::: 50%) of approximately 90% pure MP-8 in 8-10 
days [11]. The commercial product is consequently expensive. These factors, 
together with an increasing interest in MP-8 as a model for monomeric haemin 
and the recognition of a need for product of higher purity, have led to attempts to 
develop a more rapid optimised preparative schedule for MP-8. 
Analytical HPLC has provided a convenient method for monitoring the kinetics of 
the conversion of cytochrome-c to haempeptides as well as an efficient means of 
separating closely related haempeptides. As a result, a considerably more rapid 
(:::: 30 h) and efficient (:::: 90% yield) HPLC-based preparative method for MP-8 
has recently been proposed, which results in a product containing no detectable 
impurities by analytical HPLC ( > 99% pure) [4]. 
The HPLC study of temperature effects on the kinetics of the peptic digestion of 
cytochrome-c which was performed as part of this investigation, together with a 
similar study of the tryptic digestion of MP-11, have facilitated further 
optimisation of the conditions for the preparation of MP-8 [5]. By performing both 
the peptic and tryptic digestions at 40° C, it has become feasible to purify pure 
MP-8 (to the point of lyophylisation) from cytochrome-c within 4 hours [5]. In 
addition, a reduction in contamination by other haem-containing peptides has 
been achieved. 
While the shorter incubation time must reflect, in part, an Arrhenius-law rate 
increase, the fact that non-MP-11 haem-containing contaminants are reduced 
suggests that the higher temperature may be causing the cytochrome-c to adopt a 
less ordered conformation, allowing the pepsin easier access to the MP-11 
cleavage sites and resulting in a cleaner conversion of cytochrome-c to MP-11. 
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An important feature of this optimised preparation was the removal of non-haem 
peptide contaminants by ammonium sulphate precipitation of MP-11 after peptic 
digestion of cytochrome-c (Figure 3.20b). Non-haem-containing amino acids and 
peptides account for about 85% by weight of the pepsin digestion, and this 
material could act as tryptic substrates or inhibitors and, by competition with the 
MP-11, retard the conversion of MP-11 to MP-8. The removal of hydrophilic 
peptide impurities (Figure 3.20b) by ammonium sulphate precipitation reduces the 
half-life for MP-8 formation at 40°C from approximately 30 minutes for the non-
precipitated sample to approximately 80 seconds. These results are in agreement 
with those of Petersen et al. [220] who, using a similar but slower ammonium 
sulphate precipitation procedure, concluded that the precipitation step alone 
represents a considerable purification of MP-11. 
The use of a bovine serum albumin affinity column to purify MP-11 from non-
haem peptides was first proposed by Wilchek [321]. In this study, the inclusion of 
such a step enabled the removal of trypsin and MP-11-derived tripeptide from the 
tryptic digest. In contrast to the observations of Wilchek, it was found that binding 
of haem-peptide to the affinity column was much less effective when human serum 
albumin was substituted for bovine serum albumin as an affinity ligand. This may 
be explicable in terms of the kinetic differences observed, in this laboratory, 
between bovine and human serum albumin in their reaction with MP-8. MP-8 
reacts with bovine serum albumin in a single stage first-order manner, while a 
more complex, multistage and slower interaction is observed with human serum 
albumin [6 - see Appendix 1]. 
4.7 THE KINETICS AND MECHANISM OF THE INTERACTION 
BE'IWEEN HUMAN PLACENTAL GST 1r AND MP-8 
A survey of the literature on the interaction of non-substrate ligands with the GSTs 
revealed that investigations to date have been exclusively thermodynamic ( e.g., 
competitive binding, equilibrium dialysis and direct absorption spectroscopy) or 
quasi-thermodynamic ( e.g., effects of non-substrate ligands on the steady-state 
kinetics of the enzyme-catalysed conjugation reaction) in nature. While 
undoubtedly of considerable value, such studies may not be amenable to 
unambiguous interpretation when taken in isolation. Klotz and co-workers [ 46] 
have recently cautioned against using purely thermodynamic grounds to determine 
the number and nature of ligand/protein binding sites. In addition to highlighting 
the difficulties associated with thermodynamic studies of GST /ligand interactions, 
Boyer and Kenney [39] have emphasised that considerable care must be exercised 
in the mechanistic interpretation of steady-state studies of the inhibition of GSTs 
by non-substrate ligands. 
In this investigation, the interaction of the non-substrate ligand MP-8 and human 
placental GST was studied by observation and analysis of the time-course of the 
binding process (Section 3.6). This represents the simplest and most direct 'extra-
thermodynamic' procedure by which the mechanism of ligand/protein interaction 
can be studied, and to the author's knowledge, no such study of the reaction 
between substrate/non-substrate ligands and any of the GSTs has yet been 
published. 
The observed quenching of the MP-8 Soret peak on addition of GST to solutions 
of MP-8 (Section 3.6) suggests a hydrophobic interaction between haem peptide 
and protein, involving the porphyrin macrocycle interacting via 7r-7r bonding with 
aromatic amino acid residues at the binding site, rather than axial ligation of the 
iron by donor ligands (imidazole of histidines) on the protein. In support of this 
statement, it is noted that the interaction of MP-8 with human serum albumin and 
apo-myoglobin (both of which bind haemin by axial ligation of the iron) leads to a 
red shift in the ).max (Soret) of approximately 15 nm (6 (Appendix 1)]. In contrast 
to this, when uroporphyrin I (a largely monomeric porphyrin) interacts hydro-
phobically with ligandin, changes in the ).max (Soret) have been found to be very 
small (2 nm) [294]. This result is also consistent with the concept of an enzyme 
which interacts with a wide range of non-iron-containing hydrophobic substrates 
and non-substrate ligands. 
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As described in Section 3.6, the kinetics of quenching followed a biexponential 
time course over the whole range of MP-8 concentrations used in this study. 
Attempts to model the kinetics using a single exponential function gave statistically 
inadequate fits. The observed straight-line dependence of the individual pseudo-
first-order rate constants on MP-8 concentration (Figure 3.24) suggests that the 
biexponential kinetics are due to two separate uncoupled pseudo-first-order 
processes. 
Bilirubin is a non-substrate ligand which has previously been shown to interact 
with human placental GST at a site which is spatially distinct from the catalytic site 
on the enzyme [308]. Preincubation of bilirubin with GST prior to addition of 
MP-8 eliminated the slow binding phase of MP-8 to GST (Section 3.6), so that 
the resultant kinetic data were best described by a first-order process (Figure 3.26). 
The pseudo-first-order rate constant obtained from the data of Figure 3.26 
(3.2 x 10-3 s-1) agrees well with the value of 3.4 x 10-3 s-1 interpolated at an MP-8 
concentration of 3.5 x 10-7 M from the variation of k1 * shown in Figure 3.24. It is 
therefore concluded that the slow kinetic phase reflects interaction at or spatially 
very close to the hydrophobic bilirubin binding site on the enzyme. 
Addition of the co-substrate CDNB completely eliminated the rapid phase of the 
MP-8/GST interaction (Figure 3.27 and inset). The rate constant calculated for 
the resultant first-order process (7.9 x 10-4 s-1) is in good agreement with the value 
of 5.9 x 10-4 s-1 interpolated from the slow phase data of Figure 3.24. Therefore the 
rapid phase of the MP-8/GST interaction reflects binding of MP-8 close to or at 
the CDNB binding site. 
The MP-8/GST binding kinetics observed in the presence of GSH were biphasic 
(Figure 3.28). The values of k1 * (3.5 x 10-
3 s-1) and k2 * (6.5 x 10-
4 s-1) obtained 
from the biexponential fit are again close to the corresponding values interpolated 
from Figure 3.24 (i.e., k1 * = 3.4 x 10-
3 s-1 and k2 * = 5.9 x 10-4 s-1). Since GST 
catalyses the conjugation of GSH and CDNB, it is reasonable to assume that the 
binding sites for these co-substrates are adjacent on the enzyme. Therefore, the 
fact that CDNB eliminated the fast MP-8 binding site, while GSH had minimal 
effect on the binding kinetics of MP-8, suggests that the fast MP-8 binding site is 
adjacent to but not identical to the CDNB site (possibly situated on the opposite 
side of the CDNB site to that at which GSH binds). If the CDNB and fast MP-8 
sites were in fact identical, the greater size of the MP-8 would undoubtedly 
overlap to a considerable extent with the GSH binding site, resulting in significant 
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GSH effect on the fast binding stage. Since only a minimal GSH effect is observed 
to occur, we conclude that the MP-8 haem binds close to the CDNB locus distal 
to the GSH site, with the possibility that one or more residues from the octa-
peptide chain overlap the CDNB site. 
These observations can thus be summarised by stating that MP-8 binds to GST at 
two discrete, non-interacting sites on the GST subunit. The kinetically faster site is 
proximal to the CDNB site and possibly on the side opposed to the GSH binding 
site. The slower site is at or spatially close to the hydrophobic bilirubin binding 
site. 
Several possible models can be proposed to account for the biexponential kinetics 
of the binding of MP-8 to GST. One explanation might be that MP-8 binds in a 
reversible two-step manner to a single site on the enzyme, but this is precluded by 
the fact that the two sites are dissectable (with bilirubin eliminating the slow phase 
and CDNB the fast phase). The biexponential kinetics therefore represent not a 
two-step binding to a single site, but rather a random binding to two separate sites 
with different rate constants. 
The simplest mechanism apparently consistent with the observation of two discrete 
non-interacting MP-8 binding sites on the enzyme is of the random sequential 








where 'f and 's' represent the fast and slow MP-8-binding sites, respectively. 
(3) 
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Since site 'f is observed to be kinetically much faster than site 's', the system can 
be simplified and closely approximated by 
.,MP-8 k2 [MP-8l /MP-8 
GST5 , k GS~ 
-2 MP-8 
(4) 
Under pseudo-first-order conditions, the following expressions can be written for 
k1 * and k/: 
k * = 2 
k2k1[MP-8]2 
k1[MP-8] + k_1 
and when k1[MP-8] > > k_1, Eqn. 7 reduces to: 




Evaluation of the apparent rate constants from the slope and intercepts of the 
plots in Figure 3.24 yields the following values: 
at pH 7.0, µ = O.l, and 22.5°C. 
!<i = 630 (± 25) M-1 s-1 
k_2 = 3.7 (± 0.6) X 10-4 S-l, 
Immediately, it is apparent that both mechanisms (3) and (4) are over-simplifica-
tions, since the condition k1[MP-8] > > k_1 required for the straight-line 
dependence of k2 * on MP-8 concentration (Eqns. 7 and 8 above) clearly does not 
hold in this case. 
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It is hoped to demonstrate that a slightly more complex model for the interaction 
of MP-8 and GST, based on the phenomenon of salvation of the enzyme active-
site, is fully consistent with the observed kinetic data. The contribution of active-
site salvation towards the inactivation of the GSTs has been discussed in Section 














the species S is a solvated form of the enzyme in which the 'fast' MP-8 binding 
site is eliminated, but the binding integrity of the 'slow' MP-8 binding site is 
retained. In terms of the concept outlined above, the loss of hydrophobicity which 
is resultant upon salvation of the catalytic site of the enzyme (the CDNB 
interaction locus) profoundly affects further hydrophobic binding at the site. 
MP-8 is therefore prevented from binding at the CDNB site (represented by the 
kinetically fast phase), but can still bind at the bilirubin site (slow phase). When 
CDNB is incubated with GST prior to the addition of MP-8 (as in Figure 3.27), 
the CDNB facilitates salvation of the active-site and therefore the kinetically fast 
phase of the MP-8 binding kinetics is eliminated. 
This explanation for the biphasic binding kinetics of MP-8 and GST is suggested 
by the observation that the limiting value of k1 * at zero MP-8 concentration 
(0.0021 ± 0.0004 s-1) is virtually identical to the pseudo-first-order rate constant 
observed for dilutional inactivation of GST 7r (0.0024 ± 0.0004 s-1 at 25 °C). 
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Moreover, it can be demonstrated kinetically that mechanism (5) is consistent with 
the experimental observations. If the 'fast' phase of mechanism (5) is isolated, it is 
equivalent to the simple system describing two parallel and independent first-order 
reactions [29], viz. 
(6) 
where A and B correspond to GST and the GST • MP-8 complex, respectively, S is 
the solvated form of the enzyme and ks corresponds to the solvation rate constant. 








(k1 + ks)[A] 
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The rate of formation of B (the GST • MP-8 complex monitored in the fast kinetic 





which integrates to yield 
[B] 
ki(A]
0 l -kt I = -e k (Eqn. 12) 
The first-order 'fast' rate constant k1 *, evaluated experimentally from the 
biexponential kinetic fits, is now equivalent to k in Eqn. 12, which is itself 
equivalent to ki + ks. Also, since ki_ in mechanism (6) is equal to k1[MP-8] in 
mechanism (5), we thus obtain k1 * = k1[MP-8] + ks. The dependence of k1 * on 
MP-8 concentration is therefore predicted to be straight-line, with slope k1 and 
intercept equal to ks at [MP-8] = 0, in agreement with the experimental 
observations. 
An independent measurement of ks, determined by following the pseudo-first-
order dilutional inactivation of GST (see Table 4.1), was found to be 2.5 
(± 0.3) x 10-3 s-1 (at 25°C, pH 6.5, µ = 0.1), in good agreement with the value of 
2.2 (± 0.4) x 10-3 s-1 obtained from Figure 3.24 at 22.5°C. Furthermore, the error 
limits on the values of ks allow us to estimate approximately a maximum value for 
k_1 (the rate constant for dissociation of MP-8 from the fast site) to be of the 
order of 4 x 10-4 s-1. 
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It is possible to discriminate further between mechanism (5) and mechanism (3). 
For mechanism (3), the relative proportion of the total absorbance change 
occupied by each phase should be independent of MP-8 concentration. However, 
for mechanism (5), the relative absorbance change due to the fast phase of the 
reaction (Ar), where 
(Eqn. 13) 
should approach zero as the [MP-8] .... 0 [29]. Figure 3.25 demonstrates such a 
dependence of Ar on MP-8 concentration, thereby favouring mechanism (5). 
Using the values for k1, k_1 max• k2 and k_2 calculated from Figure 3.24, we can 
calculate dissociation constants for the fast and slow kinetic sites. These are found 
to be Kr= 7.2 x 10-8 M (upper limit) and K
5 
= 5.9 x 10-7 M, respectively. These 
values lie well within the range of K0 values observed for other GSTs [39] and are 
in good agreement with the value of Ki = 10-7 reported for the inhibition of human 
erythrocyte GST p by haemin [110]. 
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4.8 THE INHIBITION OF HUMAN PLACENTAL GST BY MP-8 
Studies of the steady-state inhibition of the GST-catalysed conjugation reaction are 
an important technique by which the spatial relationship between non-substrate 
ligand binding loci and the enzyme catalytic site may be investigated [39] and, 
when viewed in the context of the kinetics of binding of the non-substrate ligand to 
the enzyme, such studies can provide a particularly valuable insight into the 
detailed nature of non-substrate ligand/GST interaction (see Section 4.7). 
Accordingly, the investigations reported here of the MP-8-mediated inhibition of 
the GST n-catalysed GSH/CDNB conjugation reaction are interpreted in the light 
of the direct GST /MP-8 binding kinetic studies discussed in Section 4.7. 
Incubation of MP-8 with GST for various times prior to assay (using CDNB and 
GSH as substrates) resulted in a pseudo-first-order loss of enzyme activity with 
time (Figure 3.29). Since control values ( enzyme incubated in buffer alone) were 
subtracted from each data point in Figure 3.29, the data are corrected for the first-
order inactivation which occurs on dilution of the enzyme in buffer (see Section 
4.5). However, the pseudo-first-order rate constant calculated for the MP-8-
mediated inactivation (kobs = 2.3 (± 0.4) x 10-3 s-1, at 22.5°C) was identical to the 
value found for dilutional inactivation alone (2.4 (± 0.2) x 10-3 s-1), with only the 
extent of inactivation differing in the presence of MP-8. 
Steady-state kinetic studies at constant GSH and varying CDNB concentrations 
established the inhibition by MP-8 as being of the linear mixed-type [252], shown 
below, 
s Ks ES 
kp 
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From the parameter values shown in Table 3.8 for the linear mixed-type inhibition 
system, it is noted that Ki at 30°C (3.3 x 10-7 mol) is in reasonable agreement with 
the ~(max) value of 7.2 x 10-8 mol for MP-8 binding proximal to the CDNB 
binding site at 22.5 ° C, inferred independently from microscopic rate constants 
(Section 4.7). This agreement provides good evidence that the MP-8/GST fast 
binding site and the MP-8 catalytic inhibition site are one and the same. 
For human erythrocyte GST p (an enzyme physically, catalytically and immuno-
chemically identical to the placental isoenzyme studied here [100,305]) Harvey and 
Beutler [110] have concluded that haemin inhibits the enzyme competitively. This 
conclusions was based on the observation that Dixon plots (at two CDNB 
concentrations) intersected at a point clearly above the concentration axis. 
However, the Dixon plots obtained for pure competitive inhibition are known to 
be identical to those for the mixed-type system (scheme 7) elucidated here [252]. 
Indeed, assuming mechanism (7) for the data of Harvey and Beutler [110], values 
for Ks and Ki could be obtained for the erythrocyte isoenzyme at 37 ° C. These 
values are shown in Table 3.8, and are in excellent agreement with the results 
obtained here for human placental GST. Accordingly, a detailed study of 
haempeptide interaction with human erythrocyte GST is being conducted in this 
laboratory. 
This investigation has shown that the MP-8-mediated inhibition of the steady-
state GST-catalysed conjugation reaction between GSH and CDNB is caused by 
MP-8 binding close to the CDNB interaction locus at the active-site. MP-8 and 
GSH affect each others interaction with the enzyme only minimally. These results 
are in excellent accord with the conclusions reached in the direct study of 
MP-8/GST binding kinetics (Section 4.7). Interestingly, it appears that whereas 
the binding of CDNB blocks that of MP-8 to the kinetically fast binding site 
(Section 4.7), incubation of the enzyme with MP-8 gives a complex which can still 




The simplest steady-state random sequential Bi Bi mechanism is sufficient to 
explain the reported non-hyperbolic kinetics of GST 3-3 [184] and those observed 
here for GSTs 3-3 and 3-4. This mechanism is consistent with all the kinetic, 
equilibrium binding and product inhibition data for these isoenzymes. Neither 
more complex steady-state mechanisms nor the superimposition of product inhibi-
tion or enzyme memory on the basic steady-state random sequential mechanism 
are necessary to account for the non-hyperbolic steady-state kinetics of the GSTs. 
Steady-state studies of other GST isoenzymes in this investigation have indicated 
that rat liver GST 2-2 is similarly best described by a steady-state random 
mechanism, while the hyperbolic kinetics observed for human placental GST 7f 
over wide ranges of substrate concentrations are consistent with a simpler rapid 
equilibrium random sequential Bi Bi mechanism. 
Isoenzymes 2-2, 3-3 and 7f, are representative of the Alpha, Mu and Pi categories 
of GST, respectively. The first two isoenzymes originate from rat liver, while 
GST 7f originates from human placenta. It remains to be established whether the 
kinetic mechanisms of the GSTs varies between species or isoenzyme classes. It 
would therefore be of value to investigate the nature and extent of the kinetic 
variability of GST isoenzymes, as it may be possible that kinetic mechanism may 
be a further criterion to distinguish GST isoenzyme categories. 
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The time-dependent inactivation of vanous GSTs, by a variety of different 
inactivating agents in unrelated experiments, follows a first-order rate law with a 
pseudo-first-order rate constant of approximately 2.5 x 10-3 s:1 The similarity 
between this value and that of the pseudo-first-order rate constant for the 
inhibition observed on dilution of concentrated solutions of GST suggests that 
these compounds are not inactivating agents per se. They merely facilitate an 
increase in the extent of salvation of the hydrophobic active-site. The proposed 
concept of salvation inactivation provides a simple explanation for the observation 
of various kinetically stable conformational states for different GST isoenzymes. 
These conformational states result from the interaction of GST with different 
inactivating agents and/or agents (such as GSH and foreign proteins) capable of 
providing partial protection from inactivation (see Section 4.5). 
This investigation has resulted in a much more rapid method for preparation of 
. MP~8, with higher yield and greater purity than possible by conventional methods. 
This was achieved by the optimisation of digest temperature and the introduction 
of steps designed to reduce contamination by non-MP-8 and non-haem impurities 
(Section 3.5). Clearly, HPLC procedures will have a major impact on studies of the 
haempeptides of cytochrome-c, by facilitating the rapid preparation in high yield 
of ultra-pure samples of these compounds. Further studies are at present in 
progress in this laboratory designed to exploit HPLC procedures in the optimisa-
tion and purification of haem-peptides MP-6, MP-7 and MP-9 in a time period 
of hours, rather than the days currently required. 
The nature of the binding sites for the non-substrate ligand MP-8 on human 
placental GST has been investigated here by examining the binding kinetics of 
MP-8 with the enzyme, and the effects of other substrate/non-substrate ligands 
on these kinetics (Section 4.7). The binding constants obtained in these 'extra-
thermodynamic' studies are assessed directly from microscopic rate constants and 
are therefore more directly interpretable than those obtained in the 
thermodynamic procedures usually employed to study GST /non-substrate ligand 
interactions. 
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Microperoxidase-8 (as an aqueous phase model for monomeric haemin) has be_en 
shown to bind to GST 1r at two sites, the first of which is identified with the 
hydrophobic bilirubin-binding locus, and the second being adjacent to the 
hydrophobic CDNB co-substrate binding site. These studies have therefore 
provided direct confirmation of the independence of the catalytic and bilirubin-
binding sites of GST 1r [306,308]. On the basis of the kinetic studies described, it is 
plausible that the kinetically more rapid site is at or close to the CDNB binding 
' site, while the slower binding site is the same as or close to the bilirubin binding 
site. From the fact that GSH has only a minimal effect on the interaction of MP-8 
with GST 1r, we can infer that the kinetically fast binding site is adjacent but not 
identical to the CDNB binding site. 
Furthermore, the direct kinetic binding studies reported here have proved valuable 
in allowing unambiguous interpretation of the inhibition by MP-8 of the steady-
state kinetic of the GSTs. The agreement between the MP-8/GST binding 
kinetics and the studies of the MP-8-mediated inhibition of the conjugation 
reaction (Section 4.8) provides strong evidence that the effect of MP-8 on 
catalysis occurs in the region of the CDNB locus at the active-site. 
The rate constant observed for the time course of MP-8-mediated GST inhibition 
(2.3 x 10-3 s-1), which was also found independently in the binding studies in 
Section 4.7, is identical to that found for dilutional inactivation of GST in buffer 
alone at pH 6.5, 22.5 ° C. The excellent agreement between these values probably 
signifies the occurrence of some type of solvational interaction at the catalytic site. 
It is conceivable that the binding of MP-8 close to the CDNB site may well 
increase the extent of salvation of the active-site with a concomitant increase in 
polarity and decrease in catalytic efficiency of the enzyme-catalysed conjugation 
reaction. 
Finally, this study has demonstrated that MP-8 is a potentially valuable analogue 
of monomeric haemin with which to investigate the nature and location of 
metalloporphyrin binding sites on the haem-binding GSTs. 
145 
APPENDIX 1 
Heme-peptide/Protein Interactions : The Binding of the Heme Octa- and 
Undecapeptides, Microperoxidase-8 and -11, to Human Serum Albumin. 
By 
Paul A Adams1*, Richard D Goold2 and Alfred A Thumser2 
1 MRC Biomembrane Research Unit 
Department of Chemical Pathology 
and 
2 Department of Medical Biochemistry 




Republic of South Africa 
* Author to whom all correspondence is addressed 
146 
Abstract : The interaction of the heme octa- (MP-8) and undeca- (MP-11) 
peptides derived from cytochrome-c with lipidated human serum albumin (HSA) 
has been investigated in aqueous solution. It is demonstrated that complex 
formation occurs in each case with a 1: 1 stoichiometry. CN- binding has been used 
to investigate the accessibility of the heme in each complex by comparison with 
CN- interaction with methemalbumin. A preliminary study of the kinetics of the 
Fe3+MP-8(11)/HSA interaction demonstrates a clear ligand size related effect 
on mechanism of interaction - an ad hoc explanation of which is given in terms of 
HSA existing as two non-converting conformers in solution. 
Introduction : The kinetics of the interaction between hemin and human serum 
albumin is more complex than observed for the corresponding reaction with 
hemopexin (1,2). Further complicating the interpretation of small ligand-binding 
studies with HSA has been the recent suggestion that HSA exists as two non- ( or 
very slowly inter-) converting conformers, which show different affinities toward 
hemin (2,3 ). These conformers ( designated I (one) and II (two)) are present in the 
ratio I/II "" 2 and bind deuteroporphyrin IX with Ka = 1.5 x 107 M-1 and 
4.9 x 108 M-1, respectively. 
Equilibrium binding studies of the hemin/HSA reaction ( 4) and comparative 
kinetic studies of metalloporphyrin/defatted HSA interaction (5) indicate one 
primary high-affinity HSA hemin-binding site; in addition, as many as 10 weaker 
binding sites - which also bind fatty acid residues - were observed per molecule of 
HSA. The primary binding site for the metalloporphyrin appears to be in a 
hydrophobic region of the protein, with limited access to the bulk aqueous solvent 
(6), a conclusion which is in agreement with kinetic studies of the reaction between 
monomeric hemin and lipidated HSA (7). This study interpreted the binding 
mechanism as a two stage process (1), 
Hm + HSA I Met·Hm·Alb (1) 
the first stage of the process is a reversible bimolecular reaction followed by a 
reversible unimolecular 'internalization' of the bound hemin to its transport site 
within the protein. 
As part of a general study of the interaction of pure heme-peptides derived from 
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cytochrome-c (the microperoxidases) and their derivatives, with a number of 
heme-binding proteins and apo-proteins, we have investigated the interaction 
between the heme octa- and undeca-peptides (MP-8 and MP-11, respectively) 
with lipidated HSA. 
Materials and Methods : Human serum albumin (HSA) crystalline and essentially 
globulin free obtained from fraction V, was from Sigma Chemical Co. MP-11 and 
MP-8 were prepared by peptic and tryptic digestion of horse heart cytochrome-c 
(Sigma Chemical Co.) and purified by HPLC as described elsewhere (8). Hemin 
was recrystallized by the chloroform-pyridine method, and stored under N2 at 4 ·c 
until required. Concentration of stock solutions were determined spectrophoto-
metrically using the following extinction coefficients; 
1.57 x 105 M-1 cm-1 
1.78 x 105 M-1 cm-1 
1.74 x 105 M-1 cm-1 
3.74 x 104 M-1 cm-1 
(pH 7.00, µ = 1); 
(pH 2.25); 
(Neat DMSO, 405 nm); 









The purity of the KCN used here was determined by AgN03 titration (13), and 
found to be 98.1 %. CN- ion concentrations at each pH were calculated according 
to 
where pKHCN = 9.21 in aqueous solution at 25°C (14). Kinetic data was fitted to 
mono-, bi- and tri-exponential functions 
Abs = ao + al ekl*t ( + ~ ek2*t + (~ ek3*t)) 
by a non-linear least-squares procedure (15) utilizing the Marquhardt algorithm, to 
give pseudo-first-order rate constants k1 *, k2 * and k/. 
Spectrophotometric studies were carried out using a Varian 635 or Hewlett 
Packard 8450A UV /Visible spectrophotometer. Absorbance linearity and accuracy 
were checked using pure p-nitrophenoxide anion as described elsewhere (16). 
The photometric stability of the 635 machine was reflected in an absorbance drift 
of < 2 x 10-4 AU3961409nm per hour after stabilization for 2 hr. Peak to peak noise 
level was < 3 x 10-4 AU. 
Results : Interaction of MP-8 and MP-11 with HSA : Addition of HSA (2 x 10-5 
mol dm-3) to MP-8 (2 x 10-6 mol dm-3) at pH 7.0, µ = 0.1, 25 ·c results in the 
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spectral and difference spectral changes shown in Fig. 1. Similar changes were 
observed when MP-8 was replaced by MP-11. 
Spectrophotometric titration of these concentrations of MP-8 and MP-11 at 
15°C was carried out by incubation of the heme peptides with varying concentra-
tions of HSA. Samples were removed and A409 - A396 in the difference spectrum 
(vs MP-8/11) was measured, results (corrected for HSA absorbtion) are shown 
for the MP-11/HSA system in Fig. 2. Values for the Hill parameter 'n' and the 
association constant were determined for the MP-11/HSA interaction as 
described previously (16), values of 0.99 and 5 (± 1) x 104 mor1 dm3 respectively 
being obtained. In the case of MP-8/HSA the stoichiometry was 1:1 but Ka was 
too high to measure using this technique. 
Binding of CN- by Fe3 + MP-& HSA and Fe3 + MP-ll·HSA : Addition of CN-
([KCN] = 1.8 x 10-3 mol dm-3 = [CN-] = 1 x 10-5 mol dm-3) to the Fe3+ MP-8· 
HSA conjugate gave no detectable change in the visible absorbtion spectrum of 
the conjugate over a period of 1 hr (Fig. 3b ). Difference spectroscopy showed that 
a very slight broadening of the soret peak was occurring with no shift in ).max• we 
do not attribute this change to formation of a CN-/hemeprotein complex. 
In contrast to this observed lack of CN- interaction with MP-8·HSA, addition of 
CN- to F e3 + MP-11 · HSA resulted in a soret shift from 406 to 408 nm with a 
decrease in intensity of"" 10% (Fig. 3c). Difference spectroscopy showed the final 
complex to be indistinguishable from CN-·Fe3+MP-11. The pseudo-first-order 
rate constant for the spectrophotometric change was 0.05 (± 0.008) s-1 at 25°C and 
this may be compared to a rate-constant for MP-11 dissociation from the HSA 
complex of 0.0108 s-1 measured at 15°C (see later). 
A comparative study of CN- binding was carried out using methemalbumin 
prepared by incubation of hemin (5 µM) with a 5 x 10-5 mol dm-1 solution of HSA 
at pH 7. Binding of CN- to this species was observed to occur slowly and in an 
accurately first-order manner. At constant pH the observed first-order rate 
constant was independent of [CN-] over a ten-fold concentration range (Fig. 4) 
implying that CN- is not reacting with methemalbumin directly in a second-order 
manner (such interaction would require - under the concentration conditions of 
the experiment - that kobs = kr[CN-] + kr) but with free hem.in as it dissociates 
from the methemalbumin complex. The pH variation of kobs was investigated in 
the region pH 7 to 7.6 and the results are shown in Fig. 5. Included in Fig. 5 is the 
limiting rate constant for the dissociation of hemin from methemalbumin (k_2 in 
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scheme (1)) determined in 37.5% DMS0/H20 by asymptotic kinetic studies of 
monomeric hemin HSA interaction (7), µ = 0.05. These values may also be 
compared to values of 0.005 s-1, obtained for the limiting dissociation rate constant 
of methemalbumin measured by interprotein transfer kinetics in 40% DMSO/ 
Buffer, µ = 0.3 (1) and 0.002 s-1 obtained by dithionite reduction of 
methemalbumin in 2.5 % DMSO/Buffer µ = 0.3 pH 7.0 (2). We conclude therefore 
that the spectral changes observed when CN- is added to F e3 + MP-11 · HSA and 
methemalbumin result not from CN- hemeprotein interaction, but from CN-
trapping of the heme(peptide) as it dissociates from the heme(peptide)·HSA 
complex. The complete lack of reaction observed on addition of CN- to 
Fe3+MP-8·HSA indicates that the dissociation of MP-8 from the final complex 
is exceedingly slow. 
Addition of CN- to Fe3 + myoglobin at similar concentrations to those used for the 
heme peptide/RSA complexes led to complete formation of the CN- Mb complex 
within 5 sec. Addition of CN- to Fe3+ cyt b5, where the Fe
3+ is inaccessible due to 
bis axial ligation by histidine imidazoles, gave no detectable change in either the 
spectrum or the difference spectrum. We thus conclude that the heme in the HSA 
complex is not accessible to small anionic ligands (see discussion). 
Dithionite reduction of Fe3 + MP-8/ll·HSA conjugates: Addition of small amounts 
of solid sodium dithionite to the Fe3 + MP-8/11 HSA conjugates produces typical 
Fe2+ hemoprotein spectra (Fig. 6). The CJ./ f3 band intensity ratio in each case is 
1.31, typical of low-spin hemoproteins with one strong axial ligand. Reduction of 
methemalbumin with solid sodium dithionite in 10% DMSO/aq. gave similar 
spectral changes, the CJ./ f3 ratio was again found to be 1.31. Addition of dithionite 
(at half the concentrations used for reduction of the protein complexes) to 
solutions of MP-8/11 of the same concentration as above gave immediate 
bleaching of the Soret peak (Fig. 6). 
Kinetics of the Fe3+ MP-8/ 11-HSA interaction: A preliminary investigation of the 
Fe3+MP-8(11)/HSA reaction kinetics has been carried out. The reaction of the 
heme-peptides with HSA was followed by UV /visible spectrophotometry with 
manual mixing, monitoring the absorbance increase at 409 nm or decrease at 
396 nm. Kinetic traces were obtained under conditions of [HSA]/[MP-8/11] > 10 
over a 7.5 fold range of HSA concentrations. Kinetic traces for the MP-8/HSA 
reaction were in all cases multiphasic, as can be seen in Fig. 7. Mono- and bi-
exponential functions did not adequately model the experimental curves. The 
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former was rejected on the basis of both non-random distribution of residuals, and 
gross underfitting of experimental data as assessed by the ratio 
estimated/observed precision (a* /a) (17). The biexponential fit, although giving 
a* /a= l, was rejected on the basis of non-random distribution of residuals (18) at 
the 95% level. A triexponential function was found in all cases to model the data 
adequately, i.e. without overfitting and with residuals distributed randomly at the 
95% level or greater. In the case of the MP-11/HSA interaction, a single 
exponential function was found to model the data adequately at all MP-11 
concentrations. Pseudo-first-order rate constants (k1 *, etc.) for the three phases of 
the MP-8/HSA reaction were obtained (with Std. Deviations) at all HSA 
concentrations. These are plotted in Figs. 8 a-c vs [HSA], included in Fig. 8a are 
the data for the first-order Fe3+MP-11/HSA interaction. 
Discussion: We have provided strong evidence in this study that both Fe3+ MP-8 
and Fe3+MP-11 interact with lipidated HSA with a 1:1 stoichiometry to form 
discrete heme-peptide protein complexes. Spectral features shown by the 
dithionite-reduced heme peptide protein complexes are consistent with a low spin 
state configuration, in which the iron (II) is coordinated by a strong donor axial 
ligand. 
The inability of CN- to interact with heme or heme peptide when bound to HSA 
shows that the iron porphyrin is not accessible to the approach of small ligands in 
these -complexes (see results), in agreement with our previous contention that the 
heme in methemalbumin is internalized by the protein for transport (7). Clearly 
such internalization can be rationalized from a physiological point of view as it 
would be undesirable to have protein-bound, and thus potentially enzymatically-
active heme circulating freely in vivo. 
The lack of CN- trapping observed with MP-8·HSA is consistent with a very low, 
or zero rate constant for dissociation from Fe3+MP-8·HSA. This is in agreement 
with both the very high Ka inferred from the titration data, and a limiting 
dissociation rate constant of < 0.00002 s-1 observed for formation of the final 
Fe3+MP-8·HSA complex (Fig. 8c and discussed later). 
The kinetics of the MP-11/HSA reaction conform to a simple second-order 
reversible mechanism as shown in (2). 
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Fe3+MP-ll + HSA Fe3+MP-ll·HSA (2) 
Rate constants for the process were evaluated from Fig. 8a, assuming (2), and give 
k1 = 4.40 (± 0.62) x 102 moi-1 s-1 dm3, k_1 = 0.0108 (± 0.001) s-1. This gives a 
Ka(calc) = 4.1 (± 0.5) x 104 moi-1 dm3, in good agreement with the value of 
Ka(app) = 5 (± 1) x 104 moi-1 dm3 calculated from the equilibrium binding studies. 
In contrast to the MP-11/HSA system, the MP-8/HSA reaction is by no means 
simple. The secondary plots of the rate constants k1 * and k2 * (Figs. 8a/b) suggest a 
mechanism of the type ( 1) found for methemalbumin. Indeed, if we evaluate the 
forward and reverse rate constants for each stage of the reaction using the data of 
Figs. lla/b values of k1 = 4.3 (± 0.4) x 10
2 moi-1 s-1 dm3, k_1 = 0.030 (± 0.003) s-1, 
k2 = 0.023 (± 0.004) s-
1, and k_2 = 0.002 (± 0.004) s-
1 are obtained, in addition a 
value of K1 ( = k1/k_1) of 1.9 x 10
4 moi-1 dm3 is obtained as a parameter from the 
transient state equation fit to Fig. 8b (7). 
Several points should be made at this stage for the MP-8/HSA kinetics: 
(i) k1 and k_1 are extremely close to the values obtained for the MP-11/HSA 
reaction above. 
(ii) K1 calculated from the ratio of the microscopic rate-constants k1/k_1 obtained 
from the data shown in Fig. 8a, is 1.4 (± 0.3) x 104 moi-1 dm3, again in good 
agreement with the value of 1.9 (± 0.5) x 104 mo1-1 dm3 obtained when K1 is 
evaluated as a parameter in the analysis of the k2 * vs concentration data (7) - this 
part of the model is therefore internally self consistent. 
The data of Fig. 8c suggest that a slow parallel reaction of the type (3) is also 
occurring, 
+ HSA Fe3+MP-8·HSA (3) 
k r 
rate constants evaluated for this model give kf = 70 (± 3) moi-1 s-1 dm3, 
kr < 0.00002 s-1, and we note that this implies a Ka > 3.5 x 106 moi-1 dm3, in 
agreement with the fact that the Ka is too high to measure by spectrophotometric 
titration. In addition lack of reaction of CN- with MP-8 when mixed with 
Fe3+MP-8·HSA is in good agreement with kr < 0.00002 s-1. 
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Before discussing the possible causes of the complex kinetics exhibited by the 
MP-8/HSA system, we will state, with reasons, several factors which we consider 
not to be responsible for the observed effects. 
(a) Aggregation : In common with most iron porphyrins in aqueous solution, 
MP-8/11 aggregate to form dimers and possibly higher oligomers (9). In the 
present system however, MP-8 is > 90% monomeric at 15 ° C and exhibits 
complex interaction kinetics while MP-11 (which shows a greater tendency to 
aggregation due to the a and c-NH2 groups of Valine and Lysine respectively) 
shows particularly simple second-order binding kinetics. We do not therefore 
consider aggregation to be responsible for the observed kinetics. 
(b) HSA preparation : The HSA preparation used in this study was shown by gel-
filtration to be > 95% monomeric, we do not consider therefore that the effects 
observed reflect binding kinetics for a heterogeneous population of HSA 
molecules (mopomer, dimer and trimer) each with different numbers (1, 2 and 3 
respectively) of identical primary binding sites. Indeed, this possibility is also 
rejected by the 1:1 binding stoichiometry observed for each hemepeptide/protein 
system. 
A simple ad hoc model, which allows a semiquantitative interpretation of the 
observed transition in binding kinetics as the ligand size increases from monomeric 
ferriprotoporphyrin IX to Fe3+MP-11 can be put forward if the HSA is 
considered to exist as two non-converting conformers, as referred to in the 
Introduction. The model assumes that the accessibility of ligands greater than a 
certain size is sterically more hindered in the HSA conformer II than in conformer 
I. Thus if ferriprotoporphyrin IX has equivalent access to each site, and if the 
interaction rate constants for the two parallel reactions are of the same order of 
magnitude, then the kinetics observed for two parallel reactions of type (1) will be 
a biphasic process (an average of the two reactions) as found previously (7). 
In the case of Fe3+ MP-11 we assume that access to the primary site of the second 
conformer-II is totally restricted, however the undecapeptide can react with 
conformer I to the intermediate stage of mechanism 1. Fe3 +MP-8 interaction 
kinetics would be expected to lie somewhere between these extremes, as is indeed, 
observed. Interaction with the less restricted primary site of conformer one 
proceeds at a rate comparable to Fe3+MP-11, followed by partial internalization 
by conformer one, to a final form in which the heme is closer to the protein surface 
than for methemalbumin. At the same time a parallel but much slower interaction 
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occurs with the more restricted site of conformer two, to give the intermediate (I in 
(1)) which again due to steric constraint by the octapeptide chain cannot 
internalize the Fe3+ MP-8, but in which the heme peptide is more tightly bound 
(kr = 0). 
While we accept that the above model is to a large extent conjectural it should be 
stressed that the experimental results presented here are reasonably explained e.g., 
the high Ka for Fe3+ MP-8/HSA observed after 48 hr incubation results from the 
fact that - due to the very low kr of (3) - eventually most of the Fe3+ MP-8 will 
bind to conformer two. The CN- binding studies, in which we have shown that 
reaction only occurs on dissociation of MP-11 from the intermediate (I) complex 
with conformer one, while no reaction is observed with the complex of MP-8 with 
conformer two (since k_1 = 0 s-
1 for this intermediate), suggest that the initial 
association reaction ( characterized by k1) consists of heme-binding in a pocket or 
cleft in the protein where the heme is inaccessible to small anionic ligands. We 
therefore consider that the heme in the intermediate I is not bound at the protein 
surface in a form freely accessible from the bulk medium, but is a heme-
inaccessible complex which rearranges via the k2 stage to a completely heme-
enveloped form. 
This concept is also supported by rate constant data for the initial association stage 
of heme protein binding processes, namely "I" formation characterized by k1. 
Literature data for the binding of carboxy hemes (assumed monomeric) to 
"globjn", prepared by the relatively harsh denaturing acid-acetone procedure, 
shows that k1 values are of the order of 10
7 - 108 moi-1 s-1 dm3 and approach the 
diffusion limiting value expected for sterically unconstrained binding (19). 
In the case of apo-myoglobin prepared by the mild acid-butanone procedure of 
Teale (20), k1 is found in the range 3-6 x 10
5 moi-1 s-1 dm3 for hemin (21,22), and a 
value of 1.6 x 106 moi-1 s-1 dm3 is obtained for monomeric MP-8 (Adams, Goold 
and Thumser, manuscript in preparation), indicating that while subject to more 
rigorous steric requirements than for denatured "globin", access to the primary 
binding site is equally facile for the iron porphyrin and heme peptide. In the case 
of HSA however, the binding rate constant k1 for monomeric hemin is 1.6 x 105 
moi-1 s-1 dm3 (in 37.5% DMSO/buffer) (7), while that for the heme peptides is a 
factor of = 4 x 102 less, indicating that the peptide moiety is now exercising a 
constraint on the process, possibly by restricting the depth to which the peptide-
bound heme can penetrate unrestricted into a "cleft" in the protein. We therefore 
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consider that the association rate constant k1 provides a useful index of the 
accessibility of the primary heme-binding locus. 
Detailed studies are at present being made of the kinetics of interaction of the 
suite of peptides MP-6, 7, 8, 9 and 11 (and their acetylated derivatives) with both 
HSA and bovine serum albumin in 20% DMSO/ Aqueous buffer, and 20% MeOH 
/ Aqueous buffer, in which the peptides are > 95% monomeric at a concentration 
of 10-6 mol dm-3. These studies are hoped to clearly demonstrate the size-
mechanism relationship postulated above. 
In conclusion we note that cytochrome-c ingested in mammalian diet is subject to 
initially peptic and subsequent tryptic digestion in the gut which will result in 
MP-11 and MP-8 formation. ff these soluble heme peptides cross the intestinal 
mucosa relatively easily then they will certainly become available for albumin 
transport in vivo, and may thus constitute a significant route by which iron enters 
the mammalian system. 
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Figure 1. Spectrophotometric changes observed on addition of HSA (2 x 10-5 mol dm-3) to MP-8 (2 x 10-6 mol dm-3). Inset shows the difference spectrum Fe3+MP-8·HSA vs Fe3+MP-8. Trace!! : MP-8; 
























Figure 3. Spectral changes observed in addition of CN- (1 x 10-5 
mol dm-3) to a) Fe3+MP-8, b) Fe3+MP-8·HSA and c) 
Fe3 +MP-ll·HSA (all 2 x 10-6 mol dm-3; [HSA) = 1 x 10-4 mol dm-3)_ 
In all cases (1) is the species prior to addition of CN- (2). In a) the 
spectrum (2) was obtained 10 s after CN- addition; in b) the spectra (1) 
and (2) are indistinguishable after 60 min, and inc) the spectrum (2) was 
obtained 1 min after addition of CN-. ). for 1 and 2 in a) are 396 nm max 











Figure 4. Variation of the rate constant for CN- interaction with methemalbumin (5 x 10-6 mol dm-3) over a range of CN- concentrations 
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Figure 6. The solid line spectrum !! shows the dithionite reduction 
product of the Fe3+MP-8·HSA complex!! (MP-8 :- 2 x 10-6 mo! dm-3 
+ HSA :- 1 x 104 mo! dm-3)_ The dashed line shows the spectrum 
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Figure 7. (a) Fitting of a single exponential function to Fe3+MP-8. 
HSA interaction data, [HSA] = 7.5 x Hf mol dm-3 [MP-8 = 1 x 10"0 
mo! dm-3, T = 15°C, pH= 7.0, J.L = 0.1. The solid line is: 
Abs = 83.78 - 30.05 e0·0078581 (b) As in a) but double exponential fit to 
data. Solid line is: Abs = 87.15 - 19.80 e0·02651 - 21.02 e0·003381 
(c) As in a) but triple exponential function fitted. Solid line is: 
Abs = 88.511 - 11.32 e0·0641t - 16.44 eo.oi4ot - 18.71 e0.0025t 
The Abs axis is in arbitrary units obtained on digitization. The inset show 
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Figure 8. (a) - (c) Secondary plots of the pseudo-first-order rate constants evaluated for the binding of MP-8(11) to HSA. The open circles in Fig. lla are the results for the MP-11/HSA reaction. The closed circles in all cases reflect the MP-8/HSA data. Concentration of MP-8 = 1 x 10-6 mol dm-3• 
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Abstract : The kinetics of the sequential peptide and tryptic hydrolysis of 
cytochrome-c to give the heme-peptides microperoxidase-11 (MP-11) and -8 
(MP-8) respectively has been investigated by HPLC and we demonstrate that 
MP-8 can be prepared from cytochrome-c to the point of lyophilization within 
4 hr. 
Introduction : The heme octapeptide, Microperoxidase-8 (MP-8), is potentially 
one of the most useful models for hemeprotein function yet developed, however 
relatively few studies of the chemistry of this compound have been published (see 
reference [1] and those contained therein). The barrier to its wider use appears to 
derive either from the tedious and inefficient column chromatographic methods 
used for preparation, or from its exceptional cost when obtained commercially. 
There is thus a real need for the development of optimised preparative schedules 
for these heme peptides species. 
We have recently reported [2] a rapid (,'°30 hr) efficient C,'°90% yield) HPLC-
based preparation of pure ( > 99%) MP-8, and have conducted preliminary 
studies on ligand binding and 0 2 activation at high pH using this pure preparation. 
In this note we report a systematic HPLC study of the kinetics of peptic and tryptic 
digestion of cytochrome-c and MP-11 and demonstrate the feasibility of preparing 
pure MP-8 (to the point of lyophilization) from cytochrome-c within 4 hr. 
Materials and Methods : HPLC procedures and buffers A and B were as described 
previously [2], minor changes in HPLC gradients are indicated where appropriate. 
Sixty mg of horse heart cytochrome-c was incubated with pepsin (1.6 mg) in 1 cm3 
buffer pH 2.1 for 15 min at 40°C. At this point 1 µl mixture was removed and 
diluted into 50 µl buffer A at 0°C. A further 1.6 mg pepsin was added at this point 
and the mixture was sampled at t = 30 min, 1 hr, 1.5 hr and 2 hr as previously 
described. Analytical HPLC of the reaction mixture indicated complete reaction 
after 2 hr (Fig. la), no further change in the HPLC trace occurred after 4 hr. 
The pH of the reaction mixture was adjusted to 5 with ammonia solution, and solid 
(NH4)iSO 4 added slowly to the stirred solution on ice. When the first traces of 
cloudiness were noted, saturated (NH4)iSO 4 solution was added dropwise to 
completely precipitate heme-containing material, leaving a colourless supernatant. 
The heme peptide(s) were centrifuged down, drained thoroughly, and redissolved 
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in 1 cm3 deionised water. The pH was adjusted to 8.5, and the sample incubated at 
the required temperature for 5 min. Trypsin (1.7 mg) was added, the solution 
mixed, and sampled at intervals of 15 or 30 sec into buffer A at 0°C. These 
samples were run isocratically on the HPLC (50% buffer A : 50% buffer B) 
monitoring the eluant at 396 nm. At the pH (:~3) and peptide concentrations 
(z 10-7 mol dm-3) used, both MP-8 and MP-11 have similar extinction 
coefficients (z 175 000), thus (peak height MP-8)/1(peak heights) is a convenient 
dimensionless measure of MP-8 formation. 
Results and Discussion : In agreement with the views of Petersen et al. [3] we 
attempt to minimise the number of concentration/purification steps in the 
preparation. It is clear from Fig. la that carrying out the pepsin digestion at 40°C 
dramatically reduces the incubation time from the total of '.::: 8-10 hr at 26 ° C used 
previously [2], to < 2 hr. Furthermore contamination by the other non-MP-11 
"stable" heme-containing peptides was reduced. While the incubation time 
reduction in part must reflect an Arrhenius-law rate increase, the fact that non-
MP-11 heme-containing contaminants are reduced suggests that the higher 
temperature may be causing the cytochrome-c to adopt a less ordered 
conformation, allowing the pepsin easier access to the MP-11 cleavage sites and 
resulting in a cleaner cyt-c -+ MP-11 conversion. 
Removal of non-heme-containing material prior to trypsin digestion (Fig. lb) is 
important. Non heme-containing amino acids and peptides account for :::::85% by 
weight of the pepsin digestion, and this material could certainly act as trypsin 
substrate or inhibitor. When the (NH4)iSO 4 precipitation step is carried out to 
remove hydrophilic peptide impurities (Fig. 1 b) the trypsin incubation at 40 ° C 
(Fig. 2) has a half life of '.:::80 sec, as opposed to :::::30 min for the non-precipitated 
sample. Our results are therefore in agreement with Peterson et al. [4] who, using a 
similar but slower (NH4)iSO 4 precipitation procedure, conclude that the 
precipitation step is in itself a considerable purification of MP-11. 
Conversion of MP-11 to MP-8 is quantitative ( > 98%) with no byproduct other 
than non-heme peptide. The kinetics adhere closely to a pseudo-first-order rate 
law (Fig. 3) indicating that (assuming Michaelis-Menten kinetics) [MP-11] < < 
Km for the process, Arrhenius behaviour is adhered to with Ea = 16.2 Kcal mole-1. 
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The MP-8 solution, which at this stage is > 95% pure in terms of heme-peptide, 
can be rapidly purified free from trypsin and MP-11 derived tripeptide by affinity 
chromatography (5) on a BSA-Sepharose 4B column (HSA-Sepharose 4B is not 
efficient due to the slow reaction of MP-8 with HSA). We have found it 
convenient to lyophilise the affinity column purified MP-8 at this stage and 
ultrapurify 1 mg samples by analytical HPLC to > 99% purity as required. 
Further studies are at present in progress designed to exploit HPLC procedures in 
the optimization and purification of heme-peptides MP-6, MP-7 and MP-9 in a 
time period of hours, rather than days as previously taken. 
Since the HPLC procedure for studying the kinetics of the MP-11 -+ MP-8 
digestion is independent of the amount of reaction mixture injected into the 
machine it represents a simple highly accurate technique for studying the kinetics 
of the reaction of trypsin with its natural substrate - peptides. The fact that 
reaction can be monitored at 396 nm means that interference from non-heme 
peptides is absent. Thus the HPLC study suggests that both pepsin and trypsin 
digestion be performed at 40°C, and recommends the MP-11-+ MP-8 conversion 
as a convenient reaction to study the peptidase activity of trypsin. 
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Figure 2. Kinetics of the trypsin catalysed MP-11-+ MP-8 conversion 
monitored at 396 nm, pH 8.5, Ratio of MP-11:trypsin was 5:1 by weight 
(assuming quantitative conversion of cyt-c to MP-11). Digestion 
temperatures a) 40°C, b) 30°C, c) 20°C, d) l0°C. The inset shows the 
MP-11-+ MP-8 conversion at t = 0 and t = 1800 s after addition of 
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